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ABSTRACT 
 
A series of experiments were designed to study alternative estrus synchronization 
and resynchronization protocols to facilitate the use of artificial insemination in cattle.  
 
Studies were conducted to study the effects of estradiol cypionate (ECP) on 
follicular dynamics, time of ovulation, and pregnancy rate to timed-AI (TAI) in CIDR-
based protocols. Although administration of 1 mg ECP did not result in synchronous 
follicular wave emergence, a dose of 0.5 mg ECP synchronized LH release and ovulation. 
Administration of ECP 24 h after CIDR removal resulted in acceptable pregnancy rate. 
However, treatment with ECP at CIDR removal resulted in acceptable pregnancy rate 
only if follicular wave emergence was synchronized with estradiol-17β (E-17β).  
 
The efficacy of two estradiol preparations (5 mg of E-17β or estadiol valerate; 
EV) and reduced doses of EV on CL and ovarian follicular dynamics and superovulatory 
response were examined. When doses of 5 mg were compared, EV treatment resulted in a 
more variable interval to follicular wave emergence and a lower superovulatory response 
than E-17β. However, EV at a dose of 1 or 2 mg was efficacious in synchronizing follicle 
wave emergence in CIDR-treated cattle. 
 
Pregnancy rates were compared following TAI in cattle given a new or previously 
used CIDR and injections of estradiol, with or without progesterone, to synchronize 
follicular wave emergence. Pregnancy rate following TAI did not differ between cattle 
treated with a new or once-used CIDR, but pregnancy rate was lower in cattle treated 
 iii
with one or two twice-used CIDR. The addition of an injection of progesterone to the 
estradiol treatment at CIDR insertion did not enhance pregnancy rate  
 
The efficacy of progestins (used CIDR and MGA), and E-17β, ECP, GnRH, or 
progesterone treatment for resynchronization of estrus in cattle not pregnant following 
TAI were investigated. Progestin treatment resulted in the majority of nonpregnant 
heifers detected in estrus over a 4-d interval. Conception rates were higher in heifers 
resynchronized with a once-used CIDR than with MGA. GnRH at CIDR insertion 
synchronized follicular wave emergence in cows, but did not increase conception rate in 
heifers. E-17β at CIDR insertion (1.5 mg) and removal (0.5 mg) resulted in decreased 
pregnancy rate following TAI. In summary, protocols described in this thesis resulted in 
acceptable pregnancy rates following TAI and resynchronization of previously 
inseminated heifers with progestins resulted in variable estrus and pregnancy rates. 
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1.0 GENERAL INTRODUCTION 
 
 Our knowledge of the physiology and endocrinology of reproduction in domestic 
animals has increased noticeably over the past few years. This has led to a tremendous 
increase in the development of biotechnological procedures for the control of farm animal 
reproduction. Several methods for synchronizing the estrous cycles of cattle, and other 
farm animals have been developed. Embryo transfer procedures have been improved; 
embryos are now produced by fertilization in vivo or in vitro. Further, sexing of embryos 
and methods for separating X- and Y-bearing sperm are available. Transgenic and cloned 
farm animal offspring have been produced by nuclear transfer techniques. These 
biotechnological procedures, along with intense selection to identify genetically superior 
females and males could result in a great impact on the genetic improvement of dairy and 
beef herds. However, the beef industry, in particular, has been slow to adopt these 
technological advances and none are currently having much impact on animal agriculture 
worldwide.  
 
Artificial insemination (AI) has been widely used for breeding dairy cattle, and 
has become one of the most important techniques for the genetic improvement of farm 
animals. Almost 90% of dairy producers in North America use AI as a method to breed 
cattle, compared to only 5% of beef producers (NAHMS, 1997). One of the main reasons 
for the low adoption of AI in the beef industry is that estrus detection is required. Estrus 
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detection is labour and time consuming, especially in large beef herds in extensive 
management. In addition, the efficiency of estrus detection has been reported to be ≤ 50% 
in dairy herds across North America. Poor estrus detection is associated with low 
pregnancy rates following AI, which in turn is the principal factor limiting cattle 
productivity and profitability. Therefore, improvements in the synchronization of estrus 
and ovulation, allowing for timed-AI (TAI) with a high success rate, will enable heifers 
and cows to be artificially bred to genetically superior sires, and lead to optimal calving 
intervals and greater profits for cattle producers. 
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2.0 REVIEW OF LITERATURE 
 
2.1 Overview of the estrous cycle 
 
Antral follicle growth during the estrous cycle in cattle occurs in wave-like 
patterns (Rajakoski 1960; Pierson and Ginther, 1984; Pierson and Ginther, 1987; Savio et 
al., 1988; Sirois and Fortune, 1988; Ginther et al., 1989a; 1989b; Knopf et al., 1991). 
Most cattle have been shown to have two or three follicular waves per cycle. The 
proportions of animals with two or three follicular waves have varied among reports 
(Ginther et al., 1989b; Sirois and Fortune, 1988; Savio et al., 1990; 1993). The first 
follicular wave typically emerges on the day of ovulation (Day 0) with no difference 
between two or three follicular wave cycles. The second follicular wave emerges 1 or 2 d 
earlier in three-wave cycles (Day 8, 9 or 10) than in two-wave cycles, and in three-wave 
cycles, a third follicular wave emerges on Day 15 or 16. It is not clear why some cows 
have two follicular waves per cycle while others have three waves; however, it has been 
shown that follicular wave pattern may be affected by the energy level in the ration 
(Murphy et al., 1991) and may change from one estrous cycle to the next (Price and 
Carrière, 2004).  
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Two recent studies suggested that conception rate to first service was reduced in beef and 
dairy cattle in which the ovulatory follicle came from the second compared to the third 
follicular wave during the estrous cycle (Ahmad et al., 1997; Townson et al., 2002). In 
another study, pregnancy rate did not differ among lactating dairy cows with different 
wave patterns of follicle development, although interval from follicular wave emergence 
to estrus was negatively related to fertility (Bleach et al., 2004). 
 
Follicular wave emergence has been defined as synchronous growth (within 1 to 2 
d) of 8 to 41 small follicles (3 to 5 mm in diameter; Ginther et al., 1989a, 1996a). Within 
3 d of initiation of a wave, one follicle is selected as the dominant follicle. This follicle 
continues to grow and the others in its cohort (subordinates) regress; this event is called 
deviation or selection (Ginther et al., 1996a). The time of deviation is further defined as 
the beginning of the greatest difference between the two largest follicles in a wave; this 
occurs on average 2.8 d after emergence, when the future dominant follicle was 8.5 mm 
in diameter. The dominant follicle eventually regresses or ovulates depending on the 
endocrine conditions during its tenure of dominance.  
 
During the late luteal phase (Day 16 to 18 of the estrous cycle), prostaglandin F2α 
(PGF) is released in a pulsatile fashion from the nongravid uterus and passes through a 
local utero-ovarian vascular pathway to the ovary and causes luteal regression (Ginther, 
1974). The dominant follicle present at the onset of luteolysis will become the ovulatory 
follicle, and emergence of the next follicular wave is delayed until the day of the ensuing 
ovulation.  
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Interovulatory intervals in two-wave cycles have been shown to be shorter than 
those of three-wave cycles (20.4 ± 0.3 versus 22.8 ± 0.6 d; Ginther et al., 1989b). Hence, 
the 21-d estrous cycle in cattle is rarely found in nature; it is an average between two- and 
three-wave cycle animals. 
 
2.2 Endocrine regulation of antral follicles 
 
2.2.1 Growth pattern of ovarian antral follicle development 
 
 The growth pattern of ovarian antral follicle development has been arbitrarily 
divided in two distinct phases (Mihm and Bleach, 2003). A ‘slow’ growth phase from 
acquisition of an antrum to a size detectable by ultrasonographic examinations (3 to 5 
mm) and the ‘fast’ growth phase from the time of follicular wave emergence to atresia or 
ovulation of the dominant follicle. Growth of ovarian antral follicles from acquisition of 
an antrum (0.3 mm) to 3 to 5 mm in diameter (‘slow’ phase) takes more than 30 d 
(Lussier et al., 1987). In cattle, it is still unclear whether this stage of follicle 
development is possible without follicle stimulating hormone (FSH). However, there is 
evidence that FSH receptors are present (Xu et al., 1995; Bao and Garverick, 1998) and 
functionally active (McNatty et al., 1999) during preantral and early antral development 
in the bovine species, suggesting that FSH may have a role in the early stages of 
follicular development. In addition, murine follicles that are unable to respond to FSH do 
not progress from preantral stages to early antral stages of development (Abel et al., 
2000). Conversely, it is well known that follicles in the ‘fast’ phase are absolutely 
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dependent on adequate concentrations of both FSH and luteinizing hormone (LH; 
reviewed in Mihm and Bleach, 2003).  
 
2.2.2 Recruitment of follicular waves 
 
As mentioned earlier, follicular wave emergence has been defined as synchronous 
growth of several small follicles (3 to 5 mm of diameter). The emergence of each 
follicular wave is preceded by a transient increase in FSH in cycling cattle (Adams et al., 
1992a; Sunderland et al., 1994; Gong et al., 1995; Bodensteiner et al., 1996), in calves 
(Evans et al., 1994; Adams et al., 1994), during pregnancy, and in the postpartum 
anestrous period (Ginther et al., 1996b). Suppression of the FSH increase, with either 
bovine follicular fluid (Turzillo and Fortune, 1993) or exogenous estradiol (Bó et al., 
1995a,b) prevents new wave emergence, while follicular wave emergence will occur 
when FSH is concurrently administrated (Bergfelt et al., 1994a). On average, all follicles 
in a wave (FSH-dependent) grow at a similar rate and produce considerable amounts of 
systemic FSH suppressants (e.g. inhibin and estradiol) that are responsible for the decline 
of FSH to basal levels. When FSH declines, FSH-dependent follicles begin to show 
characteristic follicular fluid changes leading to atresia (Mihm et al., 1997; Austin et al., 
2001). Administration of physiological amounts of FSH during the FSH decline prevents 
characteristic changes in follicular fluid and atresia of subordinate follicles (Adams et al., 
1993a; Mihm et al., 1997). Only the selected follicle (i.e. the dominant follicle) is capable 
of growing in a low FSH environment because it acquires LH dependency and has a 
competitive advantage over follicles destined to become atretic (which are still dependent 
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on FSH). However, basal FSH concentrations are still essential for the dominant follicle 
to maintain several follicular functions, such as aromatase activity, and insulin-like 
growth factor (IGF), activin and inhibin synthesis (Badinga et al., 1992; Mihm et al., 
1997; Austin et al., 2001).  
 
2.2.3 Selection of follicles for dominance 
 
The future dominant follicle has to gain the capacity to survive during a decline in 
FSH by continuing to grow and produce estradiol, while granulosa cells in subordinate 
follicles undergo apoptosis (Austin et al., 1997). As explained earlier, the term follicular 
deviation or selection usually refers to the stage of the follicular wave when a perceptible 
difference in size is observed between the dominant follicle and its largest subordinate. 
However, it is likely that selection of the future dominant follicle is a progressive process 
and that the initial stages of selection occur even before the ‘fast’ growth phase of follicle 
development. Based on ultrasonographic studies in heifers, it has been proposed that the 
future dominant follicle emerges 6 to 12 h earlier than the future largest subordinate 
follicle (Ginther et al., 2001; Jaiswal et al., 2004).  
 
One of the most significant characteristics of the dominant follicle is the increased 
production of estradiol; this is associated with a termination in the rise of FSH and with a 
return of FSH to basal levels (Ginther et al., 2000). Concentrations of estradiol in 
follicular fluid were much higher in dominant follicle isolated on Day 5 of the estrous 
cycle than in recruited follicles on Day 3, whereas subordinate follicles on Day 5 had 
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concentrations of estradiol similar to recruited follicles on Day 3 (Fortune, 1994; Badinga 
et al., 1992; Fortune et al., 2001). Bao and Garverick, (1998) showed that dominant 
follicles have higher levels of messenger ribonucleic acid (mRNA) for LH receptors (in 
theca and granulosa cells) and enzymes involved in androgen and progestin synthesis 
(cytochrome P450 side chain cleavage [P450scc], cytochrome P450 17alpha-hydroxylase 
[P450c17], cytochrome P450 aromatase [P450arom], 3beta-hydroxysteroid 
dehydrogenase [3β-HSD], and steroidogenic acute regulatory protein [StAR]), than 
recruited follicles. Although it is not clear why granulosa cells of dominant follicles attain 
LH receptors, it has been hypothesized that this allows it involves a shift from FSH- to 
LH-dependence and an increase in the capacity for estradiol production (Ginther et al., 
2001).  
 
Another still unknown paradigm is why only one follicle is selected to be 
dominant from a group of similar follicles. There is increasing evidence that the IGF 
system may play a critical role in selection of the dominant follicle (Fortune et al., 2001). 
Insulin-like growth factors sustain follicular growth by stimulating granulosa cell 
proliferation and synergizing with gonadotrophins to promote differentiation of both 
theca and granulosa cells (Spicer and Echternkamp, 1995). Therefore, follicles within the 
cohort with higher follicular fluid concentrations of available IGF are more likely to 
become dominant. Interesting, changes in components of the intrafollicular IGF system, 
particularly concentrations of low molecular weight IGF-binding proteins (IGFBP) seem 
to be closely related to selection of the future dominant follicle (Fortune et al., 2001). In 
this regard, Mihm et al. (2000) reported that, based on bovine follicular fluid samples 
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taken on Day 1.5 of the first follicular wave, the follicle with the lowest concentration of 
IGFBP-4 always became the dominant follicle. In addition, Armstrong et al. (1998) 
reported that IGFBP-2 was lower in the dominant follicle compared to subordinate 
follicles. 
 
In high producing dairy cows, the mechanism of follicle deviation seems to be 
disrupted; the incidence of double ovulation was shown to be three times greater in high 
than in low producing cows (Fricke and Wiltbank, 1999). Lactating dairy cows with high 
milk production have increased blood flow to the liver, which increases steroid hormone 
metabolism (Wiltbank et al., 2000) resulting in lower levels of steroid hormones in the 
peripheral circulation than dairy heifers (Sartori et al., 2004; Wolfenson et al., 2004). 
Wiltbank et al. (2000) proposed that as a result of decreased circulating estradiol 
concentrations, FSH remains elevated allowing more than one follicle to become 
dominant. However, the possibility of involvement of additional mechanisms cannot be 
dismissed. In this regard, double ovulations were more frequently observed in cows with 
three (28.6%) than with two (1.7%) follicle waves per estrous cycle (Bleach et al., 2004), 
and if luteolysis was induced at the time of follicular wave emergence (Mussard et al., 
2003) indicating that progesterone concentrations and LH pulsatility may also play 
important roles in the mechanisms of dominant follicle selection.  
 
After the decline in circulating FSH, LH secretion seems to be critical to maintain 
dominant follicle viability. Treatment with exogenous progesterone during early 
metestrus has been shown to suppress the diameter of the first-wave dominant follicle in 
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a dose-dependent manner (Adams et al., 1992b; Burke et al., 1994), possibly by 
suppressing LH pulse frequency (Ireland and Roche, 1982; Goodman and Karsch, 1980; 
Price and Webb, 1988). Administration of LH pulses prolongs the dominance of the first 
wave dominant follicle in cyclic cows (Taft et al., 1996) and causes increased estradiol 
secretion in postpartum anestrous beef cows (Duffy et al., 2000). Moreover, low 
progesterone concentrations in cattle treated with progestagens resulted in increased LH 
pulse frequency, which in turn prolonged the dominance of the dominant follicles 
destined to ovulate (Savio et al., 1993; Stock and Fortune, 1993). 
 
Continued suppression of LH (as a consequence of luteal-phase progesterone 
secretion) causes the dominant follicle to cease its metabolic functions and eventually it 
undergoes atresia. Soon after the decrease in its metabolic functions, there is an increase 
in circulating FSH concentrations, and the emergence of a new follicular wave, with the 
ovarian follicle cycle repeating itself. However, at the end of the luteal phase, a reduction 
in circulating progesterone concentration results in increased LH pulse frequency and 
increased estradiol secretion, which are responsible for the preovulatory surge of 
gonadotrophins and ovulation of the preovulatory follicle (Nett et al., 1984; Bryner et al., 
1990; Nett et al., 2002). 
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2.3 Estrus synchronization  
 
Effective synchronization of estrus in beef and dairy cattle has been a goal of the 
cattle industry since AI techniques first became available. In the last 60 years, many 
hormonal or technical approaches have been evaluated to minimize the need for estrus 
detection in cattle. Prostaglandin F2α and its analogues are the most common treatment 
used to shorten the luteal phase and synchronize estrus, thereby reducing the need for 
estrus detection. Progestagens have been used to extend the luteal phase, resulting in 
synchronous estrus after progestogen withdrawal. More recently, gonadotrophin releasing 
hormone (GnRH) and estradiol alone or in combination with progesterone have been 
used in estrus synchronization programs. These will be described in control of follicular 
wave patterns.  
 
2.3.1 Estrus synchronization with prostaglandin 
 
The effectiveness of PGF in causing luteolysis and inducing estrus and ovulation 
in cattle is well established. The luteolytic properties of exogenous PGF in cattle have 
been reported since 1972 (see Seguin 1980). Three important factors regarding PGF as a 
treatment for estrus synchronization must be considered. Firstly, it is necessary that a 
functional corpus luteum (CL) be present for PGF to be effective. Early postpartum 
anestrous cows and prepuberal heifers are not good candidates for PGF protocols because 
they will not have a functional CL. Secondly, the CL prior to Day 5 after ovulation is 
nonresponsive to a single injection of PGF (Momont and Seguin, 1982; Wiltbank, 1997). 
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The unresponsiveness of the early CL is apparently not due to a lack of PGF receptors; 
early and late CL were not different with respect to numbers and affinity of PGF 
receptors (Sakamoto et al., 1994; 1995; Wiltbank et al., 1995). Although responsiveness 
increases progressively from Day 6 until Day 8 of the estrous cycle (Momont and Seguin, 
1982; 1984; Kastelic et al., 1990a), there is a difference, in term of early CL response to 
PGF treatment, between heifers and cows (Wiltbank et al., 1997). The CL in cows has 
been reported to be unresponsive until Day 6-7 post-estrus, whereas the CL in heifers was 
responsive on Day 5 (Wiltbank et al., 1997). To overcome this problem, a double-
injection system of two doses of PGF separated by 11 (in heifers) to 14 d (in cows) is 
usually used to ensure that a high proportion of animals have a responsive CL at the time 
of the second PGF treatment. Although the double dose approach reduces estrus 
detection, it may result in reduced conception rates, particularly in those animals 
responding to the first PGF treatment (Xu et al., 1997). Low progesterone concentrations 
prior to the second PGF treatment seems to account for the reduced fertility since the 
addition of a CIDR insert restored fertility (Xu et al., 1997). The third factor to take into 
account when using PGF, is the great variability in the interval from treatment to 
behavioral estrus and ovulation among treated animals. In the presence of a responsive 
CL, estrus can be induced by a single administration of PGF; however, the interval to the 
resulting estrus and ovulation is dependent on the stage of development of the dominant 
follicle at the time of treatment (Kastelic et al., 1990a; Kastelic and Ginther, 1991).  
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2.3.2 Estrus synchronization with progestagens 
 
Since the discovery that progesterone inhibits estrus and ovulation (Christian and 
Casida, 1948; Ulberg et al., 1951), administration of progesterone or progestagens have 
used in synchronization schemes to improve reproductive management (Trimberger and 
Hansel, 1955; Hansel et al., 1961; Wiltbank et al., 1967). Relatively long durations of 
progestogen treatment (i.e., ≥ 14 d), which allowed for spontaneous occurrence of 
luteolysis before treatment withdrawal, resulted in synchronous estrus, but reduced 
fertility (Trimberger and Hansel, 1955; Hansel et al., 1961; Wiltbank et al., 1967). 
However, it was not realized until the use of transrectal ultrasonography and endocrine 
analysis (approximately 30 years later) why fertility is compromised in cattle with 
spontaneous luteal regression prior to progestagen withdrawal (Sirois and Fortune, 1990; 
Savio et al., 1993; Stock and Fortune, 1993). Essentially all commercially available 
progestagen treatments do not produce progesterone/progestagen concentrations that are 
comparable to that during luteal phase. Although  ‘low’ progestagen concentrations will 
inhibit behavioural estrus and the preovulatory LH surge, they are insufficient to inhibit 
normal pulsatile LH secretion, which will stimulate continued follicular growth. Follicles 
with prolonged growth profiles (“persistent follicles”) have been extensively described in 
the literature (Sirois and Fortune, 1990; Savio et al., 1993; Stock and Fortune, 1993; 
Revah and Butler, 1996; Kinder et al., 1996; Kojima et al., 2003).  
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Cattle that ovulated a persistent follicle had lower pregnancy rates than those that 
ovulated a “healthy” dominant follicle (Savio et al., 1992; Stock and Fortune, 1993; 
Mihm et al., 1994). Although fertilization rate and mean number of accessory sperm in 
the zona pellucida was not affected in beef cows that ovulated a persistent follicle, fewer 
embryos reached ≥ 16-cell stage of development (Ahmad et al., 1995). Death of embryos 
in cattle ovulating a persistent follicle may be due to premature activation of the oocyte 
(Revah and Buttler, 1996; Mihm et al., 1999), or high and prolonged exposure to 
estrogen, which could alter the pattern of oviductal secretory proteins (Binelli et al., 
1999). The uterine environment is unlikely to be inappropriate since pregnancy rate 
following transfer of embryos 7 d after estrus did not differ from cows that ovulated a 
normal dominant follicle (Wehrman et al., 1996b).  
 
Before widespread use of ultrasonography, several scientists attempted to improve 
the fertility of progestagen-treated animals by shortening the duration of progestagen 
treatment. Pharmacological doses of estradiol (Wiltbank and Kasson, 1968; Mauleon, 
1974) or PGF (Wishart, 1974; Thimonier et al., 1975) were given in combination with 
‘short’ progestagen treatment to induce luteolysis. Estrus synchrony and fertility 
responses improved, but remained quite variable (Wishart, 1974; Thimonier et al., 1975).  
 
In summary, estrus synchronization schemes involving the use of PGF, 
progestagens or combinations of both fairly predictably induce luteolysis and are able to 
induce estrus at a desired time, however, variability in interval to estrus and fertility 
remains an impediment to their successful use. Moreover, all these schemes still require 
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that estrus detection be performed. Hence, alternative approaches to controlling ovarian 
follicle growth must be undertaken to overcome the problems associated with the 
development of persistent follicles or the occurrence of asynchronous estrus and 
ovulation. 
 
2.4 Control of ovarian follicle dynamics during diestrus 
 
2.4.1. Removal of the suppressive effect of the dominant follicle: Physical methods of 
removal  
 
Physical methods of removing the suppressive effect of the dominant follicle have 
included electrocautery and transvaginal ultrasound-guided follicle ablation. 
Cauterization of the dominant follicle of heifers on Days 3 or 5 (day of ovulation = Day 
0) resulted in follicular wave emergence in 2.5 ± 0.4 and 2.0 ± 0.3 d after cauterization, 
respectively (Ko et al., 1991). Dominant follicle cauterization caused early emergence of 
wave 2 and increased the incidence of 3-wave interovulatory intervals when compared to 
controls. Similarly, Adams et al. (1993b) found that the emergence of wave 2 was 
hastened (Day 6.3 versus 9.3) and more heifers had three waves per interovulatory 
interval (5/6 versus 2/7) when the dominant follicle was cauterized on Day 3 of the 
estrous cycle. 
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Transvaginal ultrasound-guided follicle ablation for the synchronization of 
follicular wave emergence was first reported by Bergfelt et al. (1994b). Ablation of all 
follicles ≥ 5 mm in diameter at random stages of the estrous cycle in heifers resulted in a 
transient increase in FSH and synchronous emergence of a new follicular wave 
approximately 2 d after ablation. Subsequent experiments demonstrated that FSH 
treatments given 1 d following follicle ablation resulted in superovulatory responses that 
were similar to that achieved when FSH was given at the expected time of emergence of 
the second follicular wave (Bergfelt et al., 1997) or hormonal-induced follicular wave 
emergence (Baracaldo et al., 2000). Thus, transvaginal ultrasound-guided follicle 
aspiration combined with PGF and LH or GnRH treatment was successfully used to 
synchronize ovulation in cattle (Bergfelt et al., 1994b; Brogliatti et al., 1998). Although 
physical methods of follicle ablation resulted in a very precise control over the initiation 
of a new follicular wave, they are not very practical approaches to implement in the field.  
 
2.4.2 Gonadotrophin releasing hormone (GnRH)  
 
Administration of GnRH produces acute increases in LH and FSH (Kaltenbach et 
al., 1974; Chenault et al., 1990; Martínez et al., 2003b), with the magnitude depending on 
stage of the follicular wave (Kastelic and Mapletoft, 1998). The LH surge is induced, on 
average 2 h after GnRH treatment (Chenault et al., 1990; Martínez et al., 2003b), which 
in turn will induce ovulation in those animals that have a dominant follicle ≥ 9 mm in 
diameter (Martínez et al., 1999). It was also proposed that either ovulation or 
luteinization of a dominant follicle after GnRH treatment was followed by emergence of 
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a new follicular wave (Macmillan and Thatcher, 1991). However, new wave emergence, 
which usually occurs within 2 d (Twagiramungu et al., 1995b), was synchronous only if 
ovulation of the dominant follicle was induced (Martínez et al., 1999). Since follicular 
waves emerge approximately every 7 to 10 d (see overview of the estrous cycle), 
spontaneous emergence of a new wave (in the absence of ovulation) could occur at 
approximately the same time as the emergence of a new wave following GnRH-induced 
ovulation in some heifers (Martínez et al., 1999). Although the occurrence of 
luteinization of follicular wall cells following GnRH administration in cyclic animals has 
not been adequately studied, luteinization has been observed following treatment of 
follicular cysts with GnRH (Kesler et al., 1981). 
 
Several factors may determine whether ovulation occurs in response to GnRH 
treatment. The most important is likely to be the day of the estrous cycle (Martínez et al., 
1999; Moreira et al., 2000) i.e., progesterone concentrations and the size of the dominant 
follicle at the time of GnRH administration. The former is likely to affect the magnitude 
of LH release (Di Gregorio and Nett, 1995) and the latter is related to attainment of LH 
receptors on granulosa cells (Xu et al., 1995). Although ovulatory response to an 
injection of GnRH was higher on Days 5 and 15 to 18 of the estrous cycle (dominant 
follicle ≥ 10 mm; Moreira et al., 2000), ovulation did not occur consistently in heifers 
expected to have a dominant follicle > 10 mm diameter at the time of treatment (Martínez 
et al., 2003b). In addition, Pursley et al. (1995) reported that ovulation occurred in 
approximately 55.0% of GnRH-treated heifers versus 85.0% of GnRH-treated lactating 
dairy cows, regardless of the stage of the estrous cycle. Hence, following GnRH 
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treatment, ovarian follicle development is not effectively controlled in heifers as 
compared to cows. In addition, dose (Mihm et al., 1998) and commercial preparation 
(Martínez et al., 2003b) have been reported to affect the ovulatory response to GnRH 
treatment during diestrus in cattle.  
 
2.4.3 Luteinizing hormone (LH) 
 
Because progesterone has a negative effect on pituitary LH release, exogenous 
LH administration during diestrus is expected to result in a greater ovulatory response 
than GnRH administration. Treatment of beef heifers with porcine LH (pLH) at precise 
stages of the first follicular wave (Days 3, 6, or 9 after spontaneous ovulation) resulted in 
ovulation in 78% of heifers (Martínez et al., 1999), which was higher than following the 
administration of GnRH in the same study (56%) or that reported by Pursley et al. (1995) 
in dairy heifers. Although this finding would suggest that LH might be more effective in  
synchronizing follicular wave emergence in heifers than GnRH, LH has not been widely 
used. The main reason may be cost, because the price of pLH (Lutrophin-V) is double 
that of commercially available GnRH preparations, even at half of the recommended dose 
of 25 mg Armour. One study investigated the ovulatory response to different doses of 
pLH to induce ovulation of a dominant follicle in beef heifers. Oswald et al. (2000) 
reported that the proportion of heifers, with a dominant follicle ≥ 9 mm, that ovulated to 
an LH treatment was 66.6, 100, and 71.4% for doses of 5, 10, and 25 mg Armour of pLH, 
respectively. This result suggested that the dose of Lutropin-V could be reduced to 5 mg 
without significantly affecting its efficacy in inducing ovulation of a dominant follicle. 
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However, in another experiment, Ambrose et al. (2004) reported that none of the Holstein 
heifers receiving 5 mg of pLH ovulated, compared to 50% of those treated with 100 μg of 
GnRH. Therefore, more studies are needed to further examine the efficacy of reduced 
doses of pLH to control ovarian follicular dynamics. 
 
2.4.4 Human chorionic gonadotropin (hCG) 
 
Human chorionic gonadotrophin may also be used to synchronize follicular wave 
emergence. Ovulation and formation of an accessory CL following administration of 
various doses of hCG during diestrus have been reported (Price and Webb, 1989; 
Rajamahendran and Sianangama; 1992; Fricke et al., 1993; Sianangama and 
Rajamahendran, 1996; Schmitt et al., 1996a,b; Diaz et al., 1998). However, few studies 
have characterized ovarian follicular dynamics following hCG treatment (Sianangama 
and Rajamahendran, 1996; Diaz et al., 1998). Administration of hCG (1000 international 
units; IU) to lactating Holstein cows at the time of insemination (Day 0), Day 7, or Day 
14 resulted in ovulation in 37.5, 77.7, and 44.4% of cows, respectively (Rajamahendran 
and Sianangama, 1992). In another experiment (Sianangama and Rajamahendran, 1996), 
ovulation of Day-7 follicles occurred in 100% of hCG-treated cows, and the time of 
emergence of the second wave of follicular growth was advanced compared to that of 
control cows (10.8 ± 0.3 versus 12.7 ± 1.4 d). However, the second-wave dominant 
follicle had a slower growth rate in cows treated with hCG compared with that of the 
controls (0.8 versus 1.3 mm/d). It is also noteworthy that the second-wave dominant 
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follicle was the ovulatory follicle in 83.3% of control cows, but only in 50% of hCG-
treated cows.  
 
Recently, Diaz et al. (1998) treated heifers on Day 5 of the estrous cycle with 
3000 IU of hCG. All treated-heifers formed an accessory CL and had three follicular 
waves. The second wave emerged earlier and maximum diameter of the dominant follicle 
was smaller in hCG-treated heifers than in control heifers (7.3 versus 10.4 d and 12.8 ± 
0.8 versus 15.6 ± 0.8 mm). However, the interovulatory interval did not differ between 
hCG and control groups (22.9 ± 0.9 versus 22.1 ± 0.9 d). Although ovulatory response 
and day of follicular wave emergence following hCG treatment appears to be similar to 
that reported for GnRH or pLH treatments, hCG has not been widely incorporated into 
estrus synchronization protocols. Rather, hCG has been used to improve fertility 
following AI or embryo transfer because of its ability to increase plasma progesterone 
concentrations. 
 
2.4.5 Steroid hormones: Progesterone & estradiol 
 
As described earlier, the administration of exogenous progesterone reduced the 
size of the dominant follicle of the first follicular wave (Adams et al., 1992; Burke et al., 
1994) by reducing LH pulses (Ireland and Roche, 1982; Goodman and Karsch, 1980; 
Price and Webb, 1988). Suppression of LH pulses for 30 h seemed to be enough to 
induce atresia of a persistent follicle and this was achieved with treatment with a 
progesterone insert containing 1.9 g of progesterone for 24 h (McDowell et al., 1998; 
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Cavalieri et al., 1998). In other studies, atresia of persistent follicles was attained with a 
single injection of either 100 mg progesterone in oil in Bos indicus (Cavallieri et al., 
1998) or 200 mg progesterone in oil in Bos taurus (Anderson and Day, 1994) cattle. 
Injection of 200 mg progesterone in cattle with persistent follicles resulted in emergence 
of a new follicular wave 3.5 ± 0.3 d later (Anderson and Day, 1994). Although, a single 
injection of progesterone has provided a practical and useful approach to the 
synchronization of follicular wave emergence in cattle with persistent follicle, it may not 
be reliable in other physiological conditions. Progesterone administration suppressed LH 
pulse frequency (Ireland and Roche, 1982) but had no significant effect on FSH secretion 
(Goodman and Karsch, 1980; Price and Webb, 1988; Adams et al., 1992), so it is potently 
capable of inducing atresia of only LH dependent follicle. Therefore, administration of 
physiological concentrations of progesterone is unlikely to be useful in the 
synchronization of follicular wave emergence if atresia of both FSH- and LH-dependent 
follicles is intended (i.e when treatments are given at random stages of the estrous cycle).  
 
Administration of exogenous estradiol to nonlactating Holstein cows on Day 16 
of the estrous cycle induced atresia of the potential preovulatory follicle (Engelhardt et 
al., 1989). However, administration of estradiol alone in heifers on Day 1 of the estrous 
cycle resulted in transient or incomplete suppression of the dominant follicle and delayed 
emergence of the next follicular wave (Bó et al., 1994). In the absence of progesterone, 
bolus administration of estradiol, which results in superphysiological concentrations in 
the circulation, initially inhibited secretion of gonadotrophins for several hours, and this 
was followed by a surge release of LH and FSH (Kesner et al 1981; Butler el al., 1983; 
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Martínez et al., 2003a). However, physiological concentrations or administration of 
exogenous estradiol via sequential implants in sheep and cattle with low progesterone 
concentration, has been reported to have variable effects on LH secretion. The 
administration of estradiol decreased LH pulse amplitude in sheep (Goodman and 
Karsch, 1980; Rawlings et al., 1984) and cattle (Price and Webb, 1988), but did not 
significantly suppress LH pulse frequency (Goodman and Karsch, 1980; Price and Webb, 
1988). In a series of experiments using the ovariectomized bovine model, estradiol 
consistently increased mean concentration and pulse amplitude of LH (Day et al., 1986; 
Imakawa et al., 1986; Stumpf et al., 1988). However, estradiol treatment resulted in 
decreased (Day et al., 1986; Imakawa et al., 1986) or no effect (Stumpf et al., 1988) on 
LH pulse frequency. Conversely, suppression of FSH secretion has been shown to occur 
after treatment with an injection or implant of estradiol in ovariectomized (Butler et al., 
1983; Bolt et al., 1990; O’Rourke et al., 2000; Martínez et al., 2003a) or intact (Price and 
Webb, 1988; Bó et al., 1994) cattle. As indicated earlier, estradiol-induced gonadotrophin 
suppression was followed in approximately 6 h by a dramatic increase in LH 
concentration in both ovariectomized and non-progesterone implanted animals, indicating 
that the differential effect of estradiol on gonadotrophin hormones would depend on 
progesterone concentrations at the time of treatment. In fact, the FSH suppression 
following treatment with estradiol was more prolonged in progestagen-implanted heifers 
whether they had been ovariectomized (Bolt et al., 1990) or not (Bó et al., 1994). In 
addition, several studies have suggested that estradiol and progesterone given in 
combination have an additive suppressive effect on LH secretion (Goodman and Karsch, 
1980; Price and Webb, 1988; Stumpf et al., 1993; Bó et al., 1994). Collectively, these 
 22
studies suggest that a more controlled gonadotrophin secretion and subsequently more 
precise manipulation of ovarian follicular dynamics could be attained if both steroid 
hormones were given in combination. 
 
The combination of estradiol and progesterone treatment to control follicular 
dynamics has been extensively studied in the past 10 years. Bó et al. (1995b) 
demonstrated that administration of 5 mg of estradiol-17β (E-17β) to progestagen-
implanted heifers will induce follicular regression and emergence of a new follicular 
wave (on average, 4.3 ± 0.1 d after treatment), regardless of the stage of development of 
the dominant follicle of the first follicular wave. Several studies, including those in this 
thesis, have evaluated the effect of longer acting forms of estrogen esters on follicular 
wave development and fertility in cattle (see Mapletoft et al., 2002a; 2003).  
 
2.5 Control of estrous behaviour, gonadotrophin surge and ovulation 
 
Some of the hormonal treatments used to induce new follicular wave emergence 
could be also used during pro-estrus to synchronize LH surge and ovulation. As described 
earlier, GnRH or LH treatment will result in ovulation if a dominant follicle ≥ 9 mm 
diameter is present at the time of treatment. Either hormone could be used to induce 
synchronous ovulation of a growing dominant follicle in addition to inducing emergence 
of the wave from which that follicle arose. GnRH is usually administered 48 h after PGF 
treatment in TAI protocols (Pursley et al., 1995; 1998). When GnRH was given during 
the follicular phase, ovulation was reported to occur between 24 and 32 h after treatment 
 23
(Pursley et al., 1998). When GnRH was administered during proestrus, ovulation of the 
dominant follicle was associated with a decrease in estradiol concentrations in the 
peripheral circulation (Twagiramungu et al., 1994) and the occurrence of spontaneous 
behavioural estrus was diminished (Martínez et al., 2002c). In addition to an absence of 
estrous behaviour, less uterine tone and cervical-vaginal fluid make cattle treated with 
GnRH more difficult to inseminate than those in spontaneous estrus.  
 
Although LH has not been extensively used to synchronize ovulation, two studies 
investigated ovulatory response to different doses of pLH in heifers after PGF-induced 
luteolysis (Oswald et al., 2000; Ambrose et al., 2004). Ovulation of a dominant follicle 
>10 mm was similar whether heifers were given 5, 10, or 25 mg pLH 48 h after a PGF 
injection (overall, 96.4%; Oswald et al., 2000). Likewise, the interval from pLH 
treatment to ovulation did not differ among treatment groups (47 ± 10.5, 52.8 ± 13.4, and 
38.4 ± 9.6 d for 5, 10, and 25 mg of pLH, respectively). Ambrose et al. (2004) reported a 
similar ovulatory response following administration of 5 or 12.5 mg pLH or 100 μg 
GnRH in CIDR-treated dairy heifers; however, the range of ovulation times was wider in 
heifers treated with 5 mg pLH.  
 
The use of exogenous estradiol after termination of progesterone treatment was 
developed as a treatment regime to facilitate the expression of estrus and ovulation in 
cyclic (Wiltbank et al., 1971; Nancarrow and Radford, 1975) and anestrous (McDougall 
et al., 1992) cattle. Several authors have reported a decreased variation in time of onset of 
estrus (Nancarrow and Radford, 1975; Welch et al., 1975; Ryan et al., 1995; Hanlon et 
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al., 1996; 1997) and increased submission rates (Hanlon et al., 1996; Macmillan et al., 
1996; Lamoglia et al., 1998) following estradiol treatment. However, pregnancy rates 
were reported to be variable with the use of estradiol following PGF treatment and/or 
progesterone withdrawal. In this regard, studies have shown a beneficial (Macmillan et 
al., 1996; Lammoglia et al., 1998), detrimental (Wiltbank et al., 1971) or no effect 
(Welch et al., 1975; Hanlon et al., 1996; Lane et al., 2001) on fertility. In more recent 
studies, estradiol treatment has been used to induce a synchronized LH surge and 
ovulation in cycling cattle allowing for TAI. The synchrony of estrus and ovulation after 
the administration of estradiol at various intervals after PGF treatment or progesterone 
withdrawal has been investigated. Administration of 1 mg of estradiol benzoate 24 h, but 
not 48 h after PGF treatment, reduced the interval to estrus (Ryan et al., 1995). A similar 
treatment given 10 (Ryan et al., 1999), 12 or 24 h (Martínez et al., 2002a) after CIDR 
removal resulted in more synchronous LH release and ovulation than that given at 36 h 
(Martínez et al., 2002a). Thus, the interval from estradiol treatment to the LH surge and 
ovulation may differ depending on when estradiol is given in relation to progesterone 
withdrawal (Martínez et al., 2002a), but not on stage of follicle development (Evans et 
al., 2003). Lammoglia et al. (1998) investigated different doses of estradiol benzoate in 
heifers and cows; optimal responses were at 0.38 mg for heifers and at 1 mg for cows. 
Regardless of time of treatment and dose, circulating estradiol concentrations peaked 
approximately 15 h after administration in ovariectomized (O’Rourke et al., 2000; 
Martínez et al., 2003a) or intact (Lammoglia et al., 1998; Martínez et al., 2002a) heifers, 
and LH peaked 16 to 20 h after estradiol administration (Bó et al., 1994; Lammoglia et 
al., 1998; Martínez et al., 2002a, 2003a).  
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Other studies investigated the effects of estradiol on the hypothalamo-pituitary 
axis. Estradiol appears to alter at least two parameters involved with inducing a 
preovulatory-like surge of gonadotrophins (Turzillo and Nett, 1999; Nett et al., 2002). 
Administration of estradiol increases the sensitivity of the pituitary gland to GnRH within 
4 to 6 h (Kesner et al., 1981; Nett et al., 1984; Gregg et al., 1990; Turzillo et al., 1994), 
and then a sustained secretion of GnRH from the hypothalamus that is initiated 12 to 15 h 
after administration (Kesner et al., 1981; Moenter et al., 1991). Thus, the duration of the 
increased secretion of GnRH induced by estradiol supersedes the duration of LH surge 
(Moenter et al., 1991). Interestingly, the preovulatory LH surge induced by exogenous 
estradiol has been reported to last for approximately 10 h (Bó et al., 1994), which is 
similar to the spontaneous preovulatory LH surge (Chenault et al., 1975). However, the 
LH surge induced by an injection of GnRH had a duration of approximately 4 to 6 h 
(Chenault et al., 1990; Martínez et al., 2003b). Hence, CL function and subsequently 
pregnancy rate may be affected in those animals induced to ovulate by administration of 
GnRH compared to estradiol. Indeed, recent studies have shown a high incidence of short 
estrous cycles following GnRH-induced ovulations (Schmitt et al., 1996b; Cordoba and 
Fricke, 2002). In contrast, estradiol treatment seems to have no detrimental effect on CL 
function, even when small follicles are induced to ovulate by an injection of estradiol 
during proestrus (Evans et al., 2003). Although hormone treatments used to induce 
ovulation may affect CL morphology and capability to produce progesterone, and 
subsequent fertility, other studies have shown that reduced concentrations of estradiol 
near the time of ovulation may also affect oocyte maturation (Murdoch and Van Kirk, 
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2001) and oviductal and uterine environments (Boice et al., 1990; Murdoch and Van 
Kirk, 1998). 
 
2.6 Effect on corpus luteum function 
 
Treatment with GnRH during diestrus may affect function and morphology of the 
existing CL; an increase, decrease, or no change in progesterone production has been 
reported after treatment with GnRH or a GnRH agonist during diestrus (for review see 
Twagiramungu et al., 1995b). One study revealed that although plasma progesterone 
concentrations were not affected, numbers of large luteal cells (LLC) and the volume of 
the CL increased after buserelin (a potent GnRH agonist) treatment (Twagiramungu et 
al., 1995a). Conversely, treatment with LH or hCG not only increased the number of LLC 
(Farin et al., 1988), but it also increased plasma progesterone concentrations (Schmitt et 
al., 1996a; Diaz et al., 1998; Marques et al., 2002). Increase of plasma progesterone 
concentrations after hCG treatment was probably due to additional progesterone secretion 
by accessory CL (Schmitt et al., 1996a; Diaz et al., 1998). However, the effect on 
progesterone levels seems to be more prominent in hCG-treated animals than in those 
treated with GnRH or LH (Marques et al., 2002), likely due to stimulation of the original 
CL rather than to additional progesterone secretion by accessory CL (Fricke et al., 1993). 
It is likely that the increase in the number of LLC in GnRH- or hCG-treated animals is 
the result of an increased release of endogenous LH. Because PGF receptors are located 
on LLC (Fitz et al., 1982), the CL of animals treated with hCG, GnRH or pLH may 
become more sensitive to PGF treatment (Colazo et al., 2002b). 
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The luteolytic effects of exogenously administered estradiol esters in cattle was 
demonstrated several years ago (Wiltbank et al., 1961). The effect of estradiol on CL 
function was shown to be dose and estrous cycle stage dependent (Wiltbank et al., 1961; 
Munro and Moore, 1985) and mediated through uterine release of PGF (Peterson et al., 
2000). The observation that the exogenous administration of estradiol caused follicle 
regression and wave emergence was quite coincidental and secondary to its intended use 
in the induction of luteolysis (Bó et al., 1991). Therefore, the use of estradiol to 
synchronize ovarian follicular wave emergence in cattle with unknown pregnancy status 
is of concern. 
 
The current understanding of the endocrinology and physiology of reproduction in 
domestic animals has been briefly described. Also, methods to control ovarian follicle 
development and effects on CL function have been very briefly discussed. Based on this 
knowledge, studies in this thesis were initiated to develop and/or modify estrus 
synchronization protocols that allow for the use of artificial insemination without the 
necessity of estrus detection (TAI). It was anticipated that the development of TAI 
protocols that resulted in acceptable pregnancy rates would enhance the implementation 
of AI among beef producers. In addition, the development of synchronization protocols 
that permit reinsemination of non-pregnant animals with a minimum of estrus detection 
would noticeably increase the number of pregnant animals to AI in the first 24 d of the 
breeding season. 
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3.0 GENERAL HYPHOTHESIS 
 
This thesis is based on the general hypothesis that controlling ovarian follicular 
growth and corpus luteum function in cattle would result in protocols for precise 
synchronization of estrus and ovulation and resynchronization (of nonpregnant cattle) 
with acceptable pregnancy rates.  
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4.0 GENERAL OBJECTIVE 
 
The overall objective of the experiments reported herein was to develop 
alternative estrus synchronization and resynchronization protocols to facilitate the use of 
artificial insemination in cattle.  
  
Specific objectives for each section of this thesis are indicated in the introduction 
preceeding each study. 
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 5.0 EFFECTS OF ESTRADIOL CYPIONATE (ECP) ON OVARIAN 
FOLLICULAR DYNAMICS, SYNCHRONY OF OVULATION, AND 
FERTILITY IN CIDR-BASED, FIXED-TIME AI PROGRAMS IN BEEF 
HEIFERS 
 
5.1 Abstract 
 
Estradiol cypionate (ECP) was used in beef heifers receiving a CIDR (controlled 
internal drug release; insertion = Day 0) device for timed artificial insemination (TAI) in 
4 experiments. In Experiment 1, heifers (n = 24) received 1 mg ECP or 1 mg ECP plus 50 
mg of a commercial progesterone (CP) preparation im on Day 0. Eight or 9 d later, CIDR 
were removed, PGF was administered and heifers were allocated to receive 0.5 mg ECP 
im concurrently (ECP0) or 24 h later (ECP24). There was no effect of treatment (P = 0.6) 
on mean (± SEM) day of follicular wave emergence (3.9 ± 0.4 d). Interval from CIDR 
removal to ovulation was affected (P < 0.05) only by duration of CIDR treatment (88.3 ± 
3.8 versus 76.4 ± 4.1 h; 8 versus 9 d, respectively). In Experiment 2, 58 heifers received 
100 mg progesterone and either 5 mg estradiol-17β or 1 mg ECP im (E-17β and ECP 
groups, respectively) on Day 0. Seven (E-17β group) or 9 d (ECP group) later, CIDR 
were removed, PGF was administered and heifers received ECP (as in Experiment 1) or 1 
mg estradiol benzoate (EB) 24 h after CIDR removal, with TAI 58 to 60 h after CIDR 
removal. Follicular wave emergence was later (P < 0.02) and more variable (P < 0.002) 
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 in heifers given ECP than in those given E-17β (4.1 ± 0.4 versus 3.3 ± 0.1 d), but 
pregnancy rate was unaffected (overall, 69%; P = 0.2). In Experiment 3, 30 heifers 
received a CIDR device and 5 mg E-17β, with or without 100 mg progesterone im on 
Day 0. On Day 7, CIDR were removed and heifers received ECP as described in 
Experiment 1 or no estradiol (Control). Intervals from CIDR removal to ovulation were 
shorter (P < 0.05) in ECP0 (81.6 ± 5.0 h) and ECP24 (86.4 ± 3.5 h) groups than in the 
Control group (98.4 ± 5.6 h). In Experiment 4, heifers (n = 300) received a CIDR device, 
E-17β, progesterone, and PGF (as in Experiment 3) and after CIDR removal were 
allocated to 3 groups (as in Experiment 2), with TAI 54 to 56 h (ECP0) or 56 to 58 h 
(ECP24 and EB24) after CIDR removal. Pregnancy rate did not differ among groups 
(overall, 63.6%, P = 0.96). In summary, although 1 mg ECP (with or without 
progesterone) was less efficacious than 5 mg E-17β plus 100 mg progesterone for 
synchronizing follicular wave emergence, 0.5 mg ECP (at CIDR removal or 24 h later) 
induced a synchronous ovulation with an acceptable pregnancy rate following TAI. 
 
5.2 Introduction 
 
Estradiol-17β (E-17β) and estradiol benzoate (EB) are commonly used to 
synchronize follicular wave emergence (Bó et al., 1994; Caccia and Bó, 1998; Martínez 
et al., 2000a, 2000b) and ovulation (Hanlon et al., 1996, 1997; Colazo et al., 1999; 
Martínez et al., 2002a) in CIDR-treated cattle. However, estradiol cypionate (ECP), an 
ester of estradiol with a low water solubility that delays its release from the site of 
injection, is the only estrogen ester licensed for use in cattle in North America. Plasma 
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 concentrations of estradiol were prolonged (98 to 170 h) after intramuscular 
administration of large doses (5 or 10 mg) of ECP (Burton et al., 1990; Vynchier et al., 
1990). However, when ovariectomized beef heifers were treated with only 2 mg ECP, the 
duration of estrus (15.8 ± 1.1 h) was not different from heifers with a spontaneous estrus 
(Lefebvre and Block, 1992), suggesting that reduced doses of ECP may be useful in 
estrus synchronization regimens.  
 
The effects of ECP on ovarian follicular wave emergence and ovulation have been 
studied in lactating Holstein cows (Thundathil et al., 1997). Although 1 mg ECP was 
more efficacious than 0.5 mg in synchronizing follicular wave emergence, the authors 
concluded that the prolonged half-life of ECP made it far less efficacious than E-17β for 
synchronizing both follicular wave emergence and ovulation in CIDR-treated dairy cattle. 
However, Lopes et al. (2000a) successfully used ECP to replace the second treatment 
with GnRH to synchronize ovulation for fixed-time AI in an Ovsynch-type program in 
dairy cattle. Furthermore, Ambrose et al. (2001) reported that 0.5 mg of ECP 
administered concurrently with CIDR removal synchronized ovulation in Holstein heifers 
that had received PGF 24 h before CIDR removal. To our knowledge, the use of ECP in 
comparison or combination with E-17β or EB for timed AI (TAI) in beef cattle has not 
been reported.  
 
Four experiments were designed to study and compare the effects of ECP (with or 
without injectable progesterone), E-17β, and EB on follicular dynamics, time of 
ovulation, and pregnancy rate following TAI in CIDR-based protocols. In addition, the 
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 duration of CIDR treatment (8 versus 9 d) on the interval from CIDR removal to 
ovulation was determined. 
 
5.3 Materials and Methods 
 
5.3.1 Experiment 1 
 
Puberal, crossbred beef heifers 18 to 20 mo of age (n = 24), received a once-used 
intravaginal progesterone releasing device (CIDR; Bioniche Animal Health; Belleville, 
ON, Canada) at random stages of the estrous cycle, and were randomly assigned to 2 
groups to concurrently receive either 1 mg of estradiol cypionate im (ECP; Pharmacia 
Animal Health, Orangeville, ON, Canada; n = 13) or 1 mg ECP plus 50 mg of a 
commercial progesterone preparation (CP; Progesterone 5%®, J Webster Lab Inc, 
Victoriaville, QC, Canada; n = 11) on Day 0 (day of treatment). Heifers were randomly 
allocated to have the CIDR removed and receive treatment with 500 μg cloprostenol im 
(Estrumate, Schering Plough Animal Health, Pointe-Claire, QC, Canada) on either Day 8 
(n = 13) or Day 9 (n = 11). Heifers were further randomly allocated to receive 0.5 mg of 
ECP at CIDR removal (ECP0; n = 13) or 24 h later (ECP24; n = 11).  
 
Ovaries were examined by transrectal ultrasonography (Aloka SSD 500 with a 7.5 
MHz linear-array transducer; ISM Inc., Edmonton, AB, Canada) once daily from CIDR 
insertion (Day 0) to 48 h after CIDR removal to detect ovarian dynamics, and thereafter, 
twice daily to determine the time of ovulation. The diameter of the CL and all follicles ≥3 
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 mm were measured and recorded (Pierson and Ginther, 1984). The day of emergence of a 
follicular wave was defined as the day that the dominant follicle was first identified at a 
diameter of 4 mm (Ginther et al., 1989b). When follicular wave emergence did not occur 
during the observation period, day of follicular wave emergence prior to treatment was 
estimated from the size of the dominant follicle at the time of treatment. Ovulation was 
confirmed by the disappearance of a large (>10 mm) follicle that had been detected at the 
previous examination. 
 
5.3.2 Experiment 2 
 
Fifty-eight puberal, crossbred heifers were treated with a once-used CIDR device 
and 100 mg progesterone in canola oil im (Sigma Chemical Co, St Louis, MO, USA) and 
randomly assigned to 2 groups to receive either 5 mg of E-17β im (E17β; Sigma 
Chemical Co; n = 30) or 1 mg of ECP im (ECP; n = 28) to synchronize follicle wave 
emergence (Day 0). The CIDR devices were removed after 7 or 9 d in the E17β and ECP 
groups, respectively and 25 mg dinoprost im (Lutalyse; Pharmacia Animal Health) was 
administered. Heifers were further divided into 3 groups in a 2 x 3 factorial design to 
receive ECP as in Experiment 1 (ECP0; n = 19 or ECP24; n = 20), or 1 mg of estradiol 
benzoate (EB; Sigma Chemical Co; EB24, n = 19) 24 h after CIDR removal. All heifers 
were inseminated using TAI 58 to 60 h after CIDR removal. Ultrasonographic 
examinations were performed to determine ovarian dynamics and ovulation as described 
in Experiment 1 and 28 d after AI for pregnancy diagnosis.  
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 5.3.3 Experiment 3 
 
Puberal, crossbred beef heifers, 18 to 20 mo of age (n = 30), received a CIDR 
device (insertion = Day 0) at random stages of the estrous cycle. Concurrently, heifers 
were given 5 mg of E-17β im, alone or in addition to 100 mg of progesterone in canola 
oil im to synchronize follicle wave emergence. On Day 7, CIDR devices were removed; 
heifers were treated with 25 mg dinoprost im and randomly allocated into 3 groups to 
receive no treatment (Control; n = 10) or 0.5 mg ECP im (ECP0; n = 10 or ECP24; n = 
10) as in Experiment 1. 
 
Ultrasonographic examinations of the ovaries were conducted as described in 
Experiment 1. Heifers were observed for estrous behavior every 6 h, from 24 h after 
CIDR removal to ovulation. Blood samples were collected by jugular venipuncture into 
an evacuated tube containing heparin every 6 h from CIDR removal to detection of 
ovulation. Blood samples were centrifuged for 20 min at 1500 x g, and plasma was stored 
at –20° C until assayed. Plasma LH concentrations were determined by 
radioimmunoassay (Rawlings et al., 1984). The intra-assay coefficients of variation were 
7.2 and 6.5% for means of 0.38 and 1.04 ng/mL respectively.  
 
5.3.4 Experiment 4 
 
Angus crossbred beef heifers (n = 300), approximately 13 to 15 mo of age and 
350 to 500 kg, were kept in outdoor paddocks under feedlot conditions. Based on 
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 ultrasonographic examination of the ovaries at the beginning of the experiment, heifers 
that did not have a luteal structure were deemed prepuberal and equally allocated among 
treatment groups. All heifers received a CIDR, E-17β plus progesterone and PGF (as in 
Experiment 3) and were allocated to receive ECP (ECP0; n = 98 or ECP24; n = 99) or EB 
(EB24; n = 103) as described in Experiment 2. Heifers in the ECP0 group were 
inseminated using TAI between 54 and 56 h after CIDR removal, while heifers in the 
other 2 groups (ECP24 and EB24) were inseminated between 56 and 58 h after CIDR 
removal. Pregnancy diagnosis was done as described in Experiment 2.  
 
5.3.5 Statistical Analyses 
 
For Experiments 1 to 4, all statistical analyses were done with commercial 
statistical software (SPSS for Windows, Version 10.05; Analytical Sofware, 2001, 
Chicago, IL, USA). Single-point variables were analyzed by ANOVA and differences 
among groups were identified with a protected LSD test. Student’s t-test was used to 
compare day of follicular wave emergence between treatments (Rank Sum Test was used 
in Experiment 2). Comparison of equality of variances among groups was done by 
Bartlett’s test of homogeneity of variance. Continuous variables were compared by group 
with ANOVA for repeated measures to determine the main effects of treatment and day, 
and their interaction. Pearson correlation coefficients were calculated between diameter 
of the eventual ovulatory follicle (on Days 8, 9, and just prior to ovulation), timing of 
follicular wave emergence, and intervals to estrus, LH surge, and ovulation. An LH surge 
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 was defined as an increase in plasma LH concentration ≥ 2 SD above the overall LH 
mean. In Experiment 3, proportional data were compared by Chi-square analysis. 
 
5.4 Results  
 
5.4.1 Experiment 1 
 
Two heifers, one in each treatment group, did not respond to treatment to induce 
follicular wave emergence at CIDR insertion and they were excluded from the calculation 
of the interval from treatment to wave emergence. There was an effect of day (P < 
0.0001) on diameter of the regressing follicle, but the effects of treatment (P = 0.17), and 
the treatment by day interaction (P = 0.66) were not significant. Similarly, the effects of 
day (P = 0.35), treatment (P = 0.99) and the treatment by day interaction (P = 0.9) on CL 
diameter were not significant. There was no difference (P = 0.6) between treatment 
groups for the day of emergence of a new follicular wave (3.7 ± 0.4 and 4.0 ± 0.5 d for 
ECP and ECP/CP groups, respectively) and so groups were combined. Overall, a new 
follicular wave emerged between 2 and 7 d after treatment.  
 
The mean (± SEM) diameter of dominant follicle at the time of CIDR removal 
was numerically smaller in heifers treated with a CIDR for 8 days (10.8 ± 2.8 mm) than 
in heifers treated for 9 days (12.8 ± 2.8 mm), although this difference was not statistically 
significant (P = 0.11). Similarly, the diameter of dominant follicle prior to ovulation was 
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 not different between groups (P = 0.46; 15.3 ± 2.0 and 16.0 ± 2.3 mm for heifers in 8 and 
9 d groups, respectively). 
 
The interval from CIDR removal to ovulation was shorter (P < 0.05) in heifers 
treated with a CIDR for 9 d (76.4 ± 4.1 h) than those treated for 8 d (88.3 ± 3.8 h). Two 
heifers treated with a CIDR for 9 d ovulated by 60 h after CIDR removal. Heifers 
administered ECP at CIDR removal had a numerically shorter interval (although not 
significant; P = 0.16) from CIDR removal to ovulation (78.5 ± 3.5 h) than those treated 
with ECP 24 h later (87.3 ± 5.1 h). In heifers receiving a CIDR for 8 d, ECP treatment at 
CIDR removal tended to shorten (P < 0.09) the interval between CIDR removal and 
ovulation (80.6 ± 5.0 h) compared to ECP treatment 24 h later (96.0 ± 7.0 h). However, 
mean (± SEM) intervals from CIDR removal to ovulation were similar (P = 0.9; 76.0 ± 
5.0 and 76.8 ± 4.8 h for ECP0 and ECP24 groups, respectively) in heifers treated with a 
CIDR for 9 d. 
 
5.4.2. Experiment 2 
 
One heifer treated with ECP did not respond with emergence of a new follicular 
wave and was not included in the calculation of the interval from treatment to emergence 
of a new follicular wave. There was an effect of day (P < 0.0001), but the effects of 
treatment (P = 0.58; P = 0.28), and treatment by day interaction (P = 0.45; P = 0.56) were 
not significant for diameter of growing and regressing follicles, respectively (Figure 5.1). 
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 However, there was an effect of day (P < 0.0001) and treatment (P < 0.02) on CL 
diameter (Figure 5.1). 
 
Mean (± SEM) day of follicular wave emergence was delayed (P < 0.02) and 
more variable (P < 0.002) in heifers given ECP compared to those given E-17β (4.1 ± 0.4 
d versus 3.3 ± 0.1 d). The proportion of heifers with emergence of a new follicular wave 
on Days 3 or 4 after treatment tended to be higher (P < 0.06) in heifers treated with E17β 
(24/30; 80%) than in heifers treated with ECP (16/28; 57%). Dominant follicle diameter 
at the time of CIDR removal was larger (P < 0.01) in ECP-treated heifers than E-17β-
treated heifers (11.3 ± 2.1 versus 9.8 ± 1.5 mm). Variances were also different (P < 0.04) 
between groups (ranges, 6.5 to 14.2 mm and 7.0 to 13.2 mm for ECP and E-17β groups, 
respectively). However, there was no difference in pregnancy rates among groups 
(overall, 69%; P = 0.2; Table 5.1). Although there was no difference (P = 0.3) among 
treatments to synchronize ovulation, the ECP24 group had a numerically higher 
pregnancy rate (16/20) than the other two groups (ECP0, 11/19 and EB24, 13/19). 
Pregnancy rates did not differ (P = 0.86) between heifers treated with 100 mg of 
progesterone plus either 5 mg of E-17β (21/30) or 1 mg of ECP (19/28) to synchronize 
follicular wave emergence.  
 
Five heifers (9% of the total) ovulated prior to fixed-time AI (58 to 60 h after 
CIDR removal; 3 heifers from the ECP0 group, 1 from the EB24 group, and 1 from the 
ECP24 group). The heifers in the ECP0 and EB24 groups were subsequently diagnosed 
not pregnant, while the heifer in ECP24 group was pregnant. In contrast, 38 of 49 heifers 
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 (78%) that ovulated ≤ 24 h after AI were pregnant, regardless of treatment. Of the 4 
heifers (7% of the total) that presumably ovulated after 24 h, 2 became pregnant. It is 
noteworthy that 13% (5/39) of the heifers receiving an ECP treatment either at CIDR 
removal (n = 2) or 24 h later (n = 3) had double ovulations. 
 
Table 5.1. Pregnancy rates in heifers after treatment with 100 mg of progesterone plus 
5 mg of estradiol-17β (E-17β/) or 1 mg of estradiol cypionate (ECP) to 
synchronize follicular wave emergence, and 0.5 mg ECP at CIDR removal 
or 24 h later (ECP0 and ECP24, respectively) or 1 mg estradiol benzoate 24 
h after CIDR removal (EB24) to synchronize ovulation for timed AI.  
 
 Heifers 
 Treatment inseminated (n) pregnant (n) 
 
  E-17β/ECP0 10 7 
  E-17β/ECP24 10 6 
  E-17β/EB24 10 8 
  ECP/ECP0 9 4 
  ECP/ECP24 10 10 
 ECP/EB24 9 5 
 
There was no difference in pregnancy rates among treatments (P < 0.2). 
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Figure 5.1. Mean diameters (upper panel) for the dominant follicle that regressed (---) 
and the eventual ovulatory follicle (⎯) after treatment with either 1 mg 
estradiol cypionate plus 100 mg progesterone (♦;ECP/P, n = 27) or 5 mg 
estradiol-17β plus 100 mg progesterone (■; E-17β/P, n = 30) at CIDR 
insertion (Day 0). Day of follicular wave emergence was normalized to 
average day of emergence. Mean (± SEM) CL diameter for heifers in the 
ECP/P (♦) and E-17β/P (■) groups is shown in the lower panel. There was 
no effect of treatment on the diameter of regressing (P = 0.58) or growing (P 
= 0.28) follicles. However, there were effects of day (P < 0.0001) and 
treatment (P < 0.02) on CL diameter. 
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 5.4.3 Experiment 3 
 
Three heifers that did not respond to the first treatment (to induce a new follicular 
wave) were excluded from the statistical analyses. Means (P = 0.4) and variances (P = 
0.11) for day of emergence of a new follicular wave were not different between treatment 
groups (overall, 3.4 ± 0.7 d). There was an effect of day (P < 0.0001) on diameter of the 
dominant follicle at the time of CIDR removal, but the effects of treatment (P = 0.28), 
and treatment by day interaction (P = 0.85) were not significant.  
 
Overall, heifers receiving ECP had a shorter (P < 0.05) interval from CIDR 
removal to estrus and ovulation than control heifers (49.3 ± 3.4 and 81.6 ± 5.0 h; 51.6 ± 
2.8 and 86.4 ± 3.5 h; 60.0 ± 3.7 and 98.4 ± 5.6 h in ECP0, ECP24 and control groups, 
respectively). Nineteen of 20 heifers in ECP groups ovulated between 72 and 96 h after 
CIDR removal (1 heifer in the ECP0 group ovulated at 48 h).  
 
Examination of LH concentrations on an individual-animal basis in heifers given 
ECP (both groups) revealed that LH surges occurred at either 42 to 48 or 60 to 66 h after 
CIDR removal (data not shown). The interval from CIDR removal to the LH surge 
tended (P < 0.07) to be shorter in heifers receiving ECP than for those in the control 
group (Table 5.2). The mean (± SEM) interval from the LH surge to ovulation did not 
differ among groups (30.0 ± 1.4, 28.6 ± 1.2, and 28.7 ± 1.7 h for control, ECP0, and 
ECP24 groups, respectively; P < 0.7), but LH surge concentrations were lower (P < 0.01) 
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 in heifers in the control group than in those in the ECP groups (6.8 ± 0.6, 16.2 ± 2.3, and 
17.2 ± 4.1 ng/mL for control, ECP0, and ECP24 groups, respectively.  
 
Day of emergence of a new follicular wave was negatively correlated with 
diameter of the eventual ovulatory follicle on Days 8 and 9 after treatment (r = - 0.63 and 
r = - 0.62; P < 0.0008), and positively correlated with the timing of the LH surge (r = 
0.51; P < 0.007). However, the interval to the LH surge was negatively correlated with 
the diameter of the eventual ovulatory follicle on Day 8 (r = - 0.39; P < 0.05) and 
positively correlated with the interval to ovulation (r = 0.94; P < 0.001). In addition, the 
interval to ovulation tended to be correlated with day of emergence of a new follicular 
wave (r = 0.37; P < 0.06) and diameter of the eventual ovulatory follicle on Day 8 (r = - 
0.34; P < 0.09). 
Table 5.2. Mean (± SEM) intervals from CIDR removal to estrus, LH surge, and 
ovulation in beef heifers given 0.5 mg estradiol cypionate (ECP) at 0 or 24 h 
after CIDR removal (ECP0 and ECP24, respectively) or no treatment 
(Control). 
 
 ECP0 ECP24 Control  
 Interval (h) from  
 CIDR removal to 
 Estrus 49.3 ± 3.4a 51.6 ± 2.8a 60.0 ± 3.7b
 (Range) (36 to 66) (36 to 60) (36 to 72)    
 LH surge 54.6 ± 3.4 59.3 ± 3.5 68.0 ± 4.7 
 (Range) (42 to 66) (42 to 72) (54 to 96)    
 Ovulation 81.6 ± 5.0a 86.4 ± 3.5a 98.4 ± 5.6b        
 (Range) (48 to 96) (72 to 96) (72 to 132)  
  
ab Within a row, means with different superscripts are different (P < 0.05). 
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 5.4.4 Experiment 4 
 
Forty-nine heifers (16.3%) were prepuberal at the beginning of the experiment, 
but pregnancy rate (61.2%) was not different from those that were puberal (64.1%; P = 
0.7). Hence, pregnancy data from all heifers were combined. Pregnancy rates did not 
differ among groups (62/98, 63.3%, 64/99, 64.6%, and 65/103, 63.1% for ECP0, ECP24, 
EB24 groups, respectively; P = 0.96).  
 
5.5 Discussion 
 
Although the administration of 1 mg ECP resulted in relatively synchronous 
follicular wave emergence in the present study, synchrony was less precise than with 5 
mg of E-17β; this is consistent with a previous study in which the administration of ECP 
to dairy cows resulted in relatively asynchronous follicular wave emergence (Thundathil 
et al., 1997). Similarly, Bó et al. (1996) reported delayed or asynchronous emergence of a 
new follicular wave when 5 mg of EB (another estradiol ester) was administered. 
However, treatment with 1 or 2.5 mg EB resulted in synchrony of follicular wave 
emergence that did not differ from that of 5 mg E-17β (Caccia and Bó, 1998; Martínez et 
al., 2002a).  
 
Plasma FSH concentrations are suppressed by negative feedback from estradiol 
and inhibin released from actively growing follicles. Furthermore, periodic surges in 
circulating FSH concentration consistently precede follicular wave emergence (Adams et 
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 al., 1992a; Bergfelt et al., 1994a). In ECP-treated heifers, elevated plasma estradiol 
concentrations may have suppressed endogenous FSH release for longer and more 
variable intervals compared to that in heifers given E-17β, leading to delayed follicular 
wave emergence. Prolonged elevations in plasma concentrations of estradiol following 
treatment with ECP have been previously reported (Burton et al., 1990; Vynchier et al., 
1990), while plasma estradiol concentrations following treatment with E-17β increased 
and declined much more rapidly (Bó et al., 2000; Ginther et al., 2000).  
 
Despite the relatively asynchronous wave emergence observed in heifers treated 
with ECP, ovulation was relatively synchronous and pregnancy rate following TAI did 
not differ (21/30 and 19/28 for E17β and ECP, respectively). In a previous study, 
Kastelic and Mapletoft (1998) reported that although treatment with GnRH resulted in a 
variable interval to follicular wave emergence, cloprostenol given 6 d after GnRH 
resulted in a relatively synchronous ovulation, even in the absence of a second treatment 
with GnRH. It is important to note that all heifers in the present study were given 
estradiol (ECP or EB) to synchronize ovulation. We have previously shown the 
importance of giving estradiol after CIDR removal to achieve high pregnancy rates 
following TAI (Colazo et al., 1999). 
 
Estradiol cypionate treatment at the time of CIDR removal or 24 h later 
effectively synchronized the LH surge and ovulation; consistent with this, pregnancy 
rates did not differ among treatments (ECP0, ECP24 or EB24) in Experiment 4. 
Nevertheless, in Experiment 2, ECP treatment 24 h after CIDR removal resulted in a 
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 numerically higher pregnancy rate than ECP treatment at device removal (where several 
precocious ovulations occurred in the latter group). Overall, heifers that ovulated early 
(i.e. before AI or 60 h after CIDR removal) either had a regressed or regressing CL and a 
large dominant follicle (≥ 11.2 mm) at the time of CIDR removal. As progesterone 
concentrations were undoubtedly low in these heifers (Kastelic et al., 1990b), estradiol 
treatment or an estrogen-active dominant follicle may have induced an early LH surge, 
which induced ovulation before the expected time.  
 
Recently, Ambrose et al. (2001) reported high pregnancy rates following TAI 48 
h after CIDR removal in Holstein heifers administered ECP concurrently with CIDR 
insertion and withdrawal and administration of PGF 24 h before CIDR removal, whereas 
the ECP/ECP0 group in the present study had numerically, the lowest percentage of 
pregnant heifers; early ovulations may have adversely affected pregnancy rate in this 
group. However, administration of PGF 24 h before CIDR removal may have also 
resulted in more synchronous ovulations, resulting in higher pregnancy rates (Ambrose et 
al., 2001). In the present study, the administration of ECP at CIDR removal (to 
synchronize ovulation) was intended to eliminate handling required to administer 
estradiol 24 h after CIDR removal. Interestingly, administration of 0.5 mg ECP at the 
time of CIDR removal in heifers treated with E-17β  at CIDR insertion (Experiments 2 
and 4) did not adversely affect pregnancy rate; this approach must be further tested before 
widespread implementation.  
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 When CIDR devices were removed after 8 or 9 d, the latter group had a shorter 
interval from CIDR removal to ovulation, and a larger (although not significant) 
dominant follicle diameter at the time of CIDR removal. One additional day of treatment 
represented, on average, 2 mm more in follicular growth. In that regard, the diameter of 
the eventual ovulatory follicle at the time of PGF treatment has been shown to be 
negatively correlated with the interval from PGF treatment to estrus and to ovulation 
(Kastelic et al., 1991; Colazo et al., 2002b). Hence, the length of the treatment in CIDR-
based estrus synchronization programs should be taken in account when scheduling TAI. 
 
In these experiments, all heifers that failed to respond to the first 
estradiol/progesterone treatment developed a persistent follicle (Savio et al., 1993). 
Ovulation of persistent follicles has been shown to result in reduced conception rates 
after AI (Ahmad et al., 1995; Kinder et al., 1996; Revah and Butler, 1996); therefore, it is 
important to minimize the occurrence of persistent follicles in estrus synchronization 
protocols. It is noteworthy that non-responding heifers in the present study were either at 
late stages of the luteal phase or proestrus when treatment was initiated. In this regard, 
Martínez et al. (2002a) have also reported that the dominant follicle of 2 beef heifers 
undergoing spontaneous luteal regression at the time of CIDR insertion and treatment 
with either 5 mg E-17β or 1 mg EB plus 100 mg progesterone did not regress. 
Collectively, results suggest that in heifers undergoing spontaneous luteolysis at the time 
of CIDR insertion, estradiol/progesterone treatment will not consistently induce 
regression of the dominant follicle, and ovulation of an aged oocyte following CIDR 
removal may result in reduced pregnancy rates following TAI. Therefore, the stage of the 
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 estrous cycle at initiation of estradiol treatment may be an important factor affecting the 
synchronization of follicular wave emergence, and following CIDR removal, 
synchronous ovulation of a viable oocyte.  
 
In summary, ECP was less efficacious than E-17β for synchronization of 
follicular wave emergence in CIDR-treated heifers. However, pregnancy rate to fixed-
time AI was comparable to that achieved in these and previous studies using the shorter-
acting estradiol formulations. In addition, results suggest that the administration of 0.5 
mg ECP at CIDR removal will induce synchronous ovulation of the dominant follicle of a 
follicular wave synchronized with E-17β. Nevertheless, ECP treatment 24 h after CIDR 
removal was a highly efficacious alternative for heifers that received ECP at the time of 
CIDR insertion to synchronize follicular wave emergence. These important observations 
must be investigated further to reduce animal handling without compromising pregnancy 
rates following TAI.  
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 6.0 FERTILITY FOLLOWING TIMED AI IN CIDR-TREATED BEEF 
HEIFERS GIVEN GNRH OR ESTRADIOL CYPIONATE AND FED 
DIETS SUPPLEMENTED WITH FLAX SEED OR SUNFLOWER SEED 
 
6.1 Abstract 
 
The objectives were to determine pregnancy rates following timed AI (TAI) in 
heifers: 1) given GnRH or estradiol cypionate (ECP) to synchronize follicular wave 
emergence and ovulation in a CIDR-based protocol; and 2) fed diets supplemented with 
flax or sunflower seeds. At two locations, Angus and crossbred Angus heifers (n=983) 
were examined ultrasonically to confirm reproductive maturity and randomly allocated to 
six synchronization groups in a 2 x 3 factorial design. On Day 0 (start of synchronization 
treatments), heifers received a CIDR and either 100 µg GnRH im (n = 492) or 1 mg ECP 
plus 50 mg progesterone im (n = 491); in these groups, CIDR removal and PGF treatment 
were done concurrently on Days 7 and 8.5, respectively. Heifers were re-randomized to 
receive 0.5 mg ECP im at CIDR removal or 24 h later (with TAI 58 to 60 h after CIDR 
removal in both groups), or 100 µg GnRH im concurrent with TAI (52 to 54 h after 
CIDR removal). The heifers were fed a barley silage-based diet for 50 d (from Day –25 
to 25) supplemented with 1 kg/heifer/d of flax seed (n = 321), sunflower seed (n = 324), 
or no oilseed (n = 338). Pregnancy rate following TAI (overall, 56.2%) was not affected 
by treatment at CIDR insertion (P=0.96) but was higher (P<0.005) in heifers given ECP
 50
 24 h after CIDR removal (216/330, 65.4%) than in those given either ECP at CIDR 
removal (168/322, 52.1%) or GnRH at AI (169/331, 51.1%). Overall, there was no effect 
of diet on pregnancy rates (P=0.46). In summary, pregnancy rate following TAI was not 
significantly affected by treatment at CIDR insertion to synchronize follicular wave 
emergence, but 0.5 mg ECP 24 h after CIDR removal (to synchronize ovulation) resulted 
in the highest pregnancy rate. 
 
6.2 Introduction 
 
In progestin-based protocols for timed AI (TAI), GnRH, estradiol benzoate (EB), 
and estradiol-17β (E-17β) have all been used to synchronize follicular wave emergence 
and ovulation (Adams et al., 1995; Colazo et al., 1999; Martínez et al., 2000a; 2002b). 
Although GnRH is licensed for use in cattle in North America, neither EB nor E-17β are 
licensed. In contrast, estradiol cypionate (ECP) is a licensed product. In an initial study, 
follicular wave emergence following administration of ECP in CIDR-treated dairy cows 
was quite asynchronous (Thundathil et al., 1997). However, ECP has recently been 
successfully used to synchronize both wave emergence and ovulation in CIDR-treated 
dairy (Ambrose et al., 2001) and beef (Colazo et al., 2003b, Chapter 5) heifers. In these 
studies, ECP was given either at CIDR removal (Ambrose et al., 2001) or 24 h later 
(Colazo et al., 2003b, Chapter 5) to synchronize ovulation. 
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 The addition of specific long-chain, polyunsaturated fatty acids to cattle diets, 
particularly those of the omega-3 family, may increase fertility (Staples et al., 1998; 
Mattos et al., 2000). Furthermore, dietary supplementation with ruminant-grade 
menhaden fish-meal improved conception rates in lactating dairy cows (Burke et al., 
1997a). Menhaden fish-meal is a rich source of eicosapentaenoic and docosahexaenoic 
fatty acids, known to reduce PGF release from the uterus (Thatcher et al., 1997; 2001). 
Feeding flax seed to dairy cows has been reported to increase the proportion of linolenic 
acid in milk fat (Kenelly, 1996). Flax seed is a rich source of α-linolenic acid (Ambrose 
and Kastelic, 2003). Supplementation with α-linolenic acid can lead to the formation of 
eicosapentaenoic acid and therefore has the potential to reduce PGF secretion and early 
embryo mortality. In two recent studies, the inclusion of flax seed in the diet of lactating 
dairy cows was associated with increased conception rates (Petit et al., 2001). Unlike flax 
seed, the α-linolenic acid content in sunflower seed is very low, but it is rich in linoleic 
acid (Ambrose and Kastelic, 2003). While linoleic acid intake can increase the supply of 
arachidonic acid, a precursor to PGF synthesis, it can also have inhibitory effects on PGF 
synthesis and possibly enhance reproductive performance in cattle (Staples et al., 1998). 
 
The objectives of the present study were to determine pregnancy rates following 
TAI in heifers: 1) given GnRH or ECP (to synchronize follicular wave emergence and 
ovulation) in a CIDR-based protocol; and 2) fed diets supplemented with flax or 
sunflower seeds.  
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 6.3 Materials and Methods 
 
The study was replicated simultaneously at two feedlots, approximately 50 km 
apart. Angus and Angus cross heifers 12 to 15 mo of age and weighing approximately 
325 to 375 kg were used. Heifers were allocated to the following dietary groups: Flax 
seed, Sunflower seed and control. Oilseed supplementation commenced approximately 
25 d before initiation of the estrus synchronization program and continued for 50 d. 
Heifers in both locations were fed a base ration of barley silage and approximately 10% 
of either barley grain (Location A) or malt-sprout pellets (Location B). In heifers 
assigned to oil seed diets, 1.0 kg of either whole flax seed or sunflower seed, 
respectively, replaced 1.5 kg of barley or malt sprout pellets. Diets were delivered once 
daily in the form of a total mixed ration. Heifers were limit-fed and consumed an 
estimated 7.2 to 9.0 kg of feed per head per day on a dry matter basis. Heifers had ad 
libitum access to clean drinking water, cobalt iodized salt, and a calcium/phosphorous 
mineral supplement. 
 
Just prior to the start of the synchronization protocols, heifers were examined by 
transrectal ultrasonography (Aloka SSD 500 with 7.5 MHz linear-array transducer; ISM 
Inc., Edmonton, AB, Canada). Freemartin heifers and those without an ultrasonically 
detectable luteal structure and (or) ovarian follicles <10 mm in diameter and a uterine 
diameter <15 mm were excluded. A total of 983 heifers were assigned to the experiment 
(flax seed, n = 321; sunflower seed, n = 324; and control, n = 338). All heifers received a 
new intravaginal progesterone-releasing device (CIDR; Bioniche Animal Health Inc., 
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 Belleville, ON, Canada) and were randomly allocated to one of six synchronization 
treatments in a 2 x 3 factorial design. At CIDR insertion (designated Day 0), heifers 
received either 100 µg GnRH im (Fertagyl; Intervet Canada Ltd., Whitby, ON, Canada; n 
= 492) or 1 mg estradiol cypionate (ECP; Pharmacia Animal Health, Orangeville, ON, 
Canada) plus 50 mg Progesterone 5%® im (Vétoquinol N.-A Inc., Lavaltrie, QC, 
Canada) to synchronize follicle wave emergence (n = 491). On Day 7 and 8.5 in heifers 
given GnRH or ECP, respectively, the CIDR devices were removed and 25 mg dinoprost 
(Lutalyse; Pharmacia Animal Health) was given im. Heifers were then randomly 
allocated to three groups to receive: 0.5 mg ECP im at CIDR withdrawal (ECP0, n = 322) 
or 24 h later (ECP24, n = 330) or 100 µg GnRH im (GnRH52, n = 331) at TAI 
(approximately 52 to 54 h after CIDR removal). In the ECP0 and ECP24 groups, TAI 
was done between 58 and 60 h after CIDR removal. All inseminations at each location 
were performed by one technician, using commercial frozen-thawed semen. To facilitate 
treatments and handling, TAI was done on three consecutive days, with heifers in the 
ECP24, ECP0 and GnRH52 bred on the first, second and third days, respectively. Care 
was taken to handle each group in a similar fashion to minimize a day of breeding effect 
not attributable to treatment differences. 
 
Following TAI, heifers were observed for estrus and reinseminated until 33+1 d 
after TAI, at which time heifers were sent to pasture and exposed to bulls for 57 d; all 
bulls used were deemed satisfactory on a standard breeding soundness evaluation (Barth, 
2000). Mounting activity was noted approximately 4 d after TAI at Location B; overall, 
19 heifers were detected in estrus and re-inseminated at that time. All were considered 
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 open following TAI. It is noteworthy that 17/19 (89.4%) of these heifers were in the 
GnRH52 group.  
 
Ultrasonographic pregnancy diagnosis was conducted approximately 28 d after 
TAI. Fall pregnancy rate was determined approximately 150 d after TAI by rectal 
palpation. Fall pregnancy rate included all pregnancies (achieved by AI or natural 
service).  
 
Oilseeds, bulk-sampled once during the course of the trial, were analyzed for 
moisture, crude protein, crude fat and crude fibre in a commercial laboratory. Fatty acid 
methyl esters (FAME) in the oil seeds were prepared by a modification of previously 
reported procedures (Sukhija and Palmquist, 1990; Chin et al., 1992). To a 0.5 g sample, 
1 mL of hexane, 1 mL of nonadecanoic acid internal standard (C17:0, 4 mg/mL in 
hexane), and 3 mL of fresh 4% methanolic HCl were added. Tubes were tightly capped, 
vortexed, and heated for 1 h at 60 oC. After cooling, 5 mL of 6% K2CO3 and 2 mL of 
hexane were added to the tubes, which were vortexed and centrifuged. To the hexane 
extract, 1 g of Na2SO4 and 1 g of activated charcoal were added, vortexed and 
centrifuged again, and an aliquot of the clear hexane layer was used for gas 
chromatography. The FAME were analyzed on a Varian 3600 gas chromatograph (Varian 
Chromatography Systems, Walnut Creek, CA, USA) with a septum programmable 
injector and flame ionization detector. Separation of the FAME was performed using an 
AP2560 (100m x 0.25 id x 0.2 µm film thickness) fused silica capillary column (Supelco, 
Bellefonte, PA, USA). Purified helium (Praxair, Edmonton, AB, Canada) was used as the 
 55
 carrier gas with a head pressure of 25 psi and a flow rate of 1 mL/min. The initial column 
temperature was set at 40 0C and held for 4 min, increased to 175 0C at 13 0C per min and 
held for 25 min, further increased to 215 0C at 4 0C per min and held for 23 min, and 
finally increased to 230 0C at 5 0C per min and held for 17.5 min. The initial injector 
temperature was 100 0C, increasing at 150 0 0C per min to 250 C and held for 30 min. The 
detector temperature was set at 250 0C. Identification of peaks was based on comparison 
with retention times of standard FAME (GLC #85 and GLC #411, NuChek Prep, Elysian, 
MN, USA). Peak areas of each fatty acid were measured using the Scimatzu Class-VP 
chromatography data system (Shimatzu Scientific Instruments Inc, Columbia, MD, USA) 
and reported as a percentage of fatty acid methyl esters. 
 
6.3.1 Statistical Analyses 
 
The association between pregnancy status and treatment group, location, and diet 
were analysed using a General Estimating Equations (GEE) method to account for the 
clustering due to the pen effect. Data were analyzed with a statistical software program 
(PROC GENMOD; SAS Version 8.2 for Windows, SAS Institute, Cary, NC, USA). 
Model specifications included a binomial distribution, logit link function, repeated 
statement with subject equal to pen, and an exchangeable correlation structure. The 
treatment given at CIDR insertion (GnRH versus ECP) was analyzed as a fixed effect 
with two categories, and the treatment given to synchronize ovulation (ECP0, ECP24 and 
GnRH52) was analyzed as a fixed effect with three categories. Location and diet were 
considered as possible covariates and analyzed as categorical fixed effects. Variables 
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 remaining in the final multivariable model at P < 0.05, based on the robust empirical 
standard errors produced by the GEE analysis, were considered statistically significant. 
The main-effects model was assessed for first-order interactions, where treatment and 
location or diet remained in the model. Only interactions with P < 0.05 were reported. 
Model diagnostics included visual examination of the raw and standardized residuals. 
The residuals were plotted against predicted values of each observation. Rankit plots and 
Wilk-Shapiro tests were used to assess the normality of the residuals. The ratio of the 
final-model deviance to the model degrees of freedom was also examined. To locate 
differences among the six treatment groups, pregnancy rates were analyzed by Chi-square 
test. Differences in fatty acid composition between oilseeds were determined with a 
Student’s t-test. 
 
6.4 Results 
 
Pregnancy rate was not affected by treatments given at CIDR insertion (Table 1). 
However, pregnancy rates in heifers given ECP 24 h after CIDR removal (ECP24) was 
higher (P<0.005) than in those given ECP at CIDR removal (ECP0) or GnRH at TAI 
(GnRH52). Pregnancy rates following TAI were not influenced by location (53.4 and 
57.9% for Locations A and B, respectively, P=0.20) or by diet (52.1, 57.0 and 57.7% for 
control, flax seed and sunflower seed, respectively, combined for both locations; P=0.46). 
Overall pregnancy rate for AI (TAI and reinsemination) was 79.8% (785/983) and fall 
pregnancy rate was 95.9% (943/983; Table 6.1).  
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 The chemical composition of the oil seeds is presented in Table 6.2. The flax seed 
and sunflower seed included in the diets had a crude fat content of 34.5 and 35.3% and a 
dry matter content of 91.9 and 92.2%, respectively. There were profound differences in 
the proportion of linolenic acid (C18:3; 53.1 versus 0.18%) and linoleic acid (C18:2; 17.5 
versus 70.9%) in flax seed and sunflower seed, respectively. 
 
Table 6.1. Pregnancy rates to fixed-time AI, after rebreeding, and fall pregnancy rates 
in beef heifers receiving a CIDR and given 100 µg GnRH or 1 mg estradiol 
cypionate (ECP) and 50 mg Progesterone 5% (to synchronize follicular 
wave emergence), and subsequently given 0.5 mg ECP at CIDR removal 
(ECP0) or 24 h later (ECP24), or 100 µg GnRH concurrent with AI 
(GnRH52) to synchronize ovulation. 
 
                                                          GnRH                                         ECP 
    
                                         ECP0 ECP24 GnRH52 ECP0 ECP24 GnRH52 
 
No. heifers 162 165 165 160 165 166 
Fixed-time AI 1  
No. pregnant 78 109 89 90 107 80 
Pregnancy rate (%) 48.1a 66.1b 53.9a 56.2ab 64.8b 48.2a 
Rebreeding 1 
No. pregnant 47 31 40 41 31 42 
Pregnancy rate (%)2 77.2 84.8 78.2 81.9 83.6 73.5  
Fall pregnancy examination 3
No. pregnant 152 159 159 158 157 158 
Pregnancy rate (%) 93.8 96.4 96.4 98.8 95.2 95.2 
 
ab Percentages without a common superscript differ (P<0.001); ECP/ECP0 tended to 
differ from GnRH/ECP24 (P<0.07) and ECP/ECP24 (P<0.1) 
1 Pregnancy rate based on ultrasonography 
2 Accumulated pregnancy rate after two inseminations; percentages tended to differ 
(P<0.09). 
3 Pregnancy rate based on rectal palpation 
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 Table 6.2.  Chemical composition of the oil seeds used. 
 
End point Flax seed Sunflower seed 
 
Dry matter (%) 91.9 92.2 
Crude protein (%) 24.3 15.1 
Crude fibre (%) 8.2 21.2 
Crude fat (%) 35.3 34.5 
 
Fatty acid (% of total lipid) 
C16:0 6.3a 7.0b
C18:0 4.2a 5.1b 
C18:1 18.3a 15.3b
C18:2 (Linoleic) 17.5a 70.9b
a C18:3 (Linolenic) 53.1 0.18b
C20:0 0.17a 0.46b
C20:1 0.20a 0.12b
C20:3 0.16a 0.70b
C24:0 0.11a 0.20b
 
ab Within a row, means with different superscripts are different (P < 0.01). 
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 6.5 Discussion 
 
Pregnancy rate was not significantly affected by treatments given at CIDR 
insertion to synchronize follicular wave emergence (55.7 versus 56.4% for heifers that 
received GnRH versus ECP, respectively). Treatment with GnRH induces acute release 
of both LH and FSH; it is speculated that if the dominant follicle present at treatment has 
expressed LH receptors, it will ovulate. In that regard, dominant follicles acquire LH 
receptors at the time of selection, approximately 3 d after the emergence of a follicular 
wave, when the dominant follicle achieves a diameter of 8.5 mm (Xu et al., 1995; Ginther 
et al., 1996a). However, ovulation did not occur consistently in heifers expected to have a 
dominant follicle > 10 mm diameter at the time of treatment (Martínez et al., 2003b). 
Therefore, there may be other factors that determine whether ovulation occurs in 
response to GnRH treatment. It is noteworthy that treatment with GnRH synchronizes 
emergence of a new follicular wave only if ovulation occurred (Martínez et al., 1999), 
and ovulation occurred in only 55.6% of GnRH-treated heifers in that study (Martínez et 
al., 1999). However, since follicular waves emerge approximately every 7 to 10 d 
(Ginther et al., 1989a), spontaneous emergence of a new wave (in the absence of 
ovulation) would occur at approximately the same time as the emergence of a new wave 
following ovulation in some heifers.  
 
In contrast to GnRH, E-17β has been shown to synchronize follicular wave 
emergence in the majority of cattle, regardless of the stage of the follicular wave when 
treatment is administered (Adams et al., 1995; Bó et al., 1994). The mechanism 
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 responsible for estrogen-induced synchronization of follicular growth appears to be 
systemic rather than local (Bó et al., 2000) and to involve suppression of plasma FSH 
concentrations, followed by synchronous resurgence of FSH (Bó et al., 1994).   
 
Although there was no difference in pregnancy rates following TAI between 
heifers that received GnRH versus ECP in the present study, both treatments have been 
previously shown to be less efficacious than E-17β in synchronizing follicular wave 
emergence (Thundathil et al., 1999; Martínez et al., 2001; Colazo et al., 2003b, Chapter 
5). In cattle fed melengestrol acetate in a previous study, the interval from PGF to estrus 
was shorter and less variable (Martínez et al., 2001), and pregnancy rate was higher 
(Thundathil et al., 1999) in those given E-17β compared to those given GnRH. In 
addition, when beef heifers in a CIDR-based program were given either 5 mg E-17β or 1 
mg ECP, those in the latter group had a longer and more variable interval from treatment 
to emergence of a new follicular wave (Colazo et al., 2003b, Chapter 5). Only 57.1% of 
heifers given 1 mg ECP at random stages of the estrous cycle had a new follicular wave 3 
or 4 d later (Colazo et al., 2003b, Chapter 5).  
 
In the present study, fertility following TAI was significantly affected by 
treatments to synchronize ovulation. The pregnancy rate in heifers given ECP 24 h after 
CIDR removal (ECP24) was higher than in those given ECP at CIDR removal or GnRH 
at TAI (65.4, 52.2 and 51.1%, respectively). Furthermore, pregnancy rates in heifers 
given ECP 24 h after CIDR removal were nearly identical when heifers were given ECP 
or GnRH at the time of CIDR insertion (64.8 and 66.0%, respectively). In a previous 
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 study (Colazo et al., 2003b, Chapter 5) in which ECP was used to synchronize wave 
emergence, pregnancy rates were lower when ECP was given concurrent with CIDR 
removal than 24 h later. However, when 5 mg E-17β was used to synchronize wave 
emergence, the timing of ECP treatment (0 or 24 h following CIDR removal) did not 
significantly affect the interval to the LH surge, ovulation time, or pregnancy rate 
following TAI (Colazo et al., 2003b, Chapter 5).  
 
In estradiol-based regimens, administration of 0.5 to 1 mg of estradiol benzoate 
following progestin withdrawal and PGF treatment in cattle enhanced estrus detection, 
synchrony of ovulation, and pregnancy rates following TAI (Colazo et al., 1999; Ryan et 
al., 1995; Hanlon et al., 1996; Fike et al., 1997). Although administration of estradiol 24 
h after CIDR removal requires one additional handling compared to giving estradiol at 
CIDR removal or GnRH treatment concurrent with AI, this was offset by higher 
pregnancy rates in the present study. In an Ovsynch® protocol, ovulation occurred 
between 24 and 34 h after the second GnRH injection (Pursley et al., 1995), and 
numerically higher pregnancy rates were achieved when TAI was done 8 to 24 h after 
GnRH treatment (Pursley et al., 1998). However, similar pregnancy rates have been 
recently reported in beef cows synchronized with an Ovsynch® protocol as compared to 
those receiving the second GnRH treatment concurrently with AI (Small et al., 2001; 
Geary et al., 2001). In GnRH-based protocols, the second GnRH treatment is intended to 
synchronize ovulation in a majority of treated cattle. However, in the present study, 17 
heifers that received GnRH to synchronize ovulation were observed in estrus 4 d after 
TAI, suggesting that GnRH treatment did not induce ovulation in these heifers. We 
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 speculate that the dominant follicle failed to ovulate in response to GnRH treatment 
(because of asynchronous wave emergence and a small dominant follicle without LH 
receptors) and the heifers ovulated subsequent to a delayed estrus.  
 
At a feeding rate of 1 kg/heifer/day of oil seeds, the added quantities of crude fat, 
linoleic acid and linolenic acid were 353, 62 and 187 g, respectively, for flax seed, and 
345, 244 and 0.6 g for sunflower seed. Although the flax seed diet had a significantly 
greater linolenic acid content than the other two diets, its effect on fertility was not 
clearly demonstrated. In studies with lactating dairy cattle, Petit et al. (2001) and 
Ambrose et al. (2002) reported significant improvements in pregnancy rates in cows fed a 
flax seed-supplemented ration. In both studies flax seed was processed in some manner 
before feeding to cattle. In one study (Petit et al., 2001), flax seed was treated with 
formaldehyde to protect the fatty acids from undergoing biohydrogenation in the rumen, 
whereas in the other study (Ambrose et al., 2002), both flax seed and sunflower seed 
were rolled. Khorasani and Kennelly (1994) reported a significantly higher level of 
linolenic acid in milk of cows fed rolled compared to whole flax seed.  
 
In the present study, both oilseeds were fed unprocessed. Perhaps processing the 
oilseeds would have resulted in higher pregnancy rates. Furthermore, a higher level of 
oilseed feeding may have been more effective in improving pregnancy rates. Petit et al. 
(2001) included flax seed in the diet of dairy cows at 17% of the dry matter, whereas 
oilseeds were fed at an estimated 11% of dry matter in the present study, which is similar 
to that fed to dairy cows (10% of DM) in a recent study (Ambrose et al., 2002). Since 
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 feeding flax seed at 10% (on a dry matter basis) significantly increased both pregnancy 
rate (Ambrose et al., 2002) and the α-linolenic acid content of milk in lactating dairy 
cows (Ambrose, unpublished data), we expected that feeding oilseeds at the rate of 1.0 
kg/heifer/day would have the desired effect on pregnancy rates. It may be noteworthy that 
the pregnancy rate in dairy cows fed a control diet in the earlier study (Ambrose et al., 
2002) was much lower than the pregnancy rate in beef heifers fed a control diet in the 
present study (32.5 versus 52.1%, respectively); an increase in pregnancy rates is more 
likely when fertility is low to moderate in the control group. 
 
In summary, pregnancy rate following TAI was not significantly affected by the 
treatment given at CIDR insertion (100 µg GnRH versus 1 mg ECP plus 50 mg 
progesterone). However, 0.5 mg ECP given 24 h after CIDR removal resulted in a 
significantly higher pregnancy rate than 0.5 mg ECP given at CIDR removal or 100 µg 
GnRH given at TAI 52 h after CIDR removal. Although there was no significant effect of 
oilseeds on fertility, processing the oilseeds and (or) feeding higher levels of oilseed may 
be required. Further studies are required to verify and extend these findings. 
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 7.0 EFFECT OF ESTRADIOL VALERATE ON OVARIAN FOLLICLE 
DYNAMICS AND SUPEROVULATORY RESPONSE IN PROGESTIN-
TREATED CATTLE 
 
7.1 Abstract 
 
Three experiments evaluated the effects of estradiol valerate (EV) on ovarian 
follicular and CL dynamics, intervals to estrus and ovulation, and superovulatory 
response in cattle. Experiment 1 compared the efficacy of two norgestomet ear implants 
(CrestarTM and Syncro-Mate B; SMBTM) for 9 d (with PGF at implant removal), 
combined with either 5 mg estradiol-17β and 100 mg progesterone (EP) or 5 mg EV and 
3 mg norgestomet (EN) im at the time of implant insertion on CL diameter and follicular 
wave dynamics. Ovaries were monitored by ultrasonography. There was no effect of 
norgestomet implant. Diameter of the CL decreased following EN treatment (P<0.01). 
Mean (± SD) day of follicular wave emergence (FWE) was earlier (P<0.0001) and less 
variable (P<0.0001) in EP- (3.6 ± 0.5 d) than in EN- (5.7 ± 1.5 d) treated heifers. 
Intervals from implant removal to estrus (P<0.001) and ovulation (P<0.01) were shorter 
in EN- (45.7 ± 11.7 and 74.3 ± 12.6 h, respectively) than in EP- (56.4 ± 14.1 and 83.3 ± 
17.0 h, respectively) treated heifers. Experiment 2 compared the efficacy of EP versus 
EN in synchronizing FWE for superovulation in SMB-implanted cows. At random stages 
of the estrous cycle, Holstein cows (n=78) received two SMBTM implants (Day 0) and
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 were randomly assigned to receive EN on Day 0 or EP on Day 1. Folltropin-V treatments 
were initiated on the evening of Day 5, with PGF in the morning and evening of Day 8, 
when SMBTM were removed. Cows were inseminated after the onset of estrus and 
embryos were recovered 7 d later. Non-lactating cows had more CL (16.7 ± 11.3 versus 
8.3 ± 4.9) and total ova/embryos (14.7 ± 9.5 versus 7.9 ± 4.6) than lactating cows 
(P<0.05). EP-treated cows tended (P=0.09) to yield more transferable embryos (5.6 ± 5.2) 
than EN-treated cows (4.0 ± 3.7). Experiment 3 compared the effect of dose of EV on 
ovarian follicle and CL growth profiles and synchrony of estrus and ovulation in CIDR-
treated beef cows (n=42). At random stages of the estrous cycle (Day 0), cows received a 
CIDR and no further treatment (Control), or an injection of 1, 2, or 5 mg im of EV. On 
Day 7, CIDR were removed and cows received PGF. Follicular wave emergence 
occurred within 7 d in 7/10 control cows and 31/32 EV-treated cows (P<0.05). In 
responding cows, interval from treatment to FWE was longer (P<0.05) in those treated 
with 5 mg EV (4.8 ± 1.2 d) than in those treated with 1 mg (3.2 ± 0.9 d) or 2 mg (3.4 ± 
0.8 d) EV, while control cows were intermediate (3.8 ± 2.0 d). Diameter of the dominant 
follicle was smaller (P<0.05) at CIDR removal and tended (P=0.08) to be smaller just 
prior to ovulation in the 5 mg EV group (8.5 ± 2.2 and 13.2 ± 0.6 mm, respectively) than 
in the control (11.8 ± 4.6 and 15.5 ± 2.9 mm, respectively) or 1 mg EV (11.7 ± 2.5 and 
15.1 ± 2.2 mm, respectively) groups, with the 2 mg EV group (10.7 ± 1.5 and 14.3 ± 1.7 
mm, respectively) intermediate. Diameter of the dominant follicle at CIDR removal was 
less variable (P<0.01) in the 2 and 5 mg EV groups than in the control group, and 
intermediate in the 1 mg EV group. In summary, treatment with 5 mg EV resulted in a 
longer and more variable interval to follicular wave emergence than treatment with 5 mg 
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 estradiol-17β, which affected preovulatory dominant follicle size following progestin 
removal, and may have also affected superstimulatory response in Holstein cows. 
Additionally, 5 mg EV appeared to induce luteolysis in heifers, reducing the interval to 
ovulation following norgestomet removal. Conversely, intervals to, and synchrony of, 
follicular wave emergence, estrus and ovulation following treatment with 1 or 2 mg EV 
suggested that reduced doses of EV may be more useful for the synchronization of 
follicular wave emergence in progestogen-treated cattle. 
 
7.2 Introduction 
 
Norgestomet-based programs have been developed to synchronize estrus in cattle; 
estrus is suppressed in the presence of a norgestomet implant, but occurs relatively 
synchronously following implant removal (Odde, 1990). Two types of norgestomet-
releasing ear implants have been used in estrus synchronization programs; Syncro-Mate 
B (SMBTM TM) is a hydron implant containing 6 mg norgestomet, while Crestar  is a 
silicon implant containing 3 mg norgestomet. Treatment protocols with both types of 
implants include an injection of 5 mg estradiol valerate (EV) and 3 mg norgestomet at the 
time of implant insertion to stimulate uterine-induced luteolysis (Wiltbank et al., 1961), 
with implant removal after 9 d, followed by estrus detection and AI (Kastelic et al., 
1999).  
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 Exogenous estradiol has been shown to induce follicular atresia by suppressing 
circulating FSH levels (Price and Webb, 1988; Bó et al., 2000; Martínez et al., 2003a) 
shortly thereafter, a resurgence in FSH secretion occurs and a new follicular wave 
emerges 1 d later. The administration of 5 mg estradiol-17β in progestogen-implanted 
cattle was followed by the emergence of a new follicular wave 4.3 ± 0.2 d later, with little 
variability, regardless of the phase of follicular development at the time of treatment (Bó 
et al., 1995a,b). In other studies, a dose of 5 mg EV (Bó et al., 1993; Duffy et al., 2004) 
or estradiol benzoate (EB; Caccia and Bó et al., 1998), or 2 mg estradiol cypionate (ECP; 
Thundathil et al., 1997) suppressed ovarian follicle growth, but the interval to emergence 
of a new follicular wave was somewhat prolonged and quite variable. However, intervals 
to peak plasma FSH concentrations and follicular wave emergence were earlier and less 
variable in beef heifers treated with reduced doses of EB (Caccia and Bó, 1998; Martínez 
et al., 2002a, 2003a). In addition, reduced doses of EB (Martínez et al., 2000a; 2002c) or 
ECP (Colazo et al., 2003b; Colazo et al., 2004a; Chapters 5.0 and 6.0) have been used 
successfully in estrus synchronization regimens. The effects of reduced doses of EV on 
follicular wave dynamics have apparently not been investigated.  
 
The objectives of this study were to compare: 1) The effects of two different 
norgestomet ear-implants combined with two different injectable estrogen/progestogen 
hormonal treatments on the synchrony of follicular wave emergence (FWE), estrus and 
ovulation in beef heifers (Experiment 1); 2) The efficacy of estradiol valerate plus 
norgestomet with estradiol-17β plus progesterone in synchronizing ovarian FWE for 
superstimulation of SMB-implanted cows (Experiment 2); and 3) The effects of different 
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 doses (1, 2 and 5 mg) of estradiol valerate on ovarian follicle dynamics, CL development 
and intervals to FWE, estrus and ovulation in CIDR-treated beef cows (Experiment 3).  
 
7.3 Materials and Methods 
 
7.3.1 Experiment 1 
 
Seventy-six Simmental-crossbred heifers, 18 to 20 mo of age, weighing between 
380 and 520 kg, were assigned randomly at random stages of the estrous cycle and in two 
replicates to four treatment groups in a 2 x 2 factorial design (19 heifers/group). On Day 
0 (beginning of the experiment), heifers received either silicone (CrestarTM, Intervet 
Canada Ltd, Whitby, ON, Canada) or hydron (SMBTM; Syncro-Mate B, Sanofi Animal 
Health, Overland Park, KS, USA) ear implants that contained 3 and 6 mg of norgestomet, 
respectively, and were subdivided to receive an im injection of either 5 mg estradiol-17β 
and 100 mg progesterone (EP; Sigma Chemical Co, St. Louis, MO, USA) in oil or 5 mg 
estradiol valerate and 3 mg norgestomet (EN; Intervet Canada Ltd and Sanofi Animal 
Health). On Day 9, implants were removed and all heifers received 500 μg of 
cloprostenol (PGF; Estrumate, Schering-Plough Animal Health, Pointe-Claire, PQ, 
Canada).  
 
Heifers were monitored daily by ultrasonography (Aloka SSD 500 with a 7.5 
MHz linear-array transducer; ISM Inc., Edmonton, AB, Canada) to determine ovarian 
follicle regression and wave emergence and dominant follicle growth, and twice daily 
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 (starting 48 h after implant removal) to determine the time of ovulation. The diameter of 
the CL and all follicles ≥ 3 mm were measured ultrasonographically (Pierson and 
Ginther, 1984). The day of emergence of a follicular wave was defined as the day that the 
dominant follicle was first identified at a diameter of 4 mm (Ginther et al., 1989b). When 
FWE did not occur during the observation period, day of FWE, prior to treatment, was 
estimated from the size of the dominant follicle at the time of treatment. Ovulation was 
confirmed by the disappearance of a large (>10 mm) follicle that had been detected at the 
previous examination. Estrus detection was performed by visual observation twice daily 
for 40 min each. 
 
7.3.2 Experiment 2 
 
Lactating (n = 63) and non-lactating (n = 15) Holstein cows at random stages of 
the estrous cycle received two SMBTM implants (Sanofi Animal Health) on Day 0 and 
were randomly assigned to receive 5 mg EV and 3 mg norgestomet (EN; Sanofi Animal 
Health) im on Day 0, or 5 mg estradiol-17β and 100 mg progesterone (EP; Sigma 
Chemical Co) im on Day 1. Superstimulatory treatments (400 mg NIH-FSH-P1 of 
Folltropin-V; Bioniche Animal Health Inc, Athens, GE, USA) in twice daily decreasing 
doses (80, 60, 40, and 20 mg) over a 4-d period were initiated on the evening of Day 5 
(anticipated time of follicular wave emergence). Cows received PGF (Schering-Plough 
Animal Health) in the morning and evening of Day 8 and implants were removed in the 
evening of Day 8. Cows were artificially inseminated 12, 24 and 36 h after the onset of 
estrus, and 7 d later, ova/embryos were recovered nonsurgically by a single technician.  
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 Body condition scores (BCS; Edmonson et al., 1989) and numbers of lactations 
were recorded. Numbers of CL and unovulated follicles were determined by rectal 
palpation on the day of ova/embryo collection, and the numbers of ova/embryos, 
unfertilized ova and transferable embryos collected were recorded for each cow. 
 
7.3.3 Experiment 3 
 
Non-lactating, crossbred beef cows (n = 42), 3 to 9 yr of age received a 
progesterone-releasing vaginal insert (CIDR; Bioniche Animal Health; Belleville, ON, 
Canada) at random stages of the estrous cycle (designated Day 0). Cows were allocated 
randomly to one of four groups to receive no further treatment (Control; n = 10), an im 
injection of canola oil containing 1 mg (n = 11), 2 mg (n = 10), or 5 mg (n = 11) EV 
(Sigma Chemical Co) at the time of CIDR insertion. On Day 7, CIDR were removed and 
PGF (Schering-Plough Animal Health) was administered. Ovaries were examined by 
transrectal ultrasonography (as in Experiment 1) once daily from CIDR insertion (Day 0) 
to 48 h after CIDR removal (Day 9) to monitor ovarian dynamics, and thereafter, twice 
daily to determine the time of ovulation. The day of emergence of a follicular wave was 
defined as in Experiment 1. The interval from FWE to ovulation was also calculated for 
each animal. Estrus detection was performed by visual observation three times daily for 4 
d, from 24 h after CIDR removal. A responding cow was defined as having FWE within 
6 d (Days 1 to 7) after CIDR insertion. 
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 7.3.4 Statistical Analyses 
 
Data throughout this study are reported as means ± SD. All data were analyzed 
using a statistical computer software program (SAS v.8.2 for Windows; SAS Institute, 
Cary, North Carolina, USA). In Experiments 1 and 3, measurements of central tendency 
and variability in follicular wave emergence between treatment groups are displayed in 
Box and Whisker plots (Figures 1 and 3). Intervals from treatment to FWE, from FWE to 
ovulation, and from CIDR removal to estrus and ovulation, and diameters of the 
dominant follicle at progestin removal and prior to ovulation, were analyzed using 
ANOVA. The initial statistical model included animal, replicate (Experiment 1) and 
treatment (norgestomet-implant and estradiol preparation, Experiment 1, or EV dose, 
Experiment 3). As replicate and norgestomet implant were found to have no significant 
effect, the new statistical model included animal and estradiol treatment. Means were 
compared with the protected LSD test and equality of variances in intervals to FWE, 
estrus, and ovulation were compared by Bartlett's test. In Experiment 3, the number of 
follicles was analyzed using generalized estimating equations (GEE; PROC GENMOD). 
The main-effects model was assessed for first-order interactions where treatment and day 
remained in the model with P<0.05 for both variables in the GEE analysis. Data for CL 
diameter were analyzed by the Proc Mixed Model procedure in SAS using 
autoregressive-1 (AR-1) as the covariate structure for repeated measurements (Litell et 
al., 1998). In Experiment 2, numbers of CL and unovulated follicles, unfertilized ova, 
transferable embryos and total ova/embryos were analyzed using GEE. Model 
specifications included a poisson distribution, logit link function, repeated statement with 
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 subject equal to animal, and an exchangeable correlation structure. The statistical model 
included animal, body condition score (<2.5 or ≥2.5), number of lactations (one or ≥2), 
lactational status (lactating versus non-lactating), and treatment. Body condition score 
and number of lactations were found to have no significant effect and were excluded 
from the revised statistical model. Variables remaining in the final multivariable model at 
P<0.05, based on the robust empirical standard errors produced by the GEE analysis, 
were considered statistically significant. Proportional data were compared by Chi-square 
test.  
 
7.4 Results 
 
7.4.1 Experiment 1 
 
One heifer (CrestarTM/EP) lost her implant, one heifer (SMBTM/EP) had two 
follicular waves during the treatment period, and another heifer (CrestarTM/EP) was 
injured; data from these three heifers were removed from all analyses. Three heifers (two 
in the CrestarTM/EP and one in the SMBTM/EN group) did not ovulate within 6 d 
following implant removal. Replicates did not differ (P=0.7), and there was no effect of 
implant on the interval to follicular wave emergence (P=0.6) or from implant removal to 
estrus and ovulation (P=0.8). Follicular wave emergence occurred earlier (P<0.0001) and 
the interval was less variable (P<0.0001) in EP-treated (3.6 ± 0.5 d) than in EN-treated 
(5.7 ± 1.5 d) heifers (Figure 7.1), while the interval from implant removal to estrus was 
shorter (P<0.001) and tended to be less variable (P=0.09) in EN- (45.7 ± 11.7 h) than in 
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 EP- (56.4 ± 14.1 h) treated heifers. The interval from implant removal to ovulation was 
also shorter (P<0.01) and less variable (P<0.01) in the EN- (74.3 ± 12.6 h) than in the EP- 
(83.3 ± 17.0 h) treated heifers (Figure 7.2). Diameters of dominant follicle at implant 
removal and just prior to ovulation were not affected by implant treatment (P=0.8 and 
0.2, respectively). However, diameters of the dominant follicle at implant removal and 
just prior ovulation were greater (P<0.02 and 0.001) in heifers treated with EP (11.6 ± 2.0 
and 13.9 ± 1.6 mm, respectively) than in those treated with EN (10.3 ± 2.6 and 12.5 ± 2.1 
mm, respectively); variances for preovulatory dominant follicle size tended to differ 
(P=0.08). Diameter of the CL was affected by estradiol treatment (P<0.01), day 
(P<0.0001) and treatment by day interaction (P<0.0001), but there was no effect of 
implant (P=0.55). The CL diameter was smaller in EN- than in EP-treated heifers from 
Day 4 (P<0.02) to Day 9 (P<0.0001) after treatment. 
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Figure 7.1. Box and Whisker plots for day of follicular wave emergence (FWE) in 
heifers treated with either 5 mg estradiol valerate and 3 mg norgestomet 
(EN; n = 38) or 5 mg estradiol-17β and 100 mg progesterone (EP; n = 35) at 
the time of norgestomet implant insertion. The box encloses the middle 
fifty-percentile of the data and is bisected by a line at the value for the 
median (arrows). The vertical lines (whiskers) indicate the range of data 
values. Follicular wave emergence occurred earlier (P<0.0001) and the 
interval was less variable (P<0.0001) in EP- than in EN-treated heifers. 
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Figure 7.2. Numbers of heifers ovulating at 12 h intervals following norgestomet 
implant removal after treatment with either 5 mg estradiol-17β and 100 mg 
progesterone (EP; n= 33) or 5 mg estradiol valerate and 3 mg norgestomet 
(EN; n = 37) at implant insertion. The interval from implant removal to 
ovulation was shorter (P<0.01) and less variable (P<0.01) in the EN- than in 
the EP-treated heifers. 
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 7.4.2 Experiment 2 
 
Ten cows were not detected in estrus and were not inseminated (three cows in the 
EP group and seven cows in the EN group); data from these cows were removed from all 
analyses. Neither body condition score (overall mean of 2.9 ± 0.7), nor number of 
lactations (overall mean of 3.7 ± 1.6) affected superovulatory response (P=0.6). Results 
by lactational status and estradiol/progestogen treatment are shown in Table 7.1. There 
were fewer CL (8.3 ± 4.9 versus 16.7 ± 11.3; P<0.02) and total ova/embryos collected 
(7.9 ± 4.6 versus 14.7 ± 9.5; P<0.02) in lactating than in non-lactating cows. The number 
of transferable embryos tended to be higher (P=0.09) in EP-treated cows (5.6 ± 5.2) than 
in EN-treated cows (4.0 ± 3.7).  
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 Table 7.1. Mean number of CL, unovulated follicles, total ova/embryos collected, 
unfertilized ova, degenerate and transferable embryos following 
superstimulation in lactating (L) and non-lactating (NL) Holstein cows 
treated with either 5 mg estradiol-17β and 100 mg progesterone (EP) on Day 
1 or 5 mg estradiol valerate and 3 mg norgestomet (EN) on Day 0 (SMBTM 
implant insertion). 
 
 
    L/EP  L/EN  NL/EP  NL/EN 
 
No. cows 29 26 7 6 
 
b b aCL 9.2  7.2  17.4  15.8a
Range 2 to 20 2 to 30 6 to 30 2 to 30 
 
Unovulated follicles 0.9 1.0 1.3 2.2 
Range 0 to 4 0 to 5 0 to 2 0 to 5 
 
Total ova/embryos 9.4a 6.3a b b 15.1  14.2
Range 2 to 19 1 to 19 5 to 30 2 to 27 
 
Unfertilized ova 3.0a 1.3a b b 6.8  5.6
Range 0 to 14 0 to 8 0 to 27 0 to 10 
 
Degenerated embryos 1.3 1.2 0.1 1.6 
Range 0 to 9 0 to 6 0 to 1 0 to 5 
 
Transferable embryos 5.0cd 3.8d c 8.1  5.5c  
Range 0 to 18 0 to 15 3 to 27 0 to 12 
 
ab Means within a row with different superscripts differed significantly (P<0.05) 
cd Means within a row with different superscripts tended to differ (P=0.1) 
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 7.4.3 Experiment 3 
 
One cow (5 mg EV group) lost her CIDR, and all data from this animal were 
excluded from analyses. A new follicular wave did not emerge during the observation 
period in 3 of 10 control cows. Overall, 96.7% (30/31; P<0.05) of EV-treated cows had a 
new follicular wave within a range of 6 d (Days 1 to 7) following treatment (Figure 7.3). 
In responding cows, interval from treatment to wave emergence was longer (P<0.05) in 
those treated with 5 mg EV (4.8 ± 1.2 d) than in those treated with 1 mg (3.2 ± 0.9 d) or 2 
mg (3.4 ± 0.8 d) EV, while control cows were intermediate (3.8 ± 2.0 d). Intervals to 
follicular wave emergence (d) and from CIDR removal to estrus and ovulation (h) in all 
treated cows are shown in Table 7.2. Four cows ovulated between Days 0 and 2 of the 
experiment (three from the 2 mg EV treatment group and one from the control group), 
and diameters of the CL (14.0 ± 3.9 mm) and dominant follicle (13.5 ± 0.6 mm) for these 
cows on Day 0 suggested that they were in late diestrus or early proestrus at the time of 
the treatment. The interval from follicular wave emergence to ovulation was shorter 
(P<0.05) in cows treated with 5 mg EV (6.1 ± 0.6 d) than those in the control group (7.7 
± 2.1 d), or those treated with 1 (7.4 ± 1.0 d) or 2 (7.4 ± 1.1 d) mg EV; the interval was 
more variable (P<0.005) in the control group than in the 1 or 5 mg EV groups, and tended 
(P=0.07) to be more variable than in the 2 mg EV group. 
 
The number of small follicles was affected by day (P<0.005), but not by treatment 
(P=0.7). However, cows in the 1, 2, and 5 mg groups tended (P=0.08) to have more small 
follicles on Day 4, than those in the control group. When the numbers of small follicles 
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 were normalized to day of follicular wave emergence (Figure 7.4), only a day effect 
(P<0.001) was observed. The number of intermediate follicles was affected by day, 
treatment and day by treatment interaction (P<0.001). Corpus luteum diameter decreased 
over time in all groups. There was an effect of day (P<0.0001) on CL diameter, but the 
effect of treatment was not significant (P=0.3), while the treatment by day interaction 
tended (P=0.1) to be significant. Diameter of the dominant follicle was smaller (P<0.04) 
at CIDR removal and tended to be smaller (P=0.08) just prior to ovulation in the 5 mg 
EV group (8.5 ± 2.2 and 13.2 ± 0.6 mm, respectively) than in the control (11.8 ± 4.6 and 
15.5 ± 2.9 mm) or 1 mg EV (11.7 ± 2.5 and 15.1 ± 2.2 mm) groups; the 2 mg EV group 
(10.7 ± 1.5 and 14.3 ± 1.7 mm) was intermediate. Diameter of the dominant follicle at 
CIDR removal was less variable (P<0.01) in the 2 and 5 mg EV groups than in the 
control group, and intermediate in the 1 mg EV group. 
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Figure 7.3. Box and Whisker plots for day of follicular wave emergence (FWE) in 
CIDR-treated control cows (0; n = 10) or those receiving 1 mg (n = 11), 2 
mg (n = 10), or 5 mg (n = 10) estradiol valerate on Day 0 (CIDR insertion). 
The box encloses the middle fifty-percentile of data and is bisected by a line 
at the value for the median (arrows). The vertical lines (whiskers) indicate 
the range of data values. Treatment did not alter ovarian follicle dynamics in 
three control cows and one cow treated with 1 mg of estradiol valerate (* 
FWE was estimated to occur on Day –4 in this cow). 
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Figure 7.4. Numbers of small follicles (between 3 and 5 mm of diameter), normalized to 
the day of follicular wave emergence (Day 0), in beef cows treated with a 
CIDR and 0 (Control; n = 7), 1 mg (n = 10), 2 mg (n = 10), or 5 mg (n = 10) 
estradiol valerate (EV) on Day 0 (CIDR insertion). The number of follicles 
was affected by day (P<0.001) but not by treatment (P=0.7). 
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 Table 7.2. Mean (± SD) intervals from treatment with 0, 1, 2 or 5 mg estradiol valerate 
at CIDR insertion to follicular wave emergence (FWE), and from CIDR 
removal to estrus and ovulation. 
 
 
 Dose of estradiol valerate (mg)  
 
 0 1 2 5  
                                                                                                                                     
 Interval from treatment to FWE (d) 
No. cows 10 11 10 10 
Mean 2.2a 2.5a 3.4a b 4.8
x x y ySD 3.3  2.3  0.8  1.2
Range -4 to 6 -4 to 4 2 to 5 3 to 7 
Interval from CIDR removal to: 
Estrus (h) 
No. cows 9 11 10 8 
Mean 58.0 53.5 61.2 59.3  
SD 19.4 11.2 14.1 17.1  
Range 36 to 96 36 to 72 48 to 84 48 to 96  
Ovulation (h) 
No. cows 10 11 10 10 
Mean 86.4 85.1 91.2 90.0  
SD 18.6 12.5 14.1 22.1  
Range 60 to 120 72 to 108 72 to 120 72 to 132  
 
ab Means within the row with different superscripts differed significantly (P<0.05) 
xy SD within the row with different superscripts differed significantly (P<0.001) 
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 7.5 Discussion 
 
In this study, follicular wave dynamics following the administration of two 
different estradiol preparations and three different doses of an estradiol ester, estradiol 
valerate, were examined. Administration of 5 mg of E-17β resulted in synchronous 
emergence of a new follicular wave in 3.6 ± 0.5 d (Experiment 1), while administration 
of 5 mg EV resulted in FWE in 5.7 ± 1.5 d in heifers (Experiment 1) and 4.8 ± 1.2 d in 
cows (Experiment 3). In addition to the longer interval from treatment to FWE, there was 
considerably more variability following the administration of 5 mg EV. These findings 
are consistent with previous reports (Bó et al., 1993, 1995a,b), and are supported by a 
reduced superovulatory response following synchronization of FWE with 5 mg EV in 
Experiment 2. 
 
Emergence of a new follicular wave depends on a transient increase in circulating 
FSH concentrations. Following administration of estradiol and progesterone, circulating 
FSH concentrations and LH pulse amplitude and frequency have been shown to decrease, 
resulting in the regression of FSH- and LH-dependent follicles (Ireland and Roche et al., 
1982; Price and Webb, 1988; Bó et al., 1995b). As plasma estradiol concentrations begin 
to decline, a resurgence of plasma FSH concentrations occurs and emergence of a new 
follicular wave occurs approximately 1 d later.  
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 Different estradiol preparations have also been shown to suppress FSH release for 
varying intervals of time (O’Rourke et al., 2000; Martínez et al., 2003a). Esterified 
estrogens (e.g. EB, EV, and ECP) are absorbed very slowly following intramuscular 
injection; the longer the ester chain, the lower the water solubility and the longer the 
interval required for estradiol to be absorbed (reviewed in Mapletoft et al., 2002a). In this 
regard, it has been shown that peak circulating concentrations of estradiol occurred 
within 2 h after an injection of 5 mg estradiol-17β, followed by a return to baseline at 
about 36 h (Bó et al., 2000; Martínez et al., 2003a), while administration of 5 mg of EV 
or EB resulted in a much more gradual rise in circulating estradiol concentrations, 
reaching a peak at 12 to 24 h and returning to baseline at approximately 96 h (Bó et al., 
1993, Martínez et al., 2003a). In ovariectomized cows treated with 5 mg estradiol-17β, 
plasma FSH concentrations increased earlier and reached higher concentrations than in 
those treated with 5 mg EV or EB (Martínez et al., 2003a). These differences in 
circulating estradiol concentrations, and the delayed resurgence in plasma FSH 
concentrations following injection of 5 mg EV could account for the longer and more 
variable intervals from treatment to FWE observed in this study.  
 
Although an injection of 5 mg EV or EB resulted in elevated circulating 
concentrations of estradiol for at least 96 h, FSH concentrations began to increase at 
about 60 h (Martínez et al., 2003a), suggesting that there may be other factors affecting 
the resurgence in circulating FSH concentrations (Duffy et al., 2004). However, 
administration of lower doses of EB resulted in highly synchronous FWE (Caccia and 
Bó, 1998; Moreno et al., 2001; Martínez et al., 2002a), suggesting that reduced doses of 
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 estradiol esters can be useful for the synchronization of FWE (Caccia et al., 1998). 
Indeed, a dose of 1 or 2 mg EV in Experiment 3 resulted in an interval to, and synchrony 
of, FWE (3.2 ± 0.9 d and 3.4 ± 0.8 d, respectively) similar to that observed following 
administration of 5 mg estradiol-17β in Experiment 1, or reduced doses of EB in previous 
reports (Caccia and Bó, 1998; Moreno et al., 2001; Martínez et al., 2002a).  
 
A dose of 1 mg EB in beef heifers resulted in FWE in 4 d and has been used 
successfully in estrus synchronization programs for timed AI (Martínez et al., 2001). 
However, Caccia and Bó (1998) reported a less variable interval to FWE after the 
administration of 2.5 mg EB compared to 1 mg EB in beef cows. In another study (Day et 
al., 2000), first service conception rates tended to be higher following administration of 2 
mg EB (61.7%) in progestin-treated, lactating dairy cows, than following administration 
of 1 mg EB (49.0%). In Experiment 3, administration of 1 mg EV did not induce follicle 
regression in a cow that was in late diestrus at the time of treatment. It is not clear 
whether the apparent lack of response in this animal was due to the dose of EV or the 
stage of estrous cycle when the treatment was administered. Recent data suggest that it is 
difficult to induce follicle regression with estradiol and progesterone when cattle are 
treated late in the estrous cycle (Kastelic et al., 2004). In any case, it appears that a dose 
of 1 and 2 mg of either EB or EV should be recommended to synchronize FWE in estrus 
synchronization protocols for heifers and cows, respectively. Clearly, estradiol esters are 
efficacious in synchronizing FWE in cattle, providing the appropriate dose is used. 
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 Various factors have been reported to influence the superovulatory response of 
cattle (Kafi and McGowman et al., 1997), including those related to ovarian status at the 
time of gonadotropin treatments and the timing of treatment with respect to the estrous 
cycle (Lindsell et al., 1986). Nasser et al. (1993) and Baracaldo et al. (2000) have shown 
that gonadotropin treatments must be initiated at the expected time of the follicular wave 
emergence in order to optimize superovulatory response. Hence, synchronization of FWE 
prior to initiation of superstimulatory treatments in cattle is recommended (Mapletoft et 
al., 2002b). In Experiment 1, heifers receiving EV had greater variability in the interval to 
FWE than those receiving estradiol-17β, explaining the differences in superovulatory 
responses in Experiment 2; Holstein cows given estradiol-17β tended to have more 
transferable embryos than those treated with EV. Data suggest that the reason for this 
difference is that FSH treatments more closely coincided with FWE in estradiol-17β-
treated cows. However, data also suggest that when using estradiol esters, a 2 mg dose of 
EB (Caccia et al., 1998) or EV (Experiment 3), in combination with a progestin, would 
be efficacious in the synchronization of FWE for superstimulation, regardless of the 
category of animal.  
 
Superstimulatory response was also affected by lactational status at the time of 
initiation of gonadotropin treatments. Lactation is an extrinsic factor that has been shown 
to affect superovulatory responses of cattle (Lindsell et al., 1986). However, the effect of 
lactation is probably related more to level of nutrition and energy balance within 
individual animals. In this regard, a negative energy balance during lactation has been 
shown to be associated with decreased LH pulse frequency, and decreased growth rates 
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 and diameters of dominant follicles (Roche et al., 2000). It has also been hypothesized 
that follicles growing under these circumstances may contain oocytes of inferior quality 
(Britt, 1992). In the current study, non-lactating cows had more CL, total ova/embryos 
and transferable embryos than lactating cows. However, the numbers of transferable 
embryos seemed to be affected more by superovulatory response than oocyte/embryo 
quality. 
 
Estrogens are involved in natural luteolysis, and the luteolytic effects of 
exogenously administered estrogens have been shown to be mediated through uterine 
release of PGF (Hixon et al., 1983; Peterson et al., 2000). Although mean CL diameter 
was reduced 24 and 48 h after treatment with 5 mg estradiol-17β in this study, it 
subsequently returned to pre-treatment values and was maintained until implant removal. 
In contrast, the reduction in diameter of the CL following treatment with 5 mg EV was 
sustained and at implant removal CL diameter was significantly smaller than in the 
estradiol-17β-treated group. These findings confirm the luteolytic effect of estradiol 
esters in cattle (Wiltbank et al., 1961; Scaramuzzi et al., 1974; Munro and Moore, 1985); 
plasma progesterone concentrations decreased from 2 to 7 d after treatment with 5 mg 
EB, depending on stage of the estrous cycle when treatment was initiated (Munro and 
Moore, 1985). However, the luteolytic effects of estradiol esters would also appear to be 
dose related; a decreased CL diameter was clearly evident 4 d after treatment with 5 mg 
of EV in Experiments 1 and 3, but there was no evidence that doses of 1 or 2 mg EV 
affected luteal function in Experiment 3. 
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 Following implant removal, heifers treated with 5 mg EV had a shorter interval to 
estrus and ovulation than those treated with 5 mg estradiol-17β. Although it has been 
shown that the interval to ovulation is affected by the stage of development of the 
dominant follicle at the time of PGF treatment (Kastelic et al., 1990a; Colazo et al., 
2002b), EV-treated heifers had a smaller dominant follicle at time of PGF treatment (and 
implant removal) in the present study. The interval to estrus and ovulation may have been 
influenced by the low circulating progesterone concentrations at the time of implant 
removal, or the prolonged circulating blood levels of estradiol following the 
administration of 5 mg EV. In another study in ovariectomized cows (Larson and 
Kiracofe, 1995), plasma estradiol concentrations were found to remain elevated for 
approximately 10 d following injection of 5 mg EV, and behavioural estrus was detected 
shortly after norgestomet implant removal on Day 9. In a more recent study (Martínez et 
al., 2003a), 5 of 6 ovariectomized cows treated with 5 mg EV at CIDR insertion showed 
behavioural estrus within 12 h after CIDR removal on Day 7. 
 
Interestingly, EV-treated heifers also ovulated more synchronously than those 
treated with estradiol-17β. However, heifers given 5 mg EV also had a shorter interval 
from FWE to ovulation; the smaller diameter of the preovulatory follicle could result in 
reduced fertility. Recent reports indicate that GnRH-induced ovulation of small (≤ 12 
mm) dominant follicles may result in either lower fertility to timed AI (Vasconcelos et 
al., 2001; Colazo et al., 2004c) or increased embryonic losses (Perry et al., 2003). 
Therefore, fertility following progestin removal may be adversely affected by a dose of 5 
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 mg EV compared to smaller doses of EV or 5 mg estradiol-17β in a 7 or 9 d progestin 
protocol.  
 
In conclusion, estradiol treatment affected ovarian follicular dynamics; the 
interval from treatment to FWE in heifers was longer and more variable following 
treatment with 5 mg of EV than with 5 mg of estradiol-17β. The asynchrony of wave 
emergence following administration of 5 mg EV compared to treatment with estradiol-
17β resulted in a reduced number of transferable embryos following superstimulation of 
Holstein cows. Treatment with 5 mg EV also resulted in luteolysis in norgestomet-
implanted heifers, and a shorter interval from implant removal to estrus and ovulation. 
Dominant follicle diameter at progestin removal and just prior to ovulation was affected 
by dose and estradiol preparation. However, ovarian FWE and synchrony of estrus and 
ovulation in CIDR-treated cows given 1 or 2 mg EV were similar to those of 
norgestomet-implanted cows given estradiol-17β, suggesting that reduced doses of EV 
may be useful in protocols designed for superstimulation or estrus synchronization for 
timed AI.  
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 8.0 FERTILITY IN BEEF CATTLE GIVEN A NEW OR PREVIOUSLY USED 
CIDR INSERT AND ESTRADIOL, WITH OR WITHOUT 
PROGESTERONE. 
 
8.1 Abstract 
 
The objective was to compare pregnancy rates following timed AI (TAI) in beef 
cattle given a new or previously used CIDR insert and injections of estradiol, with or 
without progesterone, to synchronize follicular wave emergence. In Experiment 1, heifers 
(n = 616) received a new or once-used CIDR insert for 9 d and were given 1 mg estradiol 
cypionate (ECP), with or without 100 mg of a commercial progesterone preparation (CP), 
at CIDR insertion. Heifers were treated with PGF at CIDR removal and 0.5 mg ECP im 
24 h later, with TAI 55 to 60 h after CIDR removal. Pregnancy rate was not affected by 
either the number of CIDR uses (P=0.59; 48.3 versus 46.2% for new versus once-used 
CIDRs, respectively) or the addition of progesterone (P=0.42; 45.6 versus 48.8% for 
ECP+CP and ECP, respectively). In Experiment 2 (replicated at two locations), heifers (n 
= 56) and lactating beef cows (n = 307) received a once- or twice-used CIDR and an im 
injection of 1 mg estradiol benzoate (EB), with or without 100 mg progesterone, at CIDR 
insertion. Cattle received PGF in the ischiorectal fossa at CIDR removal (Day 7) and 1 
mg EB im 24 h later, with TAI 52 to 56 h after CIDR removal. Pregnancy rate was 
affected by location (P<0.002; 46.0 versus 61.1% for Locations A and B, respectively), 
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 parity (P<0.04; 67.9 versus 53.1% in heifers and cows, respectively) and numbers of 
times the CIDR had been used (P<0.03; 62.4 versus 48.4% for once- and twice-used 
CIDRs, respectively). However, the addition of progesterone to the injection of EB at 
CIDR insertion did not affect pregnancy rate (P=0.6). In Experiment 3, heifers (n = 187) 
received one new, one once-used, one twice-used or two twice-used CIDRs for 7 d and 2 
mg EB plus 50 mg of CP at the time of CIDR insertion. Heifers were treated with PGF at 
CIDR removal and 1 mg EB im 24 h later, with TAI 52 to 56 h after CIDR removal. 
Pregnancy rate was not affected by treatments (P=0.28; 57.5, 63.8, 47.9, 47.9% for one 
new, one once-used, one twice-used, or two twice-used CIDRs, respectively). In 
summary, pregnancy rate following TAI did not differ between cattle synchronized with 
a new or once-used CIDR, but pregnancy rate was lower in cattle synchronized with a 
twice-used CIDR; however, the insertion of two twice-used CIDRs did not affect 
pregnancy rates. The addition of an injection of progesterone to the estradiol treatment at 
CIDR insertion did not enhance pregnancy rate following TAI.  
 
8.2 Introduction 
 
Administration of estradiol in progestin-treated cattle (Bó et al., 1995b; Caccia 
and Bó, 1998; Martínez et al., 2000b) has been shown to result in emergence of a new 
ovarian follicular wave 3 to 5 d later. However, the administration of estradiol alone to 
cattle without progestin implants (Bó et al., 1994) or concurrent with PGF-induced 
luteolysis (Burke et al., 1997b) had variable effects on follicular growth profiles, and 
emergence of the next follicular wave was often delayed. In addition, estradiol 
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 concentrations in the largest follicle were suppressed following administration of 
estradiol benzoate and progesterone, whereas intrafollicular concentrations of estradiol 
were unchanged in heifers given only estradiol benzoate (Diskin et al., 2002), suggesting 
that follicular wave emergence may be more synchronous when progesterone was added 
to the synchronization protocol. However, insertion of a new CIDR for at least 24 h 
resulted in atresia of a persistent dominant follicle and synchronous emergence of a new 
follicular wave (Cavalieri et al., 1998), and the insertion of a new CIDR concurrent with 
administration of PGF was sufficient to facilitate estradiol-induced follicular wave 
emergence in cattle (Burke et al., 1998).  
 
When ovariectomized beef cows received a once-used CIDR, a concurrent 
injection of 100 mg of progesterone was needed to achieve plasma progesterone 
concentrations (by 24 h after CIDR insertion) that were similar to those in cows treated 
with a new CIDR (Martínez et al., 2003a). Although the initial progesterone release by a 
new CIDR insert might be sufficient to induce dominant follicle regression in cattle and 
ensure the presence of a growing dominant follicle following CIDR removal, follicular 
wave emergence may be more synchronous following treatment with estradiol and 
progesterone, in combination, especially when a new CIDR was not used. 
 
Many CIDR-based estrus synchronization protocols for timed AI (TAI) in cattle 
include an injection of estradiol and progesterone at CIDR insertion (to synchronize 
follicular wave emergence), with CIDR removal 7 or 8 d later. As CIDR inserts release 
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 progesterone for at least 15 d (Macmillan et al., 1991; Macmillan and Peterson, 1993), a 
CIDR could potentially be used at least twice in current estrus synchronization protocols. 
 
The objective of the present study was to determine pregnancy rates following 
TAI during spring breeding in western Canada in beef cattle given a new or previously 
used CIDR, and injections of estradiol, with or without progesterone, to synchronize 
follicular wave emergence.  
 
8.3 Materials and Methods 
 
8.3.1 Experiment 1 
 
Angus and Angus-cross beef heifers, 12 to 15 mo of age and 280 to 400 kg of 
weight were managed in a drylot and fed a barley silage-based diet. At the beginning of 
the synchronization program, heifers were examined by transrectal ultrasonography 
(Aloka SSD 500 equipped with a 7.5 MHz linear-array transducer; ISM Inc., Edmonton, 
AB, Canada) to determine cyclicity (evidence of luteal tissue) and eliminate those with 
abnormalities of the reproductive tract. On Day 0, heifers at random stages of the estrous 
cycle received either a new (n = 300) or once-used (n = 316) controlled internal drug 
release vaginal insert (CIDR; Bioniche Animal Health Canada Inc., Belleville, ON, 
Canada) and 1 mg estradiol cypionate (ECP; Pharmacia Animal Health, Orangeville, ON, 
Canada) alone, or plus 100 mg progesterone (CP; Progesterone 5%; Vétoquinol N-A Inc., 
Lavaltrie, QC, Canada), in a two by two factorial design.  
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 After initial use, the once-used CIDR inserts were soaked in a povidone-iodine-
based detergent solution (Betadine Scrub; Purdue Pharma, Pickering, ON, Canada) for 
approximately 2 h, individually scrubbed with a brush, thoroughly rinsed with water, 
allowed top air-dry and autoclaved (at 250°C and 20 psi for 30 min), fast-dried exhaust 
for 20 min, wrapped in brown paper, and stored at room temperature until use. The 
CIDRs were inserted into the vagina as described by Macmillan et al. (1991) and the 
nylon filament attached to the CIDR was cut even with the vulva lips to minimize 
removal by pen-mates. On Day 9, CIDRs were removed and heifers received 25 mg 
dinoprost (Lutalyse; Pharmacia Animal Health) into the ischiorectal fossa (Colazo et al., 
2002a); 24 h later, heifers received 0.5 mg ECP im.  
 
Artificial insemination was done from 55 to 60 h after CIDR removal (Colazo et 
al., 2003b), using frozen-thawed semen from two different bulls, randomized with respect 
to treatment groups. Transrectal ultrasonography for pregnancy diagnosis was done 
approximately 35 d after TAI.  
 
8.3.2 Experiment 2  
 
Location A 
 
Puberal crossbred beef heifers, 13 to 15 mo of age (n = 32), and lactating 
crossbred beef cows (n = 105), kept in an outdoor paddock under drylot conditions (fed a 
silage-based diet) were examined as described in Experiment 1. Body condition score 
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 (range, 1 to 5; Houghton et al., 1990) and days postpartum were recorded for cows. On 
Day 0, cattle (at random stages of the estrous cycle) received a once-used (n = 66) or 
twice-used (n = 71), autoclaved CIDR (as in Experiment 1) and an im injection of 1 mg 
estradiol benzoate (EB) alone, or plus 100 mg progesterone (P; both from Sigma 
Chemical Co, St. Louis, MO, USA), in 2 mL canola oil, by replicate (as they came 
through the chute), in a two by two factorial design. All cattle received 500 μg 
cloprostenol (Estrumate; Schering Plough Animal Health, Pointe-Claire, QC, Canada) 
into the ischiorectal fossa at CIDR removal on Day 7 and 1 mg EB im 24 h later. The 
CIDR inserts had been previously used for 7 d (once-used) or 14 d (twice for 7 d; twice-
used) prior to this study. In all cattle, TAI was done between 52 and 54 h after CIDR 
removal, using frozen-thawed semen from two different bulls (randomized with respect 
to treatment groups). Ultrasonographic pregnancy diagnosis was done (as in Experiment 
1) 28 d after TAI.  
 
Location B 
 
Puberal Angus beef heifers (n = 24) and lactating crossbred beef cows (n = 202) 
managed under pasture conditions were used at this location. Body condition and 
postpartum intervals were recorded for cows. Cattle were examined by transrectal 
ultrasonography as at Location A and received a once-used (n = 115) or twice-used (n = 
111), autoclaved CIDR insert for 7 d (at random stages of the estrous cycle), and estradiol 
and progesterone treatments as at Location A. Artificial insemination was done (by a 
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 single inseminator) from 27.5 to 32.5 h after the second injection of EB (equivalent to 
51.5 to 56.5 h after CIDR removal). Pregnancy diagnosis was done as at Location A. 
 
8.3.3 Experiment 3 
 
Angus and Angus-cross beef heifers (n = 187), 12 to 15 mo of age and 
approximately 300 to 425 kg were kept in outdoor paddocks under drylot conditions and 
fed a barley silage-based diet. On Day 0, heifers (at random stages of the estrous cycle) 
were randomly assigned to four groups to receive one new (n = 33), one once-used (n = 
58), one twice-used (n = 48) or two twice-used (n = 48) CIDR inserts and 2 mg EB 
(Sigma Chemical Co) plus 50 mg CP (Vétoquinol N-A Inc.). The previously used CIDR 
inserts were washed, dried, and autoclaved before use as in Experiments 1 and 2. On Day 
7, CIDRs were removed and heifers received 500 μg cloprostenol (Estrumate; Schering 
Plough Animal Health); on Day 8 (24 h later), heifers received 1 mg EB im. Artificial 
insemination was done 52 to 56 h after CIDR removal, using frozen-thawed semen from 
two different bulls, randomized with respect to treatment groups. Pregnancy diagnosis 
was done 34 to 35 d after TAI by transrectal ultrasonography. 
 
8.3.4 Statistical Analyses 
 
In Experiment 1, pregnancy status was analyzed with the Mantel-Haenszel test. 
All other qualitative comparisons in Experiments 1 and 3 were done by Chi-square 
procedures. In Experiment 2, the association between pregnancy status and treatment 
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 group, location, and parity were analyzed using generalized estimating equations (GEE). 
Data were analyzed using a statistical computer software program (PROC GENMOD; 
SAS v.8.2 for Windows, SAS Institute, Cary, NC, USA). Treatments were analyzed as 
fixed effects with two categories; location and parity were considered as possible 
covariates and analyzed as categorical fixed effects. Variables remaining in the final 
multivariable model at P<0.05, based on the robust empirical standard errors produced by 
the GEE analysis, were considered statistically significant. The main-effects model was 
assessed for first-order interactions where treatment and location or parity remained in 
the model with P<0.05 for both variables in the GEE analysis. Only interactions that were 
P<0.10 are reported.  
 
8.4 Results 
 
8.4.1 Experiment 1 
 
At the beginning of the experiment, 16.4% (101/616) of heifers were prepuberal 
(absence of luteal tissue). However, pregnancy rate did not differ (P=0.42) between 
prepuberal (43.6%) and puberal heifers (48.0%) or among treatments (P=0.47; overall, 
47.2%, Table 8.1). A total of seven CIDR inserts (1.1%) were lost; one was new and the 
other six were used (P<0.07). 
 98
 Table 8.1. Pregnancy rates after fixed-time AI in beef heifers that received a new or 
once-used CIDR plus an im injection of 1 mg estradiol cypionate (ECP) 
with (+CP) or without (-CP) 100 mg of a commercial progesterone 
preparation at the time of CIDR insertion. 
 
 
 CIDR 
 
 New Once-used 
 
 +CP -CP +CP -CP  
 
 
Heifers pregnant (n) 70/149 75/151 71/160 75/156 
 
Pregnancy rate (%) 46.9 49.6 44.3 48.0 
 
 
Pregnancy rates did not differ among treatment groups (P=0.47). 
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 8.4.2 Experiment 2 
 
 The mean (± SEM) body condition score for cows was 2.8 ± 0.28 (range, 2 to 4) 
and postpartum interval was 72.3 ± 11.6 d (range, 42 to 91 d) at Location A, and 2.8 ± 
0.27 (range, 2 to 3.5) and 91.5 ± 25.5 d (range, 41 to 176 d), respectively at Location B. 
There were effects of CIDR treatment (P<0.03), location (P<0.002), parity (P<0.0.4) and 
a location by CIDR treatment interaction (P<0.06) on pregnancy rates. However, 
pregnancy rate was not affected by body condition score (P=0.4) or injection of 
progesterone at the time of CIDR insertion (P=0.6).  
 
Pregnancy results are shown in Table 8.2. Overall, cattle that were treated with a 
once-used CIDR had a higher pregnancy rate than those treated with a twice-used CIDR 
(62.4 versus 48.4%, respectively), heifers had a higher pregnancy rate than cows (67.9 
versus 53.1%, respectively), and cattle at Location B had a higher pregnancy rate than 
those at Location A (61.1 versus 46.0%, respectively). Only cows lost CIDR inserts; the 
CIDR loss rate was 15.2% (16/105) at Location A and 6.9% (14/202) at Location B. 
Although there was no difference (P=0.6) in CIDR loss rate between those used once 
(14/30) or twice (16/30), cows that lost their CIDR inserts at Location A had a shorter 
(P<0.003) postpartum interval (67.0 ± 3.3 d) than those that did not (76.4 ± 1.1 d). 
Pregnancy rate was lower (P<0.0001) in cows that lost their CIDR inserts than those that 
did not (20.0 versus 56.7%, respectively). 
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 Table 8.2. Pregnancy rates following fixed-time AI in beef cattle synchronized with a 
once- or twice-used CIDR plus an im injection of 1 mg estradiol benzoate 
with (+P) or without (-P) 100 mg progesterone at the time of CIDR 
insertion. 
 
 
 CIDR 
    
 Once-used Twice-used 
 
 +P -P +P -P 
  
Location A  
Cattle pregnant (n) 18/34 14/32 15/35 16/36 
Pregnancy rate (%) 52.9 43.8 42.9 44.4 
 
Location B 
Cattle pregnant (n) 42/59 39/56 31/55 26/56 
a Pregnancy rate (%) 71.2 69.6a 56.4ab 46.4b
 
Overall 
Cattle pregnant 60/93 53/88 46/90 42/92 
c Pregnancy rate (%) 64.5 60.2c 51.1cd 45.6d
 
ab Within a row, percentages without a common superscript differ (P<0.03) 
cd Within a row, percentages without a common superscript differ (P<0.05) 
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 8.4.3 Experiment 3 
 
Pregnancy rates following TAI did not differ (P=0.28) among groups. Pregnancy 
rates were 57.5% (19/33) for one new CIDR, 63.8% (37/58) for one once-used CIDR, 
47.9% (23/48) for one twice-used CIDR, and 47.9% (23/48) for two twice-used CIDR 
inserts. 
 
8.5 Discussion 
 
Although fertility following TAI was not different between cattle receiving a new 
or once-used CIDR, pregnancy rate was reduced in cattle receiving a twice-used CIDR in 
Experiment 2. These results could not be confirmed statistically with the number of 
animals available in Experiment 3, but pregnancy rate in heifers treated with a twice-used 
CIDR was numerically lower, and this was not improved by the inclusion of two twice-
used CIDR inserts. The amount of progesterone released from a CIDR over a 15-d period 
has been reported to be highly repeatable (Macmillan et al., 1991; Macmillan and 
Peterson, 1993); plasma progesterone concentrations in ovariectomized cows on Days 14 
and 15 were 1.9 (Macmillan et al., 1991) and 2.3 ng/mL, respectively (Peterson and 
Henderson, 1991), suggesting that a CIDR could be used for at least two 7-d 
synchronization protocols. Plasma progesterone concentrations above 1 ng/mL were 
expected to be sufficient to suppress the endogenous LH surge (Savio et al., 1993). 
However, the lower pregnancy rate observed in cattle receiving a twice-used CIDR insert 
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 suggested that blood progesterone concentrations may not have been maintained in all 
cattle throughout the 7-d protocol. 
 
In progestin-treated cattle, the development of persistent follicles can be avoided 
by the administration of exogenous steroids at the initiation of progestin treatment. 
However, administration of estradiol to cattle with low endogenous progesterone 
concentrations had variable effects on follicle development (Bó et al., 1994; Burke et al., 
1997b). In cattle with luteal phase progesterone concentrations, estradiol treatment 
reduced both plasma FSH concentrations (Martínez et al., 2003a) and LH pulse frequency 
(Price and Webb, 1988; Diskin et al., 2002), resulting in follicle regression, followed by 
synchronous follicular wave emergence (Bó et al., 1994). We hypothesized that the 
ability of estradiol to consistently induce follicle regression (and synchronize follicular 
wave emergence) at any stage of the estrous cycle is dependent on elevated plasma 
progesterone concentrations. Since a proportion of cattle are expected to have low plasma 
progesterone concentrations when a CIDR-based synchronization protocol was initiated 
at random stages of the estrous cycle, progesterone has been included with the estradiol 
treatment, even when a new CIDR insert was used. Nevertheless, in the present study, 
fertility was not improved by the addition of an injection of progesterone at the time of 
insertion of a new or used CIDR in cattle at random stages of the estrous cycle. In this 
regard, Burke et al. (1998) demonstrated that progesterone from a new CIDR insert was 
sufficient to facilitate estradiol-induced follicle atresia in heifers in which luteolysis had 
been induced with an injection of PGF. This also suggests that fertility would not be 
compromised when treatment with estradiol and a new CIDR insert is initiated in cattle 
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 with low progesterone concentrations. However, other studies suggest that a combination 
of estradiol and progesterone did not consistently induce follicular atresia in cattle with 
low concentrations of circulating progesterone e.g., late in the estrous cycle (Martínez et 
al., 2002a; Colazo et al., 2003b, Chapter 5). Further studies are needed to characterize the 
effect of estradiol and progesterone treatments on follicular dynamics and fertility in 
cattle treated late in the estrous cycle. 
 
In the second experiment, fertility differed between the two locations; cattle at 
Location A had a lower pregnancy rate than those at Location B. One possible reason of 
this finding may have been the shorter postpartum interval in cows at Location A; the 
number of estrous periods prior to insemination has been shown to affect conception rate 
in dairy cows (Thatcher and Wilcox, 1973; Darwash et al., 1997). Although the same 
probably applies to beef cattle, low pregnancy rates in early post-partum beef cows have 
also been associated with development of a CL with a short life-span (Manns et al., 
1983). In the present study, 97.1% of the cows were cycling (based on the presence of 
luteal tissue) at the beginning of the experiment. Furthermore, progestin treatment prior 
to the induction of ovulation in post-partum cows has been shown to result in a CL with a 
normal life span (Ramirez-Godinez et al., 1981). However, fertility may have been 
adversely affected by ovulation of a low quality oocyte, embryo death, or an oviductal or 
uterine environment hostile to the developing embryo (Butcher et al., 1992; Inskeep, 
1995).  
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 Cows (in particular Location A) had a high CIDR loss rate, which seemed higher 
than that reported by others (Macmillan and Peterson, 1993; Lucy et al., 2001), but was 
similar to that reported by Martínez et al. (2000a). In Experiment 1, the CIDR loss rate 
tended to be higher in heifers receiving a used CIDR than in those receiving a new CIDR. 
Since the nylon filament attached to the CIDR was trimmed, it is unlikely that the loss 
rate was due to pen-mates pulling the CIDR out. In Experiment 2, cows that lost their 
device had a significantly shorter postpartum interval than cows that did not; the tonicity 
of the vaginal wall may increase with postpartum interval and a used CIDR may not press 
as tightly against the vaginal wall as a new CIDR. 
 
Although pregnancy rates were low in cows that lost their CIDR in this study, 
Martínez et al. (2000a) did not detect differences in estrus or pregnancy rates between 
cows that lost CIDR inserts and those that did not. However, in the present study, a 
number of cows (n = 7) that lost CIDRs were observed in estrus prior to the second EB 
treatment; these cows were unlikely to become pregnant following TAI. Burke et al. 
(2000) observed that the administration of 1 mg EB during diestrus shortened luteal 
lifespan, suggesting that the administration of estradiol in this study may have induced 
luteolysis, at least in some cattle. Therefore, some cows that lost their CIDRs may have 
had premature luteal regression, and as a result, ovulated prior to TAI. In any case, the 
loss of the used CIDRs in this study was associated with a reduced pregnancy rate, which 
would have diminished or even nullified the economic benefits of CIDR re-use.  
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 Although there are apparently no reports of disease transmission associated with 
the re-use of CIDR inserts, there is considerable potential for this to occur. In previous 
experiments (Colazo et al., 2003b, Chapter 5) we have soaked used CIDRs in a povidone-
iodine-based detergent, followed by scrubbing with a brush and rinsing with water to 
remove detergent and debris. The efficacy of this approach for prevention of disease is 
unknown. Although prolonged exposure to detergents may decrease the potential for 
disease transmission, it may also contribute to increased losses of progesterone. In the 
current experiments, CIDR inserts were autoclaved to minimize the risk of disease 
transmission. There are apparently no reports of plasma progesterone concentrations in 
cattle that received a washed as compared to an autoclaved CIDR. A further 
consideration for CIDR re-use is that the insert should be completely dry prior to 
prolonged storage, to minimize potential for microbial growth. 
 
In summary, pregnancy rates following TAI did not differ between cattle 
synchronized with a new- or once-used CIDR. However, cattle treated with a twice-used 
CIDR had a lower pregnancy rate, and the inclusion of two twice-used CIDRs did not 
significantly improve pregnancy rates following TAI. The addition of 100 mg 
progesterone to estradiol treatment (to synchronize follicular wave emergence) did not 
affect pregnancy rates, regardless of whether a new or used CIDR insert was used. 
Pregnancy rates following TAI were affected by parity; heifers were more fertile than 
cows. Overall, pregnancy rates following TAI were acceptable whether a new or a once 
used-CIDR was used and whether or not progesterone was administered at the time of 
CIDR insertion.  
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 9.0 RESYNCHRONIZATION OF PREVIOUSLY TIMED-INSEMINATED 
BEEF HEIFERS WITH PROGESTINS  
 
9.1 Abstract 
 
The objective was to determine the efficacy of a previously used CIDR insert or 
melengestrol acetate (MGA; 0.5 mg/head/d) for resynchronization of estrus in beef 
heifers not pregnant to timed-AI (TAI). In three experiments and a field trial, heifers were 
re-inseminated 6 to 12 h after first detection of estrus. Pregnancy diagnosis was done 
approximately 25 to 43 d after either TAI or the second AI. In Experiment 1, 79 heifers 
received a once-used CIDR from 13 to 20 d after TAI and 80 heifers were untreated 
controls. For these two groups, there were 34 and 35 heifers, respectively, not pregnant 
following TAI; mean ± SD intervals from TAI to onset of estrus were 21.9 ± 1.1 d versus. 
19.0 ± 2.1 d (means, P<0.001; variance, P=0.07); estrus rates were 70.6 versus. 85.7% 
(P=0.1); conception rates were 62.5 versus. 76.7% (P<0.3); and pregnancy rates were 
44.1 versus. 65.7% (P=0.07). In Experiment 2, heifers (n=651) were TAI (Day 0) and 13 
d later randomly assigned to one of seven groups (n=93 per group) to receive a once-used 
CIDR (three groups; Days 13 to 20), MGA (three groups; Days 13 to 19), or no treatment 
(Control). The three groups were: no further treatment (CIDR or MGA alone), 1.5 mg 
estradiol-17β (E-17β) and 50 mg progesterone (P) in 2 mL canola oil on Day 13, or E-
17β and P on Day 13 and 0.5 mg E-17β on Day 21 (24 h after CIDR removal or 48 h 
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 after the last feeding of MGA). Pregnancy rate following TAI was lowest (P<0.05) for 
the group given a CIDR and E-17β and P on Day 13 and E-17β on Day 21. Variability in 
return to estrus was greater (P<0.001) in the control than in progestin-treated groups. 
Conception and pregnancy rates in heifers given a CIDR (65.1 and 61.4%) were higher 
(P<0.01) than those fed MGA (49.6 and 40.4%), but not different from controls (62.2 and 
54.9%, respectively). In Experiment 3, 616 heifers received a once- or twice-used CIDR 
for 7 d, beginning 13 ± 1 d after TAI, with or without a concurrent injection of 150 mg of 
P, in a 2 x 2 factorial design. Pregnancy rate following TAI was 47.2%. In heifers that 
returned to estrus, there was no significant difference between once- or twice-used CIDR 
for rates of estrus (68.8%, P<0.3), conception (65.9%, P<0.6) and pregnancy (45.3%, 
P<0.8). Injecting progesterone at CIDR insertion increased the interval from CIDR 
removal to onset of estrus (2.5 versus. 2.3 d, P<0.05) and reduced rates of estrus (63.8 
versus. 73.8%, P<0.05), conception (60.5 versus. 70.6%, P=0.1) and pregnancy (38.6 
versus. 52.2%, P<0.02). In a field trial, 983 heifers received a once-used CIDR for 7 d, 
beginning 13 ± 1 d after TAI. Pregnancy rate following TAI was 55.2%. The median (and 
mode) of the interval from CIDR removal to estrus was 2.5 d. Estrus, conception and 
pregnancy rates were 78.2, 70.3 and 55.0% (overall pregnancy rate following TAI and 
rebreeding, 78.7%). In summary, a once- or twice-used CIDR for 7 d, starting 13 ± 1 d 
after TAI resulted in the majority of nonpregnant heifers detected in estrus over a 4-d 
interval, with acceptable conception rates; however, injecting progesterone at CIDR 
insertion significantly reduced both estrus and pregnancy rates, and estradiol treatment 
after CIDR removal decreased pregnancy rate following TAI. Fertility was higher in 
heifers resynchronized with a once-used CIDR than with MGA. 
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 9.2 Introduction 
 
There are several progestin-based protocols for synchronizing ovulation in cattle, 
enabling timed-artificial insemination (TAI) (Martínez et al., 2000a; 2002b; Colazo et al., 
2003b, Chapter 5; Colazo et al., 2004a, Chapter 6). Most cattle that fail to become 
pregnant following TAI return to estrus 15 to 25 d later (Van Cleef et al., 1996; Chenault 
et al. 2003). Hence, intensive estrus detection and re-insemination of cattle returning to 
estrus is required to maximize the number of cattle becoming pregnant to AI. Although 
the duration of estrus detection and rebreeding could be minimized by either inserting a 
previously used CIDR insert (Macmillan and Peterson, 1993; Van Cleef et al., 1996; 
Stevenson et al., 2003) or feeding MGA (Stevenson et al., 2003), fertility may be 
compromised by prolonged growth and dominance of the ovulatory follicle in cattle with 
luteal regression prior to progestin withdrawal (Stevenson et al., 2003). Therefore, in the 
absence of treatments to induce a new follicular wave, fertility to a re-insemination in 
progestin-treated cattle could be compromised by ovulation of a persistent follicle (Savio 
et al., 1993).  
 
Since pregnancy diagnosis by transrectal ultrasonography is usually not 
performed until at least 27 to 28 d after AI, treatments designed to induce a new follicular 
wave should not jeopardize pregnancy rate following TAI. Although estradiol benzoate 
treatment increased both the percentage of non-pregnant cows returning to estrus 
(Macmillan et al., 1997; Stevenson et al., 2003) and conception rates at the 
resynchronized estrus (Macmillan et al., 1997), estradiol benzoate administered on Day 
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 13 after TAI also decreased pregnancy rate in beef heifers (Cutaia et al., 2002). The use 
of a shorter-acting estradiol (i.e. estradiol-17β) warrants investigation. Furthermore, since 
progesterone treatment (100 or 200 mg per se, or a CIDR insert for at least 24 h) induced 
atresia of persistent follicles (Anderson and Day, 1994; Cavalieri et al., 1998), we 
hypothesized that progesterone could be used to synchronize ovarian follicular 
development and returns to estrus in nonpregnant heifers without adverse effects on 
pregnant heifers.  
 
The objectives of the present studies were to evaluate the efficacy of a used CIDR 
insert (once- or twice-used) or MGA feeding for resynchronization of estrus in beef 
heifers not pregnant following TAI, and to determine whether an injection of estradiol-
17β (E-17β) or a commercial progesterone preparation could be used to increase estrus 
and pregnancy rates in these heifers.  
 
9.3 Materials and Methods 
 
9.3.1  Experiment 1 
 
The objective was to compare the efficacy of a used CIDR with no treatment on 
estrous activity, conception rate, and pregnancy rate in heifers nonpregnant following 
TAI. This study was replicated at two locations. 
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  In Replicate 1, 99 Hereford and Hereford-cross heifers (approximately 13 to 14 
mo of age, 350 to 450 kg) were used. The heifers were maintained in a feedlot and were 
fed a silage-based ration, supplemented with rolled barley. Drinking water, trace-
mineralized salt and a calcium-phosphorous mineral supplement were available ad 
libitum. Heifers were randomly assigned to two synchronization protocols for TAI (Day 
of TAI designated as Day 0; Kastelic et al., 2001).  
 
 In Replicate 2, 60 Angus and Angus-cross heifers (similar age, size, weight, 
housing, and feeding as in Replicate 1) were used. The experimental design was identical 
to that of Replicate 1, with the difference that just prior to initiating the TAI protocol, all 
heifers were examined by transrectal ultrasonography (Aloka 500 with 7.5 MHz linear-
array transrectal transducer; ISM Inc., Edmonton, AB, Canada); only heifers with a 
corpus luteum detected by ultrasonography were used in this replicate.  
 
On Day 13 after TAI, heifers were allocated (by replicate, within the previous 
treatment groups) to receive either a once-used intravaginal controlled internal drug 
release insert (CIDR; Bioniche Animal Health Inc., Belleville, ON, Canada) for 7 d, or no 
CIDR insert (Controls). Before reuse, CIDR inserts were soaked in water containing 
povidone iodine (Betadine Scrub; Purdue Pharma, Pickering, ON, Canada) for 
approximately 2 h, individually scrubbed with a brush, thoroughly rinsed, and allowed to 
completely air-dry.  
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 In Replicate 1, all heifers were fitted with a pressure-sensing mount detector 
(HeatWatchTM; DDx Inc., Boulder, CO, USA) on Day 13 (at CIDR insertion in the 
treated group) and were monitored continuously for mounting activity until Day 26. 
Heifers detected in estrus (defined as ≥ 4 mounts for at least 2 sec in duration within a 6-h 
interval) were reinseminated with commercial frozen-thawed semen approximately 9 to 
12 h after the first mount. In Replicate 2, visual observation for estrus detection was 
performed for periods of 40 min three times daily from Days 13 to 26; heifers were 
reinseminated 6 to 12 h after first detection of standing estrus.  
 
Transrectal ultrasonography for pregnancy diagnosis was conducted on Day 30 in 
all heifers that had not been detected in estrus and rebred, and on approximately Day 60 
in all rebred heifers. Pregnant, rebred heifers were examined carefully to determine if the 
stage of pregnancy was consistent with conception to the first or the second insemination. 
 
Estrus, conception and pregnancy rates were defined as follows: 
Estrus rate = [(number of heifers detected in estrus)/(number of heifers detected in estrus 
+ number of heifers diagnosed nonpregnant 30 d after TAI)] x 100. 
Conception rate = [(number of heifers pregnant to rebreeding)/(number of heifers 
rebred)] x 100. 
Pregnancy rate = [(number of heifers pregnant to rebreeding)/(number of heifers detected 
in estrus + number of heifers diagnosed nonpregnant 30 d after TAI)] x 100. 
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 9.3.2 Experiment 2 
 
Angus and Angus cross heifers (n=651), 12 to 15 mo of age and weighing 
approximately 300 to 375 kg, were used between April and June, 2000. Heifers were fed 
barley silage and had ad libitum access to water, trace-mineralized salt, and a calcium-
phosphorous mineral supplement. Heifers underwent TAI (designated as Day 0) and 13 d 
later were randomly assigned to seven groups (n=93 per group) to receive a once-used 
CIDR (three groups) for 7 d (Days 13 to 20), melengestrol acetate (MGA; Pharmacia 
Animal Health, Orangeville, ON, Canada; 0.5 mg/head/day; three groups) for 7 d (Days 
13 to 19), or no treatment (Control). The three groups were: no further treatment (CIDR 
or MGA alone), 1.5 mg estradiol-17β (E-17β) and 50 mg progesterone (P; both from 
Sigma Chemical Co, St. Louis, MO, USA) in 2 mL canola oil on Day 13, or E-17β and P 
on Day 13 and 0.5 mg E-17β on Day 21 (24 h after CIDR removal or 48 h after the last 
feeding of MGA). Estrus detection was done by visual observation (as in Replicate 2, 
Experiment 1) from Days 13 to 30. Heifers detected in estrus were re-inseminated 6 to 12 
h after onset of estrus by one technician, using commercial frozen-thawed semen from 
one of two bulls (the bulls were balanced across treatment groups). Pregnancy diagnosis 
by ultrasonography was performed approximately 43 d after rebreeding. 
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 9.3.3 Experiment 3 
 
The objective was to investigate the efficacy of a once- or twice-used CIDR 
insert, with or without supplemental progesterone, for resynchronization of estrus in beef 
heifers not pregnant following TAI. Angus and Angus-cross beef heifers (n = 616), 12 to 
15 mo of age and 280 to 400 kg of weight were housed in a drylot and fed a barley-silage 
based diet. All heifers had been inseminated by TAI (Colazo et al., 2004b, Chapter 8) and 
were assigned randomly to four groups (2 x 2 factorial) 13 ± 1 d later to receive a once- 
or twice-used CIDR for 7 d, with or without a concurrent injection of 150 mg im of 
progesterone (Progesterone 5%; Vétoquinol N.-A Inc., Lavaltrie, QC, Canada). Estrus 
detection and inseminations were performed as in Experiment 2. Ultrasonographic 
pregnancy diagnosis was done approximately 30 d after rebreeding. 
 
9.3.4 Field trial 
 
This was a large-scale trial of previously-used CIDR for resynchronization of 
returns to estrus following TAI. The study was replicated simultaneously at two feedlots, 
approximately 50 km apart. Angus and Angus-cross heifers, 12 to 15 mo of age and 
weighing approximately 325 to 375 kg were used. Heifers were fed a base ration of 
barley silage at both locations, supplemented with approximately 10% of either barley 
grain or malt-sprout pellets at the two locations, respectively. Heifers had ad libitum 
access to clean drinking water, cobalt iodized salt, and a calcium-phosphorous mineral 
supplement. 
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 Just prior to the start of the synchronization protocols for TAI, heifers were 
examined by transrectal ultrasonography. Freemartin heifers and those without an 
ultrasonically detectable luteal structure and (or) with ovarian follicles <10 mm in 
diameter and a uterine diameter <15 mm were excluded. A total of 983 heifers were 
assigned to three different estrus synchronization protocols (Colazo et al., 2004a, Chapter 
6) and TAI was done on three consecutive days. On Day 13 ± 1 after TAI, all heifers 
received a previously-used CIDR for 7 d. Following CIDR removal, estrus detection and 
re-inseminations were done for 5 d. Ultrasonographic pregnancy diagnosis was 
conducted as described in Experiment 1. 
 
9.3.5 Statistical Analyses 
 
In Experiments 1 and 2, associations between pregnancy status following TAI, 
estrus, conception and pregnancy rates to rebreeding and treatment groups were analyzed 
using generalized estimating equations (GEE; PROC GENMOD in SAS). Model 
specifications included a binomial distribution, logit link function, repeated statement 
with subject equal to pen, and an exchangeable correlation structure. The model consisted 
of replicate (Experiment 1), treatments and their interactions. Treatments were analyzed 
as a fixed effect with two (Experiment 1) or three (Experiment 2) categories.  
Detailed analysis of mounting data in Experiment 1 was confined to Replicate 1. 
A Student’s t-test was used to compare the effects of a used CIDR on the interval from 
TAI to onset of estrus, duration of estrus, and number of mounts. Bartlett’s test of 
homogeneity of variance was used to compare, between the two groups, the variance of 
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 the interval from TAI to the onset of estrus. One-way ANOVA compared the intervals 
from TAI to rebreeding among treatment groups in Experiment 2. In Experiment 3, the 
main effects of CIDR (once- versus. twice-used), progesterone treatment, and their 
interaction, on interval from CIDR removal to estrus was determined by two-way 
ANOVA. Means were compared with a protected LSD test. Comparisons of equality of 
variances among groups were done by Bartlett’s test of homogeneity of variance. The 
Mantel-Haenszel test (Chi-square test for a 2x2 experimental design) was used to detect 
differences among treatment groups for estrus rates, conceptions and pregnancy rates 
following TAI and to rebreeding. Pregnancy rate between treatments by day was 
analyzed with Fisher’s exact test. As the field trial was demonstrational, no statistical 
analysis was done. All statistical analyses, except the Mantel-Haenszel test were 
conducted with the Statistical Analysis System (SAS; Version 8.2 for Windows; SAS 
Institute, Cary, North Carolina, USA). 
 
9.4 Results 
 
9.4.1  Experiment 1 
 
CIDR treatment did not affect pregnancy rate following TAI (57.0 versus 56.4% 
for CIDR and control groups, respectively; P<0.7). There were no significant differences 
between the two replicates for estrus, conception or pregnancy rates (P=0.3). Combined 
for both replicates, there were 69 heifers not pregnant to the first AI; 34 heifers received a 
used CIDR, while 35 heifers were untreated controls. The proportions of nonpregnant 
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 heifers detected in estrus and rebred were 24/34 (70.6%) versus. 30/35 (85.7%; P=0.13), 
and conception and pregnancy rates were 62.5 versus. 76.7% (P=0.3) and 44.1 versus. 
65.7% (P=0.07) for CIDR-treated and control groups, respectively.  
 
Mounting activity associated with rebreeding was characterized, in detail, in 
Replicate 1. Mean (± SD) intervals from TAI to onset of estrus were 21.9 ± 1.1 d versus. 
19.0 ± 2.1 d (means, P<0.001; variance, P=0.07) for CIDR-treated and control groups, 
respectively. However, there were no differences between groups for duration of estrus 
(overall, 10.5 ± 7.2 h; P=0.3) or number of mounts (overall, 18.8 ± 15.3; P=0.3). 
Distribution of estrus and the number of heifers that became pregnant are shown in 
Figure 9.1. 
 
It was noteworthy that there were two heifers in Replicate 1 that were detected in 
estrus and re-inseminated, but subsequently diagnosed pregnant following TAI. Both of 
these heifers had received a used CIDR. The first heifer was mounted nine times over a 
7-h interval, 20 d after TAI. The second heifer was mounted four times over a 2-h 
interval 22 d after TAI, and an additional four times over a 45-min interval, 
approximately 24 h later. 
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Figure 9.1. Number of heifers re-inseminated and pregnant, grouped by interval 
following timed-AI (TAI). Heifers received a once-used CIDR insert for 7 d 
beginning 13 ± 1 d after TAI (CIDR; n = 34) or no treatment (Control; n = 
35). Estrus rate tended to be higher (85.7 versus. 70.6%; P=0.1), but more 
variable (P=0.07) in control than in CIDR-treated heifers. Pregnancy rate 
also tended (P=0.07) to be higher in control than in CIDR-treated heifers. 
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 9.4.2 Experiment 2 
 
Reproductive outcome by group is shown in Table 9.1. Variability in the interval 
to estrus was greater in the control than in progestin-treated groups (P<0.001; Figure 9.2). 
The median interval to estrus was 2.5 d after CIDR removal and 3.5 d after the last 
feeding of MGA. Conception and pregnancy rates in heifers diagnosed not pregnant 30 d 
after TAI and given a CIDR (65.1 and 61.4%) were greater (P<0.01) than those fed MGA 
(49.6 and 40.4%), but were not different from controls (62.2 and 54.9%, respectively). 
Pregnancy rate following TAI was lower (P<0.05) for the group given a used CIDR, E-
17β and P on Day 13 and E-17β on Day 21, and tended (P=0.09) to be lower in the 
control group and heifers fed MGA and receiving E-17β and P on Day 13 than in the 
other groups (Table 9.1). 
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Figure 9.2. Number of previously TAI heifers seen in estrus and re-inseminated, 
grouped according to treatment (CIDR, Fig. A; MGA, Fig. B, and control 
Fig. C). Heifers (n= 651) were allocated to receive a once-used CIDR for 7 
d (C), C plus 1.5 mg of E-17β and 50 mg P on Day 13 (CEP), CEP plus 0.5 
mg of E-17β on Day 21 (CEPE), MGA (0.5 mg/head/d) for 7 d (M), M plus 
1.5 mg of E-17β and 50 mg P on Day 13 (MEP), MEP plus 0.5 mg of E-17β 
on Day 21 (MEPE), or no treatment (Control). Variability in the interval to 
estrus was greater in the control than in progestin-treated groups (P<0.001).
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Table 9.1. Reproductive outcome of resynchronized heifers starting 13 d after TAI (TAI=Day 0). Heifers (n= 651) were allocated to 
receive a once-used CIDR for 7 d (C), C plus 1.5 mg of E-17β and 50 mg P on Day 13 (CEP), CEP plus 0.5 mg of E-17β 
on Day 21 (CEPE), MGA (0.5 mg/head/d) for 7 d (M), M plus 1.5 mg of E-17β and 50 mg P on Day 13 (MEP), MEP 
plus 0.5 mg of E-17β on Day 21 (MEPE), or no treatment (Control).  
 
 C CEP CEPE M MEP MEPE Control 
 
No. heifers 93 93 93 93 93 93 93 
No. pregnant following TAI 44 46 31 51 42 45 42 
Pregnancy rate (%)1 47.3a 49.5a 33.3b 54.8a 45.2ab 48.4a 45.2ab
 
Rebreeding 
No. open following TAI 49 47 62 42 51 48 51 
No. in estrus 45 45 59 35 43 37 45 
Estrus rate (%)2 91.8ab 95.7a 95.2a 83.3bc 84.3bc 77.1c 88.2ac
Rebred mean (Day) 23.5a 23.1ab 23.1bc 24.9bc 24.3c 23.7c 20.8d
Variance (d) 3.5xy 2.3x 3.3xy 4.4y 2.8x 4.6y 10z
Range 22-29.5 22-29 21-28.5 19-29.5 22-29 22-29 14-28 
No. pregnant  29 33 35 14 23 20 28 
ab
ab
ab 75.3
Conception rate (%) 64.4ab 73.3a 66.1ab 40c 53.5bc 54bc 62.2
bc 54.9
b 69.9
Pregnancy rate (%)3 59.2ab 70.2a 56.4ab 33.3c 45.1bc 41.7
b 69.9
TAI & rebreeding 
Pregnancy rate (%)4 78.5ab 84.9a 71b 69.9b
 
abc Proportions within a row differed (P<0.05). 
abcd Means within a row differed (P<0.0001). 
xyz Variances within a row differed (P<0.05) 
1 CEPE versus MEP and control (P=0.09). 
2 Control versus MEPE (P=0.1). 
3 C versus MEPE (P=0.08), CEP versus control and CEPE versus MEPE (P=0.1). 
=0.09). 4 CEP versus control (P
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9.4.3  Experiment 3 
 
Overall pregnancy rate following TAI was 47.2% (291/616; Colazo et al., 2004b, 
Chapter 8). Although 325 heifers were diagnosed nonpregnant following TAI, five of 
these heifers (1.5%) had no CIDR present at the time of scheduled removal (20 ± 1 d 
after TAI); therefore, data from only 320 resynchronized heifers were used for analysis 
(Table 9.2). Resynchronization treatments did not adversely affect pregnancy rates 
following TAI (P=0.8 and 0.7 for CIDR and progesterone-treated animals, respectively). 
The interval from CIDR removal to the onset of estrus was not affected by the number of 
times that the CIDR had been previously used (overall, 2.4 ± 0.5 d; P=0.85). The mean (± 
SD) interval from CIDR removal to estrus tended (P=0.06) to be longer in heifers given 
an injection of progesterone concurrent with CIDR insertion (2.5 ± 0.6 d) as compared to 
those that did not receive this treatment (2.3 ± 0.5 d). Pregnancy rate tended (P=0.1) to be 
higher in untreated heifers reinseminated 1.5 and 2 d after CIDR removal than in 
progesterone-treated heifers. 
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Table 9.2. Estrus, conception, and pregnancy rates in beef heifers* receiving a once- or twice-used CIDR with (P) or without (no P) 
an injection of 150 mg im of a commercial progesterone preparation 13 ± 1 d after timed-AI. 
 Resynchronization 
 CIDR Pregnancy rate following TAI Estrus rate Conception rate Pregnancy rate 
 No P Once-used (%) 43.3 79.2 73.7 58.3 
  n 55/127 57/72 42/57 42/72 
 Twice-used 50.0 69.4 67.8 47.1 
  87/174 58/85 40/59 40/85 
 Total 47.2 73.8a 70.6c 52.2a 
  142/301 116/157 82/116 82/157 
 P Once-used 51.5 65.0 53.8 35.0 
   86/167 52/80 28/52 28/80 
 Twice-used 42.6 62.6 67.3 42.2 
  63/148 52/83 35/52 35/83 
 Total 47.3 63.8b 60.5d 38.6b
  149/315 104/163 63/104 63/163 
 Overall 47.2 68.7 65.9 45.3 
  291/616 220/320 145/220 145/320 
* Heifers diagnosed nonpregnant 28 d after TAI 
ab Within a column, proportions with different superscripts were different (P<0.05)   
nt superscripts tended to differ (P=0.1) cd Within a column, proportions with differe
 
 
 9.4.4 Field trial 
 
Mounting activity was noted approximately 4 d after TAI in 19 heifers; all were 
re-inseminated, considered nonpregnant following TAI, and excluded from 
resynchronization data. Pregnancy rate following TAI was 55.2% (542/983). Estrus 
detection and AI were done on 336 heifers over a 4-d interval (between 1.5 and 5.5 d 
after CIDR removal; Figure 9.3). The mean (± SD) interval from CIDR removal to AI 
was 2.6 ± 0.8 d. Six heifers (1.1%) detected in estrus and re-inseminated were 
subsequently diagnosed pregnant following TAI. Overall, estrus, conception, and 
pregnancy rates following resynchronization were 78.2% (330/422), 70.3% (232/330), 
and 55.0% (232/422), respectively. The overall pregnancy rate following TAI plus re-
insemination was 78.7% (774/983). 
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Figure 9.3. Number of heifers reinseminated and pregnant in the field trial, grouped 
according to interval to onset of estrus after CIDR removal (Day 0). A once-
used CIDR was inserted in beef heifers (n = 983) 13 ± 1 d after timed-AI 
and subsequently removed 7 d later. Estrus was detected by visual 
observation for 5 d and re-inseminations were done 6 to 12 h after first 
detection of estrus. 
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 9.5 Discussion 
 
The rationale for insertion of a previously used CIDR, or of feeding MGA, was to 
delay estrus in heifers that were not pregnant following TAI and may have had early 
luteolysis. Progestin treatment (starting 13 ± 1 d after TAI) synchronized returns to 
estrus; compared to control heifers, the range was reduced by 6 and 9 d in Experiments 1 
and 2, respectively. The numbers of heifers showing behavioural estrus peaked 
approximately 21-22.5 d after TAI in progestin-treated heifers; most of the control heifers 
were rebred before Day 20 after TAI. Overall, estrus rates ranged from 68.8 to 95.7% in 
progestin-treated heifers and from 85.7 to 88.2% in control heifers 
 
For unknown reasons, the effects of progestins on estrus rate varied between 
Experiments 1 and 2. In that regard, estrus rate tended to be lower in CIDR-treated than 
control heifers in Experiment 1, whereas in Experiment 2, estrus rates in CIDR-treated 
and MGA-treated heifers were not significantly different from that of control heifers. 
Overall, the timing of estrus and estrus rates were consistent with previous reports. Van 
Cleef et al. (1996) observed only 80% of nonpregnant heifers in estrus between 12 and 45 
d after AI. In that study, reinsertion of a used CIDR from 17 to 22 d after AI resulted in 
approximately 60% of the non-pregnant heifers detected in estrus over 4 d, compared to 
17% of control heifers over the same interval (Van Cleef et al., 1996).  
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 In Experiment 1, the conception rate in CIDR-treated heifers was lower than in 
control heifers (62.5 versus 76.7%), but the difference was not significant (unfortunately 
this study had limited power to detect a difference). Since fertility could be compromised 
by the development of persistent follicles in cattle destined to return to estrus before 
CIDR removal (Savio et al., 1993), treatments to reset the follicle wave were 
administered in Experiments 2 and 3. However, treatments designed to induce a new 
ovarian follicular wave must not induce luteolysis in cattle with unknown pregnancy 
status. Although estrogens are highly efficacious in synchronizing ovarian follicle 
development, it is well established that endogenous estrogens from the preovulatory 
follicle trigger the cascade that induces luteolysis (Niswender et al., 2000), and that 
exogenous estrogens can induce luteolysis (Wiltbank et al., 1961). The efficacy of 
estrogens to induce luteolysis appears to depend on both the formulation (i.e. ester) and 
dose. Treatment with 5 mg of estradiol valerate induced luteolysis, but lower doses were 
ineffective (Wiltbank et al., 1961; Colazo et al., 2005, Chapter 7). Similarly, plasma 
progesterone concentrations decreased from 2 to 7 d after treatment with 5 mg of 
estradiol benzoate (Munro and Moore, 1985), while 200 µg given twice daily for 3 d had 
no effect on mean cycle length (Hixon et al., 1983). It was noteworthy that 1 mg of 
estradiol benzoate given for resynchronization of returns to estrus compromised the 
ability of the CL to produce progesterone for at least 48 h in dairy cows (Burke et al., 
2000), and significantly decreased pregnancy rates following TAI in beef heifers (Cutaia 
et al., 2002). Estradiol-17β (E-17β; the active metabolite of estradiol esters) has also been 
used to synchronize ovarian follicular wave emergence and ovulation in cattle. Peak 
plasma estradiol concentrations occurred sooner and were higher in cattle treated with E-
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 17β than those treated with estradiol valerate or benzoate (Bó et al., 1993; 2000; Martínez 
et al., 2003a). Furthermore, there are no reports that low doses of E-17β will cause 
luteolysis.  
 
Recently, Bó et al. (2000) demonstrated that 1 mg of E-17β was as effective as 5 
mg of E-17β in suppressing follicles in progestogen-implanted heifers, with emergence of 
a new follicular wave 3 to 5 d later. Therefore, E-17β was used to induce a new follicular 
wave and estrus in Experiment 2. In this study, the administration of 1.5 mg of E-17β and 
50 mg of P at CIDR insertion did not adversely affect pregnancy rate following TAI, but 
the administration of 0.5 mg E-17β 24 h after CIDR removal was associated with a 
reduction in pregnancy rate following TAI. Alternatively, treatment of MGA-fed heifers 
with a 1.5 mg E-17β and 50 mg P at the beginning of the feeding period tended to result 
in reduced pregnancy rates following TAI, while the same treatment followed by 0.5 mg 
E-17β 48 h after the last feed of MGA did not. Collectively, these data are difficult to 
rationalize. Although they could be a result of chance, luteolysis may have occurred in E-
17β-treated heifers, or the administration of E-17β after CIDR removal may have resulted 
in the re-insemination of pregnant heifers.  
 
Failure to detect estrus in heifers that were subsequently diagnosed nonpregnant 
could have been due to unobserved estrus or embryonic loss (and returning to estrus after 
estrus detection had ceased). It is recognized that cattle without a viable embryo on Day 
16 return to estrus within 24 d after AI, whereas embryo loss after Day 16 delays returns 
to estrus (Betteridge et al., 1980; Humblot, 2001). We attempted to increase the 
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 proportion of nonpregnant heifers detected in estrus by giving estradiol after progestin 
withdrawal in Experiment 2. However, 90 of 96 nonpregnant heifers receiving a used 
CIDR and no estradiol treatment after CIDR removal were detected in estrus, making it 
very difficult to show a benefit for the use of estradiol. Estrus rates were also relatively 
high (approximately 84%) in MGA-treated heifers and there was no benefit of estradiol 
treatment after the termination of MGA. The effect of adding estradiol to progestin-based 
resynchronization protocols on the proportion of cattle returning to estrus after TAI has 
been controversial. In previous studies, treatment with estradiol esters (benzoate or 
cypionate) at CIDR insertion and 24 h after CIDR withdrawal increased (Macmillan et 
al., 1997; Stevenson et al., 2003) or did not increase (El-Zarkouny and Stevenson, 2004) 
the percentage of non-pregnant cows returning to estrus. In another study, the number of 
beef heifers returning to estrus after TAI was not increased by treatment with 0.5 mg of 
estradiol cypionate at first feeding and 24 h after last feeding of MGA (Stevenson et al., 
2003). Results from CIDR- and MGA-treated heifers in the present study would also 
indicate no benefit to giving estradiol after cessation of progestin treatment. Regardless, 
the use of E-17β and progesterone at CIDR insertion and E-17β after CIDR removal can 
not be recommended for resynchronization of returns to estrus at this time. 
 
There is considerable evidence that blood progesterone concentrations are 
positively correlated with embryo development and the production of INF-τ (Garret et al., 
1988; Mann et al., 1999). However, previous attempts to improve fertility by 
supplementing progesterone during the luteal phase have yielded inconsistent results 
(Macmillan and Peterson, 1993; Van Cleef et al., 1996; Chenault et al., 2003). Macmillan 
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 and Peterson (1993) reported that inserting a new CIDR between 4 and 9 d after AI in 
lactating dairy cows significantly improved pregnancy rates; whereas insertion of a CIDR 
10 to 16 d or 14 to 17 d after AI did not. Van Cleeff et al. (1996) also reported that 
insertion of a used CIDR for 5 d (17 to 22 d after AI) apparently did not affect the 
proportion of heifers pregnant to the first insemination. Conversely, it has been shown 
that inserting a new or used CIDR 1 or 2 d after AI in heifers reduced pregnancy rates 
(Van Cleef et al., 1996). Chenault et al. (2003) also reported a small (4.0%) but 
significant reduction in pregnancy rate to first breeding in dairy cows that received a new 
CIDR for 7 d (starting 14 ± 1 d after AI). In Experiment 3, there were no indications that 
the injection of progesterone at the time of used-CIDR insertion 13 ± 1 d after TAI 
adversely affected pregnancy rate following TAI. Therefore, further studies involving 
large numbers of cattle are required to ensure that resynchronization with a used CIDR 
does not reduce pregnancy rate following TAI. 
 
In the present studies, heifers that received only a used CIDR had conception rates 
following re-insemination that ranged from 60 to 70%. Macmillan and Peterson (1993) 
reported conception rates of 65.6% in dairy cows resynchronized with a new CIDR 
insert. Although Chenault et al. (2003) reported conception rates of 26.7% in dairy cows 
resynchronized with a new CIDR, this was not statistically different from non-
resynchronized cattle. Conversely, Stevenson et al. (2003) reported lower conception 
rates in heifers receiving a used CIDR to resynchronize returns to estrus (33.3%) as 
compared to untreated controls (60.0%). It is noteworthy that despite the previously 
mentioned precautions, treatment with E-17β and progesterone at CIDR insertion on Day 
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 13 in Experiment 2 resulted in nonsignificant increases in rates of estrus, conception and 
pregnancy, and a small reduction in the variance in returns to estrus (compared to used-
CIDR treatment alone). However, the overwhelming benefit for the use a used CIDR to 
resynchronize returns to estrus would appear to be the reduced amount of time spent on 
estrus detection. In the field trial, 336 heifers were observed in estrus over a 4-day 
interval (with a mean interval of 2.6 d from CIDR removal to onset of estrus). Estrus, 
conception and pregnancy rates were considered highly satisfactory with more than 78% 
of the heifers pregnant following TAI and re-insemination. 
 
A used CIDR resulted in higher conception and pregnancy rates than the feeding 
of MGA in nonpregnant heifers resynchronized following TAI (Experiment 2). MGA has 
been shown to be less effective than progesterone in suppressing serum LH 
concentrations in cattle without a CL resulting in persistent follicles (Kojima et al., 1995). 
Consequently, short-term (e.g. 7- or 8-d) MGA-based protocols for TAI typically include 
treatments such as estradiol, GnRH or LH at the start of MGA feeding to prevent the 
development of persistent follicles (Savio et al., 1993) These protocols have resulted in 
pregnancy rates following TAI that have not differed from those of similar protocols 
utilizing a CIDR (Martínez et al., 2002b). In the present study, giving estradiol and 
progesterone concurrent with the initiation of MGA feeding (with or without estradiol 
treatment after the cessation of MGA) resulted in an increase in conception rates that was 
approximately 14% higher than that achieved with MGA alone; however, conception 
rates (and pregnancy rates) were still significantly lower than in CIDR-treated heifers 
given estradiol and progesterone at the time of CIDR insertion. Therefore, MGA would 
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 not appear to be a good alternative for the resynchronization of previously time-
inseminated heifers. 
 
In Experiment 3, 150 mg of progesterone was given concurrent with CIDR 
insertion in an attempt to cause regression of the dominant follicle, and to synchronize 
follicular wave emergence. Administration of 200 mg of progesterone in Bos taurus 
cattle (Anderson and Day, 1994) or 100 mg progesterone or a new CIDR for 24 h in Bos 
indicus cattle has been reported to induce atresia of persistent follicles (Cavalieri et al., 
1998). Although it was not expected that heifers in the present study would have a 
persistent follicle, the administration of progesterone concurrent with insertion of a used-
CIDR resulted in a significantly longer interval from CIDR removal to estrus, suggesting 
that a new wave of ovarian follicular development may have emerged in response to 
treatment in at least some heifers. However, progesterone treatment also resulted in 
reduced rates of behavioural estrus and conception, and as a result, pregnancy rates were 
also reduced. In particular, progesterone treatment tended to result in reduced fertility in 
heifers detected in estrus within the first 2 d after CIDR removal. The reason for this 
observation is not known, but based on the current results, an, injection of supplemental 
progesterone concurrent with CIDR reinsertion can not recommended. Further studies are 
needed to investigate alternative approaches to synchronize follicular growth in 
previously inseminated cattle. 
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 The reuse of CIDR inserts is not recommended by the manufacturer, but there are 
many reports of successful reuse of CIDR in estrus synchronization programs (Colazo et 
al., 2004b, Chapter 8). Although the efficacy of cleaning and disinfection procedures 
utilized in this study is unknown, there are apparently no reports of disease transmission 
associated with the reuse of CIDR inserts. Our previous studies have indicated a greater 
potential for CIDR loss with reused CIDR inserts (especially following autoclaving) with 
reduced pregnancy rates following TAI in those cattle (Colazo et al., 2004b, Chapter 8). 
However, the loss of used CIDR inserts in this study was extremely low. In addition, 
twice-used CIDR inserts seemed to perform as well as once-used inserts in the present 
study. However, fertility was reduced in cattle receiving a twice-used CIDR in a TAI 
protocol (Colazo et al., 2004b, Chapter 8). Therefore, twice-used CIDR inserts would 
appear to be efficacious for resynchronization protocols (and perhaps estrus 
synchronization programs which utilize estrus detection), but they cannot be 
recommended for TAI protocols. 
 
Detection of estrus followed by AI in pregnant animals when resynchronizing 
cattle with unknown pregnancy status is of concern; estrus has been reported to occur in 3 
to 6% of pregnant cattle (Roberts, 1986). In Experiment 1 and the field trial, two and six 
heifers, respectively, that were detected in estrus and re-inseminated were subsequently 
diagnosed pregnant; these heifers represented 4.4 and 1.1% of all heifers pregnant 
following TAI. However, the number of pregnant heifers that were detected in estrus, 
rebred, and subsequently lost the TAI pregnancy is not known, and is of greater concern. 
In previous studies, embryonic or fetal mortality following AI of pregnant cattle has been 
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 estimated to range from 24 to 49% (Sturman et al., 1980; 2000). Based on the low 
incidence of rebred heifers that were subsequently diagnosed pregnant following TAI and 
reported rates of embryonic death in re-inseminated cattle, we infer that very few 
pregnant heifers were detected in estrus and re-inseminated. However, the pregnany rates 
following TAI in CIDR-treated heifers that received estradiol treatment after CIDR 
removal is still troublesome. It is not clear whether treatment with E-17β following CIDR 
removal will cause behavioural estrus in pregnant animals.  
 
In summary, insertion of a once- or twice-used CIDR effectively synchronized 
returns to estrus in the majority of heifers nonpregnant following TAI; fertility was 
acceptable, with 70 to 80% of heifers pregnant following TAI and the subsequent re-
insemination. However, pregnancy rates were substantially lower when MGA was fed in 
lieu of using CIDR inserts. Treatment with 1.5 mg of E-17β and 50 mg of progesterone at 
CIDR insertion was associated with in small increase in conception rate; however, 
treatment with 0.5 mg of E-17β after CIDR removal was associated with reduced 
pregnancy rates following TAI. Therefore, giving estradiol to increase the expression of 
behavioural estrus after cessation of progestin treatment cannot be recommended. 
Injecting 150 mg of progesterone at CIDR insertion had a detrimental effect on 
expression of estrus and subsequent pregnancy rates. Future studies will have to be 
directed toward improving the synchrony of follicle growth and increasing the expression 
of estrus in cattle not pregnant to an initial insemination without compromising 
pregnancy rate to the timed-insemination. 
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 10.0 OVARIAN FUNCTION, ESTRUS, AND FERTILITY IN BEEF CATTLE 
RESYNCHRONIZED WITH PROGESTINS AND ECP, GnRH OR 
PROGESTERONE  
 
10.1 Abstract 
 
Three experiments were conducted to determine the effects of progestins (MGA 
versus CIDR), and estradiol cypionate (ECP), gonadotrophin releasing hormone (GnRH) 
or progesterone treatment during diestrus on ovarian follicular dynamics, CL function, 
estrus and ovulation rates, and fertility in beef cattle. In Experiment 1, nonlactating beef 
cows received a once-used CIDR insert 12.3 ± 0.7 d after ovulation (Day 0) and were 
randomly allocated to concurrently receive one of the following four treatments: no 
further treatment (n=10); 1 mg of ECP (n=11); 100 μg of GnRH (n=11); or 150 mg of 
progesterone (n=11). On Day 7, all CIDR inserts were removed and half of the cows 
received 0.5 mg of ECP. Follicular wave emergence was most synchronous (P<0.0001), 
and diameter of the dominant follicle on Day 7 was least variable (P=0.01) in cows given 
GnRH. Intervals from CIDR removal to estrus and to ovulation were not affected by 
treatment on Day 0 (P=0.2). However, 10/43 cows were not seen in estrus following 
CIDR removal on Day 7 (13.6% were given ECP and 33.3% received no treatment; 
P<0.1). In Experiments 2 and 3, beef heifers were allocated to resynchronization 
treatments 13 or 14 d after timed-AI (TAI; Day 0) and were given either no treatment or 
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 0.5 mg of ECP on Day 7, and then, reinseminated 6 to 12 h after onset of estrus. In 
Experiment 2, all heifers (n=675) were fed MGA (0.5 mg/head/d) from Days 0 to 5; on 
Day 0 they received no further treatment (Control) or 100 μg GnRH. In Experiment 3, 
heifers (n=317) received a once-used CIDR for 7 d or were fed MGA (as in Experiment 
2). Combined for Experiments 2 and 3, pregnancy rate following TAI was 38.1% 
(treatments did not affect pregnancy rate following TAI). In Experiment 2, estrus rate 
tended (P<0.1) to be higher in heifers given ECP on Day 7 (69.6 versus 62.7%); onset of 
estrus was more synchronous (P<0.05) in heifers given GnRH only or GnRH on Day 0 
and ECP at CIDR removal. In Experiment 3, heifers given a CIDR and no further 
treatment had the most synchronous onset of estrus (P<0.003). Furthermore, heifers given 
a CIDR had higher conception (68.8 versus 56.7%; P<0.1) and pregnancy (54.1 versus 
39.2%; P<0.04) rates than those fed MGA. In summary, GnRH at CIDR insertion in late 
diestrus synchronized follicular wave emergence without affecting estrous cycle length; 
0.5 mg of ECP at CIDR removal tended to increase the number of nonpregnant heifers 
detected in estrus without affecting fertility following TAI or reinsemination. Fertility 
was higher in heifers resynchronized with a used CIDR than those fed MGA. 
 
10.2 Introduction 
 
Highly synchronous returns to estrus and distinct estrous behaviour in cattle non-
pregnant to timed-artificial insemination (TAI) would facilitate reinsemination. Based on 
previous resynchronization studies, synchrony of behavioural estrus and the proportion of 
nonpregnant cattle detected in estrus must be improved (Macmillan and Peterson, 1993; 
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 Van Cleef et al., 1996; Stevenson et al., 2003; Chapter 9). However, treatments designed 
to synchronize ovulatory follicle growth and increase estrous detection rate must not 
jeopardize pregnancy following TAI.  
 
Estradiol treatment of progestin-treated cattle has been shown to induce a new 
follicular wave, regardless of stage of the estrous cycle at the time of treatment (Bó et al., 
1995a,b), and a reduced dose of estradiol cypionate (ECP) at progestin withdrawal 
induced estrous behavior and synchronous LH release and ovulation (Colazo et al., 
2003b, Chapter 5). However, estradiol treatment of previously inseminated heifers has 
been reported to reduce pregnancy rate following TAI (Cutaia et al., 2002; Chapter 9). 
An injection of progesterone at CIDR insertion (13 ± 1 d after TAI) did not affect 
pregnancy rate following TAI, but the incidence of behavioural estrus and fertility in 
nonpregnant heifers displaying estrus were decreased (Chapter 9).  
 
Gonadotrophin releasing hormone (GnRH) may be an alternative for 
synchronizing follicular wave emergence in cattle with unknown pregnancy status. It has 
also been suggested that GnRH treatment during diestrus would result in most cattle 
having three follicular waves (Clark et al., 1998), which may potentially increase fertility 
at the subsequent estrus (Townson et al., 2002). However, when GnRH was given to 
cows between Days 12 and 16 of the estrous cycle, cycle length was significantly longer 
than in control cows (Macmillan et al., 1985).  
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 Recently, pregnancy rate was reported to be higher in cattle resynchronized with a 
used progesterone intravaginal insert (CIDR) than in those fed melengestrol acetate 
(MGA) for 7 d (Stevenson et al., 2003; Chapter 9). Because of variable MGA clearance 
rate from the digestive tract, a shorter-term MGA regimen warrants further investigation.  
 
The objectives of the present studies were to evaluate the effects of ECP, GnRH 
or progesterone treatment during diestrus in non-bred beef cows on ovarian follicular 
dynamics, CL function, estrus, and ovulation, and to determine whether these treatments, 
along with MGA or a used CIDR, would increase estrous and pregnancy rates in beef 
heifers not conceiving following TAI. 
 
10.3 Materials and Methods 
 
10.3.1 Experiment 1 
 
Nonlactating, nonpregnant crossbred beef cows (n = 41), 3 to 9 yr of age were 
previously synchronized with an estradiol-CIDR based protocol and ovulation time was 
determined by twice-daily ultrasonography (Colazo et al., 2005, Chapter 7). On Day 12.3 
± 0.7 d (mean ± SD; Day 0) after ovulation, all cows received a once-used CIDR insert 
(Bioniche Animal Health, Belleville, ON, Canada) that had been washed and disinfected 
as previously described (Colazo et al., 2004b, Chapter 8). At the same time, cows were 
randomly allocated to concurrently receive one of the following four treatments: no 
further treatment (Control; n = 10), 1 mg of estradiol cypionate (ECP; Pharmacia Animal 
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 Health, Orangeville, ON, Canada; n=11), 100 μg of gonadotrophin releasing hormone 
(GnRH; Cystorelin, Merial Can Inc., Victoriaville, PQ, Canada; n=11) or 150 mg of 
progesterone in 2 mL canola oil (Sigma Chemical Co., St. Louis, MO, USA; n=11). The 
ECP, GnRH and progesterone were all given as intramuscular (im) injections. On Day 7, 
CIDR inserts were removed from all cows, and half in each group received 0.5 mg im of 
ECP.  
 
Cows were monitored once daily (Days 0 to 8) by ultrasonography (Aloka SSD 
500 with a 7.5 MHz linear-array transducer; ISM Inc., Edmonton, AB, Canada) to 
determine ovarian follicular dynamics, and twice daily (Days 8 to 12) to determine the 
time of ovulation. The diameter of the CL and all follicles ≥3 mm were measured and 
recorded (Pierson and Ginther, 1984). The day of emergence of a follicular wave was 
defined as the day that the dominant follicle was first identified at a diameter of 4 mm 
(Ginther et al., 1989b). When follicular wave emergence did not occur during the 
observation period, day of follicular wave emergence prior to treatment was estimated 
from the size of the dominant follicle at the time of treatment. Ovulation was confirmed 
by the disappearance of a large (>10 mm) follicle that had been detected at the previous 
examination.  
 
Visual observation for estrous behaviour was done three times daily (40 min each) 
from Days 8 to 12. Blood samples were collected by coccygeal venipuncture at 24-h 
intervals (Days 1 to 9) into an evacuated tube containing heparin. Blood samples were 
centrifuged at 1500 x g for 20 min and plasma separated and stored at –20 °C until 
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 assayed for progesterone by an enzyme-immunoassay (Del Vecchio et al., 1995). The 
intra- and inter-assay coefficients of variation were 7.1 and 10.2%, respectively. 
 
10.3.2 Experiment 2 
 
Angus and Angus-cross heifers (n=675), 12 to 15 mo of age and weighing 
approximately 320 to 400 kg, were used between April and June, 2003. All heifers were 
managed in a drylot (8 pens), fed a barley-silage based diet and were synchronized with 
an MGA-based protocol for TAI. Thirteen or 14 d after TAI, heifers were fed 
melengestrol acetate (MGA; Pharmacia Animal Health; 0.5 mg/head/d) for 6 d 
(designated Days 0 to 5). On Day 0, heifers were randomly allocated to one of two 
groups to receive either no further treatment (Control) or 100 μg im of GnRH at the first 
feeding of MGA. On Day 7 (2 d after the last feeding of MGA), half of the heifers in 
each group received 0.5 mg im of ECP in a 2 by 2 factorial design.  
 
Estrus detection was done as in Experiment 1. Heifers observed in estrus were 
reinseminated 6 to 12 h later by a single technician, using commercial frozen-thawed 
semen from one of two bulls, balanced across treatment groups. Ultrasonographic 
pregnancy diagnosis was conducted approximately 28 d after TAI in heifers not seen in 
estrus following resynchronization, and approximately 55 d after the second AI in those 
that were detected in estrus and reinseminated. 
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 10.3.3 Experiment 3 
 
Angus and Angus-cross heifers (n=317) were managed (2 pens), fed, 
synchronized and submitted to TAI as described for Experiment 2. On Day 0 (13 to 14 d 
after TAI), heifers were randomly allocated to either be fed MGA (as in Experiment 2) or 
receive a once-used CIDR insert for 7 d. On Day 7, CIDR inserts were removed and half 
of the CIDR- and MGA-treated heifers were given 0.5 mg im of ECP. Estrus detection, 
reinsemination and pregnancy diagnosis were done as in Experiment 2. 
 
10.3.4 Statistical Analyses 
 
Throughout this study, data are reported as means ± SD. A one-way ANOVA was 
used to compare the intervals from treatment during diestrus to follicular wave 
emergence, and from CIDR removal to estrus and ovulation among treatments 
(Experiment 1), and from TAI to reinsemination among treatment groups in Experiments 
2 and 3. Means were compared with the protected LSD test and equality of variances was 
compared by Bartlett's test. In Experiment 1, the number of follicles by day was 
categorized according to follicle size; small (3 to 5 mm), intermediate (6 to 9 mm) and 
large (10 mm or greater). Data for each size category were analyzed using generalized 
estimating equations (GEE; PROC GENMOD). The main-effects model was assessed for 
first-order interactions where treatment and day remained in the model, with P<0.05 for 
both variables in the GEE analysis. Data for CL and follicle diameters and plasma 
progesterone concentrations were analyzed by the Proc Mixed Model procedure in SAS 
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 using autoregressive-1 (AR-1) as the covariate structure for repeated measurements 
(Littel et al., 1998). In Experiments 2 and 3, associations between pregnancy status 
following TAI and rebreeding and treatment groups were analyzed using a GEE (PROC 
GENMOD) method to account for clustering due to pen effect (Experiment 2). Model 
specifications included a binomial distribution, logit link function, repeated statement 
with subject equal to pen, and an exchangeable correlation structure. Treatments were 
analyzed as a fixed effect with two categories. Proportional data were compared by Chi-
square test. All data were analyzed using a statistical computer software program (SAS 
Version 8.2 for Windows; SAS Institute, Cary, North Carolina, USA). 
 
10.4 Results 
 
10.4.1 Experiment 1 
 
Follicle wave emergence following treatment on Day 0 was most synchronous 
(P<0.0001), and diameter of the dominant follicle at CIDR removal on Day 7 was least 
variable (P=0.01) in the GnRH group (Table 10.1). The largest follicle present on Day 0 
was the ovulatory follicle in 50.0, 36.4, 18.2, and 54.5% of cows in the control, ECP-, 
GnRH-, and progesterone-treated groups, respectively (P=0.3). Ovulation occurred 48 h 
after GnRH treatment in eight of 11 cows; a new follicular wave emerged 24 h before 
ovulation in seven of these cows. However, in one cow, the largest subordinate follicle 
became the dominant follicle.  
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 Diameters of the dominant follicles (≥9mm), present on Day 0 that regressed or 
continued growing after treatment are shown in Figure 10.1. In those cows in which 
follicle regression occurred, regression rate (from Days 0 to 7) was not different among 
treatments (overall 0.59 ± 0.24 mm per day; P=0.7). However, the regressing dominant 
follicle was smaller (P<0.05) in the ECP and control groups than the GnRH group from 
Day 4 until CIDR removal (Figure 10.1A). Dominant follicles that did not regress and 
continued growing tended to grow more slowly in ECP- and progesterone-treated cows 
than in control cows (0.6 ± 0.5 and 0.5 ± 0.4 versus 1.0 ± 0.4 mm per day, respectively, 
P=0.09; Figure 10.1B).  
 
The number of small follicles (3 to 5 mm) was affected by day (P<0.0001) and 
tended to be affected by treatment (P<0.07; Figure 10.2). The number of intermediate-
sized follicles (6 to 9 mm) tended to be affected by day (P=0.08) and there was a day by 
treatment interaction (P<0.06). The diameter of the CL was affected by day (P<0.0001) 
and tended to be affected by treatment (P<0.1) and there was a treatment by day 
interaction (P=0.06; Figure 10.3A). However, there was only an effect of day (P<0.0001) 
on plasma progesterone concentrations (Figure 10.3B).  
 
Intervals from CIDR removal to estrus and ovulation were not affected by 
treatments on Day 0 (P=0.2; Table 10.2). However, 10/43 cows were not seen in estrus 
after CIDR removal (13.6 % received ECP and 33.3% received no treatment on Day 7; 
P<0.1). The interval from CIDR removal to ovulation tended to be affected (P=0.07) by 
administration of ECP at CIDR removal (68.7 ± 9.2 versus 75.0 ± 12.2 h for ECP and 
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 control groups, respectively) and was affected (P<0.05) by the interaction between 
treatments at CIDR insertion and removal. Cows given either GnRH or ECP at CIDR 
insertion and no further treatment at CIDR removal had a longer interval from CIDR 
removal to ovulation than cows in the other 6 treatment groups (Table 10.2). One cow in 
the control group and one cow in the progesterone-treated group did not ovulate by Day 
12 of the experiment. 
 
Table 10.1. Mean (± SD) day of follicular wave emergence, and diameter of the 
dominant follicle at CIDR removal and prior to ovulation in beef cows given 
a CIDR (Control), or a CIDR and concurrently treated with 1 mg of 
estradiol cypionate (ECP), 100 μg of GnRH (GnRH) or 150 mg of 
progesterone (P) on Day 0 (Day 12.3 ± 0.7 of diestrus). At CIDR removal 
(Day 7), half of the cows in each group received 0.5 mg of ECP. 
 
 
 Control ECP GnRH P  
                                                                                                                                                         
No. cows 10 11 11 11 
 
Day of follicular wave emergence 
 
Mean 0.2 0.7 0.8 -0.2 
SD1 3.7 4.1 0.8 3.3 
Range -5 to 6 -6 to 5 -1 to 2 -6 to 5 
 
Diameter (mm) of dominant follicle  
 
 At CIDR removal (Day 7)  
 
Mean 14.4 12.4 13.1 14.3  
SD2 4.3 3.2 1.4 2.7  
Range 7 to 20 8 to 19 12 to 17 10 to 19  
 
 Just prior to ovulation 
 
Mean 17.7a b b ab 15.3  15.6  16.4   
SD 2.6 2.0 1.4 2.5  
Range 14 to 21 13 to 20 14 to 18 13 to 21  
 
ab Means within the row tended to differ (P=0.08) 
1 Standard deviations within the row differed (P<0.0001) 
2 Standard deviations within the row differed (P=0.01) 
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 Table 10.2. Estrus and ovulation rates and mean (± SD) intervals from CIDR removal to 
estrus and ovulation in beef cows given a CIDR (Control), or a CIDR plus 1 
mg of estradiol cypionate (ECP), 100 μg of GnRH (GnRH) or 150 mg of 
progesterone (P) on Day 0 (Day 12.3 ± 0.7 of diestrus). At CIDR removal 
(Day 7), half of the cows in each group received 0.5 mg of ECP. 
 
 
 Control ECP GnRH P  
 
Estrus 
No further treatment 
No. cows 2/5 3/5 5/6 4/5 
Interval (h) 
Mean 32.0 50.7 48.0 35.0 
SD 0.0 4.6 11.3 10.0 
Range 32 48 to 56 38 to 64 24 to 48 
Treated with ECP  
No. cows 4/5 5/6 5/5 5/6 
Interval (h) 
Mean 40.0 35.2 40.0 36.8 
SD 9.2 7.7 11.3 9.1 
Range 32 to 48 28 to 48 32 to 56 28 to 56 
 
Ovulation1
 No further treatment  
No. cows 4/5 5/5 6/6 5/5 
Interval (h) 
Mean 66.0 81.6 82.0 67.2 
SD 6.9 10.0 14.0 6.6 
Range 60 to 72 72 to 96 72 to 108 60 to 72 
Treated with ECP  
No. cows 5/5 6/6 5/5 5/6 
Interval (h) 
Mean 69.6 68.0 67.2 70.0 
SD 10.0 9.8 10.7 9.3 
Range 60 to 84 60 to 84 60 to 84 60 to 84 
                                                                                          
1 Interval from CIDR removal to ovulation; effect of treatment at CIDR insertion (P=0.2), 
effect of treatment at CIDR removal (P=0.07) and their interaction (P=0.05).  
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Figure 10.1. Mean diameter of dominant follicles that regressed (A) or continued 
growing (B) in beef cows given a once-used CIDR insert (Control) 12.3 ± 
0.7 d after ovulation (designated as Day 0), or a once-used CIDR plus 1 mg 
of ECP (ECP), 100 μg of GnRH (GnRH), or 150 mg of progesterone (P). A) 
Diameter of dominant follicles that regressed was smaller in the ECP (n=7) 
and control (n=5) groups than in the GnRH (n=3) group from Day 4 until 
CIDR removal (P<0.05). B) Dominant follicles that did not regress after 
treatment tended to grow more slowly in ECP- (n=4) and P- (n=6) treated 
cows than in control (n=5) cows (0.6 ± 0.5, 0.5 ± 0.4, and 1.0 ± 0.4 mm per 
day, respectively; P=0.09). There was no dominant follicle in the GnRH-
treated group because it either ovulated (n=8) or regressed (n=3). 
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Figure 10.2. Numbers of small follicles (3 to 5 mm; A) and intermediate follicles (6 to 9 
mm; B) in beef cows given a once-used CIDR insert (Control) or a once-
used CIDR plus 1 mg of estradiol cypionate (ECP), 150 mg of progesterone 
(P) or 100 μg of GnRH (GnRH) 12.3 ± 0.7 d after ovulation (designated as 
Day 0). The number of small follicles was affected by day (P<0.0001) and 
treatment (P=0.07). The number of intermediate follicles tended to be 
affected by day (P=0.08) and a treatment by day interaction (P<0.06). 
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Figure 10.3. CL diameter (A) and plasma progesterone concentrations (B) in beef cows 
given a once-used CIDR insert 12.3 ± 0.7 d after ovulation (designated as 
Day 0), with no further treatment (Control), or a once-used CIDR plus 1 mg 
of ECP (ECP), 100 μg of GnRH (GnRH), or 150 mg of progesterone (P). 
On Day 7, all CIDR inserts were removed and half of the cows received 0.5 
mg of ECP. The diameter of the CL was affected by day (P<0.0001) and 
tended to be affected by treatment (P<0.1) and a treatment by day 
interaction (P=0.06). There was an effect of day (P<0.0001) on progesterone 
concentrations. 
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 10.4.2 Experiment 2  
 
 Pregnancy rate following TAI was 37.8% and was not affected by treatments on 
Day 0 (P=0.7) or Day 7 (P=0.3). Overall, 419 heifers were diagnosed ultrasonically to be 
not pregnant following TAI. Treatment with GnRH on Day 0 had no effect on estrous 
rate (P=0.5), whereas ECP treatment on Day 7 tended to increase (P<0.1) estrous rate 
(69.6 versus 62.7%; Table 10.3). Interval from Day 7 (ECP treatment) to reinsemination 
was more synchronous (P<0.05) in heifers in the GnRH and GnRH/ECP groups (2.3 ± 
1.2 and 1.9 ± 1.1 d, respectively) than in control heifers, whether they received ECP (2.2 
± 1.4 d) or not (2.1 ± 1.4 d).  
 
Table 10.3. Reproductive outcome of nonpregnant heifers resynchronized with MGA 
starting 13 or 14 d (Day 0) after timed-AI (TAI). All heifers (n=675) were 
fed MGA (0.5 mg/head/day) for 6 d and were allocated to receive 100 μg of 
GnRH or nothing on Day 0 (first day of MGA feeding) and 0.5 mg of ECP 
or nothing on Day 7. 
 
 Control GnRH Control/ECP GnRH/ECP 
 
No. heifers 
nonpregnant to TAI 108 107 101 103 
 
Resynchronization 
No. in estrus 67 68 74 68 
b b a b  63.5  73.3  66.0Estrus rate (%) 62.0
 
No. pregnant  
to reinsemination 30 35 39 27 
Conception rate (%) 44.8 51.5 52.7 39.7 
Pregnancy rate (%)1 27.7 32.7 38.6 26.2 
 
ab Within a row, percentages without a common superscript tended to differ (P=0.1). 
1 Based on numbers of heifers subsequently found to be not pregnant following TAI. 
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 10.4.3 Experiment 3 
 
Pregnancy rate following TAI was 38.7% and was not affected by treatments on 
Day 0 (P=0.5) or Day 7 (P=0.2). Overall, 195 heifers were diagnosed ultrasonically to be 
not pregnant following TAI (Table 10.4). There was no effect of treatment on estrous rate 
(P=0.4; overall, 73.8%). However, heifers receiving a CIDR only had a more 
synchronous (P<0.003) interval from Day 7 (CIDR removal) to reinsemination (2.2 ± 0.7 
d) than those in the other three groups (2.6 ± 1.3, 2.6 ± 1.3, and 2.4 ± 1.4 d for 
CIDR/ECP, MGA, and MGA/ECP groups, respectively). Furthermore, heifers receiving a 
CIDR tended (P<0.1) to have a higher conception rate (68.8 versus 56.7%) and had a 
higher (P<0.04) pregnancy rate (54.1 versus 39.2%) than those fed MGA. Treatment with 
ECP on Day 7 had no effect on conception (P=0.4) or pregnancy (P=0.8) rates. 
 
Table 10.4. Reproductive outcome in nonpregnant heifers resynchronized with MGA or 
a used-CIDR starting 13 or 14 d (Day 0) after timed-AI (TAI). Heifers 
(n=317) were given MGA (0.5 mg/head/day) for 6 d or a once-used CIDR 
for 7 d and were subsequently given 0.5 mg of ECP or nothing on Day 7. 
 
 MGA MGA/ECP CIDR CIDR/ECP 
 
No. heifers 
nonpregnant to TAI 56 41 51 47 
 
Resynchronization 
No. in estrus 38 29 37 40 
Estrus rate (%) 67.8 70.7 72.5 85.1 
 
No. pregnant  
to reinsemination 22 16 28 25 
aConception rate (%) 57.9  55.2a b b 75.7  62.5
Pregnancy rate (%)1 40.4c 39.0c d d 54.9  53.2
 
ab Within a row, percentages without a common superscript tended to differ (P=0.1) 
cd Within a row, percentages without a common superscript were different (P=0.04) 
1 Based on numbers of heifers subsequently found to be not pregnant following TAI. 
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 10.5 Discussion 
 
Gonadotrophin releasing hormone was the only treatment that effectively 
synchronized follicular wave emergence in cows treated with a CIDR insert during 
diestrus (12.3 ± 0.7 d after ovulation). Administration of GnRH induced ovulation and 
emergence of a new follicular wave in more than 80.0% of cows, but it did not alter 
estrous cycle length, suggesting that GnRH maybe useful in the resynchronization of 
cows following TAI. In a previous study, treatment with a GnRH agonist on Day 11 of 
the estrous cycle increased estrous cycle length, primarily by reducing the incidence of 
cycles less than 20 d in length (Macmillan et al., 1985). However, other studies involving 
treatment with either GnRH (Macmillan and Thatcher, 1991) or hCG (Price and Webb, 
1989) during diestrus revealed no effect on estrous cycle length.  
 
In cattle resynchronized with progestins, fertility could be compromised by 
prolonged growth and dominance of the ovulatory follicle in those that had spontaneous 
luteal regression prior to progestin withdrawal. Follicles with prolonged dominance 
(“persistent follicles”) have been extensively described in the literature (Sirois and 
Fortune, 1990; Savio et al., 1992; 1993; Stock and Fortune, 1993; Mihm et al., 1994; 
Kojima et al., 2003); oocytes from these follicles had a lower fertility (pregnancy rate) 
than those from “healthy” dominant follicles (Savio et al., 1992; Stock and Fortune, 
1993; Mihm et al., 1994). Two recent studies showed that fertility tended to be (65.7 
versus 44.1%) (Chapter 9), or was higher (60.0 versus 33.3%) (Stevenson et al., 2003) in 
untreated control heifers than in heifers treated with a used CIDR following TAI. This 
can be overcome by inducing a new follicular wave at the time of initiating progestin 
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 treatment. In addition, it has been suggested that cattle with three follicular waves have 
higher fertility than those with two follicular waves (Townson et al., 2002) and 
treatments that result in all animals having three follicular waves should increase fertility. 
Administration of GnRH during diestrus significantly increased the proportion of cattle 
with three-waves (Clark et al., 1998) and induced a new follicular wave in high 
proportion (80%) of cows in Experiment 1. However, GnRH treatment did not increase 
conception rate in reinseminated heifers (in Experiment 2), even though the synchrony of 
estrus suggested that GnRH had synchronized follicle wave emergence. Heifers may not 
have been as good model as cows to test this hypothesis because of the previously 
reported lower ovulatory response following GnRH treatment during diestrus in heifers 
(Pursley et al., 1995; Martínez et al., 1999). 
 
Administration of either 1 mg of ECP or 150 mg of progesterone during diestrus 
did not effectively synchronize follicular wave emergence in this study; the range in the 
interval from treatment to follicular wave emergence for both groups did not differ from 
that in the control group. Colazo et al. (2003b, Chapter 5) have previously reported that 
follicular wave emergence was quite variable in CIDR-treated beef heifers following 
treatment with 1 mg of ECP. In addition, the administration of 150 mg of progesterone 
concurrent with insertion of a used CIDR 13 to 14 d after TAI in heifers resulted in 
reduced estrous behaviour, conception and pregnancy rates at the subsequent estrus 
(Chapter 9).  
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 Circulating FSH concentrations and LH pulse amplitude have been shown to 
decrease following administration of estradiol and progesterone (Price and Webb, 1988; 
Bó et al., 1995b), resulting in the regression of FSH- and LH-dependent follicles (Bó et 
al., 1995b). Since progesterone affects LH pulse frequency (Ireland and Roche, 1982), 
progesterone treatment is most likely to affect only LH-dependent follicles (Adams et al., 
1992b), i.e. dominant follicles ≥9 mm of diameter (Ginther et al., 2001). Although all 
cows had a dominant follicle ≥9 mm of diameter on Day 0 in Experiment 1, injection of 
150 mg progesterone (and insertion of a used CIDR) resulted in emergence of a new 
follicular wave in only 45.5% of cows. In non-responding cows, growth rate of the 
dominant follicle was reduced, suggesting that progesterone treatment may have been 
partially effective in suppressing LH release. In other studies, the induction of atresia of 
persistent follicles has been successfully achieved with short-term increases in 
progesterone, presumably due to decreased LH pulse frequency (Ireland and Roche, 
1982; Price and Webb, 1988), and administration of 200 mg progesterone in cows with 
persistent follicles resulted in a relatively synchronous emergence of a new follicular 
wave 3.5 ± 0.3 d later (Anderson and Day, 1994). In another study, treatment with 100 
mg progesterone (in oil) or a new CIDR insert for 24 h induced atresia of persistent 
follicles in Bos indicus cattle (Cavalieri et al., 1998), suggesting that persistent follicles 
may be more sensitive to short-term changes in LH pulse frequency than “healthy” 
dominant follicles.  
 
 154
 Resynchronization of estrus in cattle must not disrupt ongoing pregnancies from a 
previous insemination. In this regard, the use of estradiol to initiate a follicular wave 
emergence or increase estrous activity is of some concern in cattle with unknown 
pregnancy status. In Experiments 2 and 3, there was no indication that any of the 
resynchronization protocols affected pregnancy rate following TAI. Similarly, reduced 
dosages of estradiol benzoate or estradiol cypionate to synchronize follicular wave 
emergence (Macmillan et al., 1997; Stevenson et al., 2003) and ovulation (Stevenson et 
al., 2003; El-Zarkouny and Stevenson, 2004) in resynchronized dairy and beef cows did 
not seem to affect pregnancy rate following TAI. Conversely, the same dosages of 
estradiol benzoate (Cutaia et al., 2002) or estradiol-17β (Chapter 9) to resynchronize beef 
heifers was associated with reduced pregnancy rates following TAI. The diameters of the 
CL present at the time of treatment, and plasma progesterone concentrations, were not 
affected by any of the treatments in CIDR-treated cows in Experiment 1. Plasma 
progesterone concentrations in CIDR-treated cows were not different between those that 
received GnRH or no further treatment, even though GnRH induced an accessory CL in 8 
out of 11 cows. In addition, treatment with GnRH during diestrus may affect morphology 
of the CL and have a varied effect on progesterone production (for review see 
Twagiramungu et al., 1995b). Although plasma progesterone concentrations were not 
affected, the number of large luteal cells and volume of the CL were increased following 
buserelin treatment (Twagiramungu et al., 1995a).  
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 Follicle numbers tended to be affected by treatment at CIDR insertion in 
Experiment 1; numbers of small follicles increased 1 and 4 d after treatment in GnRH- 
and ECP-treated cows, respectively, but declined following treatment with injectable 
progesterone. However, GnRH induced ovulation between 24 and 48 h after treatment in 
8 of 11 cows, suggesting that the number of small follicles increased before ovulation, 
likely due to increased concentrations of FSH following GnRH treatment (Chenault et al., 
1990), rather than ovulation of the dominant follicle (Adams et al., 1992a). Indeed, 
emergence of the new follicular wave after ovulation occurred in only one GnRH-treated 
cow. However, ovulation or atresia of the large dominant follicle is necessary to prolong 
the growth of FSH-dependent follicles (Adams et al., 1993a). In GnRH-treated cows, the 
number of medium-sized follicles increased between Days 2 and 4 (peak on Day 3), 
which may reflect the continued development of follicles emerging as a result of the more 
transient increase in FSH following GnRH treatment. In this regard, Macmillan and 
Thatcher (1991) also reported that a single injection of a GnRH agonist on Day 12 
increased the average number of medium-sized follicles 1 to 6 d later. 
 
High rates of both synchronous estrus and conception are needed to optimize 
pregnancy rate in nonpregnant cattle returning to estrus following AI. In previous studies 
that used only progestins to resynchronize estrus, there was a clear need to increase the 
number of nonpregnant cattle showing estrus following progestin removal (Van Cleef et 
al., 1996; Stevenson et al., 2003; Chapter 9). In two previous studies (Van Cleef et al., 
1996; Chapter 9), reinsertion of a used CIDR resulted in approximately 60.0 to 80.0% of 
the non-pregnant heifers detected in estrus over a 5-d period, and in yet another study, the 
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 proportions of non-pregnant heifers that returned to estrus following resynchronization 
with either MGA or CIDR treatments were 65.9 and 63.6%, respectively (Stevenson et 
al., 2003). To our knowledge, there has been only one experiment in which 90.0% of 
heifers showed behavioural estrus after progestin withdrawal (Chapter 9; Experiment 2).  
 
Although estrus was detected by visual observation in most of the previous 
studies, the proportion of non-pregnant cattle detected in estrus was not greatly improved 
when a HeatWatchTM system was used (70.6 and 84.0%, Stevenson et al., 2003 and 
Chapter 9, respectively). We hypothesized that the inclusion of estradiol at the time of 
progestin removal would increase the proportion of non-pregnant cattle observed in 
estrus. In Experiment 1, treatment with 0.5 mg ECP at CIDR removal tended to increase 
the proportion of cows observed in estrus; estradiol at CIDR removal also tended to 
shorten the interval from CIDR removal to ovulation, with a more profound effect in 
cows given either GnRH or ECP at CIDR insertion. Estradiol treatment also tended to 
increase the number of heifers seen in estrus in heifers fed MGA in Experiment 2. 
Although estradiol treatment had no effect on estrous detection rate in Experiment 3, 
numerically more CIDR-treated heifers were seen in estrus. However, due to a reduced 
conception rate, pregnancy rate (the product of estrus detection and conception rates) was 
not improved in CIDR-treated heifers given ECP (compared to CIDR-treated heifers). 
Therefore, there was no benefit to giving estradiol after progestin withdrawal in these 
experiments, which is in agreement with our previous study (Chapter 9). 
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 Overall, conception and pregnancy rates were higher in nonpregnant heifers 
resynchronized following TAI with a used-CIDR as compared to feeding MGA 
(Experiment 3). We have previously reported that conception and pregnancy rates in 
heifers fed MGA for 6 d (49.6 and 40.4%, respectively) were lower than in those given a 
CIDR for 7 d (65.1 and 61.4%, respectively) or untreated-controls (62.2 and 54.9%, 
respectively; Chapter 9). A shorter-term MGA regimen and the attempt to synchronize 
ovarian follicular dynamics did not improve fertility in MGA-fed heifers in the present 
study. In Experiment 2, administration of GnRH at first feeding of MGA did not improve 
conception rate, despite a more synchronous estrus. Similarly, Stevenson et al. (2003) 
reported that 0.5 mg ECP treatment at first feeding and after cessation of MGA feeding 
(13 and 20 d after AI, respectively) did not increase conception rates over that in 
untreated-controls. Although estradiol-17β and progesterone treatment at the initiation of 
feeding MGA on Day 13, in a previous study, resulted in an increase of 14.0% in 
conception rate of over untreated-MGA fed heifers, fertility was still lower than in 
untreated-control (9.0%) and estradiol-CIDR-treated (20.0%) heifers (Chapter 9; 
Experiment 2). Therefore, MGA would not appear to be a good alternative for the 
resynchronization of returns to estrus in time-inseminated cattle.  
 
Insertion of used CIDR inserts into previously inseminated cattle resulted in a 
decreased numbers of days necessary for estrus detection (Chapter 9). Thus, it was a 
simple approach to the resynchronization of estrus in nonpregnant cattle, with acceptable 
fertility in reinseminated heifers (Chapter 9). In this regard, Macmillan and Peterson, 
(1993) reported conception rates of 65.6% in cows resynchronized with a new CIDR 
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 insert. It is noteworthy, that in the present study, fertility at the resynchronized estrus in 
progestin-treated heifers was not compared to that in untreated-control heifers. However, 
Chenault et al. (2003) reported conception rates of 26.7% in lactating dairy cows 
resynchronized with a new CIDR which was not different than in untreated-controls 
(30.9%). Conversely, Stevenson et al. (2003) reported lower conception rates in heifers 
receiving a used-CIDR to resynchronize estrus (33.3%) as compared to untreated-
controls (60.0%). In a previous study, we found that conception rate in CIDR-treated 
heifers was numerically lower than in untreated-control heifers (62.5 versus 76.7%), but 
the difference was not significant due to limited power to detect a difference (Chapter 9; 
Experiment 1). Based on these reports, we could assume that CIDR treatment to 
resynchronize estrus in previously inseminated cattle might result in marginally lower 
conception rates. However, the reduced amount of time required for estrus detection may 
compensate for this reduction in fertility. 
 
In summary, GnRH treatment during diestrus synchronized follicular wave 
emergence in noninseminated cows and shortened the estrus detection period in 
nonpregnant heifers resynchronized following TAI. In contrast, 1.0 mg ECP or 150 mg 
progesterone given at CIDR insertion did not synchronize follicular wave emergence in 
nonlactating beef cows, but ECP treatment following progestin removal tended to shorten 
and synchronize the interval to onset of estrus. Feeding MGA resulted in lower 
conception and pregnancy rates than a used-CIDR insert for resynchronization; 
administration of GnRH at first feeding of MGA did not improve fertility. Overall, 
treatment with ECP at or after progestin withdrawal tended to increase the estrous 
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 detection rate, but numerically decreased conception rate in CIDR-treated heifers. None 
of the treatment protocols affected CL function, estrous cycle length or ongoing 
pregnancies to timed-AI.  
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 11.0 GENERAL DISCUSSION  
 
 Reproductive physiologists have been working on the development of estrus 
synchronization programs that overcome the problems and limitations associated with 
visual estrus detection. In addition, the synchronization of estrus will increase the use of 
artificial insemination (AI) with less intensively managed cattle. Timed artificial 
insemination (TAI) has a direct impact on cost-efficiency by reducing time and labor 
associated with estrus detection. However, to make TAI a widely used technique, 
hormonal treatments used in estrus synchronization systems need to be commercially 
available, economical and result in acceptable pregnancy rates. The studies reported in 
this thesis had as an objective to develop alternative estrus synchronization and 
resynchronization protocols to facilitate and increase the use of AI in beef cattle. 
Nevertheless, several factors such as oocyte competence, fertilization rate, CL function, 
and embryo development may affect fertility following estrus synchronization and TAI. 
The following sections are intended to review studies reported herein, and to discuss 
factors affecting fertility that should be considered in future studies. 
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 11.1 Synchronizing follicular wave emergence for estrus synchronization schemes 
 
 The effects of different estradiol preparations on the pattern of gonadotrophin 
release and ovarian follicular dynamics have been previously described. It was reported 
that 5 mg of estradiol-17β (E-17β) resulted in a transient decrease in FSH concentrations, 
followed by a transient increase in FSH, and synchronous follicular wave emergence 4.3 
d after treatment (Bó et al., 1995b). Length of suppression of endogenous FSH release 
and the interval to follicular wave emergence depended on estradiol preparation and dose 
(Martinez et al., 2003a). Slow absorption, prolonged elevations in plasma concentrations 
of estradiol and subsequently delayed and asynchronous follicular wave emergence were 
reported in cattle treated with large doses (5-10 mg) of estradiol esters (see Chapters 5 
and 7). In this regard, Caccia and Bó (1998) reported that 2.5 mg estradiol benzoate (EB) 
induced more synchronous emergence of a new follicle wave than a dose of 5 mg. To our 
knowledge, the effects of reduced doses of estradiol cypionate (ECP) had been reported 
in only one study (Thundathil et al., 1997), and the effects of reduced doses of estradiol 
valerate (EV) had not been studied. Thus, ECP was the only estradiol preparation 
commercially available in North America and EV was under consideration for licensing 
along with the norgestomet implant called CrestarTM, so we elected to study the use of 
these esters in TAI protocols. We hypothesized that administration of reduced doses (1-2 
mg) of ECP or EV would result in synchronous follicular wave emergence regardless of 
stage of the estrous cycle at the time of treatment. However, present studies revealed that 
in beef heifers, 1 mg of ECP was less precise in synchronizing follicular wave emergence 
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 than 5 mg of E-17β, while in beef cows, a dose of 1 or 2 mg of EV resulted in 
synchronous follicular wave emergence.  
 
 We confirmed that EV, an estradiol ester, is efficacious in synchronizing follicle 
wave emergence in cattle, providing the appropriate dose is used. This is in agreement 
with previous studies in which reduced doses of EB, another estradiol ester, was 
investigated. In contrast, the 1 mg dose of ECP utilized in studies described in Chapter 5 
did not result in synchronous follicular wave emergence, which is consistent with the 
findings of Thundathil et al. (1997). Lopes (2000b) showed that a dose of 1 mg ECP 
resulted in circulating E-17β plasma concentrations of 10-15 pg/mL, which would appear 
to be required to suppress circulating FSH concentrations sufficiently to induce follicle 
atresia, and then emergence of a new follicular wave following a transient FSH surge 
(Diskin et al., 2002). Hence, we do not consider it necessary to increase the dose of ECP 
to improve its efficacy in synchronizing follicle wave emergence. On the contrary, a 
higher dose of ECP may result in a more delayed and asynchronous emergence of the 
new follicular wave because of the duration of increase plasma estradiol concentrations. 
 
 Gonadotrophin releasing hormone (GnRH) has been used extensively to 
synchronize follicular dynamics. A gonadotrophin surge (Kaltenbach et al., 1974; 
Chenault et al., 1990; Martinez et al., 2003b) and ovulation in approximately 85% of 
cows and 54% of heifers (Pursley et al., 1995) following administration of GnRH has 
been described. Ovulation of a selected dominant follicle will ensure the emergence of a 
follicular wave, on average 2 d after treatment. Whether a proportion of animals that do 
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 not ovulate in response to GnRH treatment will initiate a new follicular wave due to 
dominant follicle luteinization, or by chance, is still controversial. The likelihood of 
ovulation would seem to depend on follicular wave status at the time of GnRH treatment. 
If ovulation is a prerequisite for the development of a new follicular wave, then the 
success of GnRH-based protocols is dependent on stage of the follicle development when 
treatment is initiated. On the contrary, estradiol/progestin protocols may be a better 
alternative than GnRH-based protocols when treatment is initiated at random stages of 
the estrous cycle, as these two steroids are potentially able to induce atresia of both FSH- 
and LH-dependent follicles. In Chapter 6, 100 μg GnRH or 1 mg ECP was used to 
synchronize follicular wave emergence. Although we did not conduct daily 
ultrasonographic examinations to compare efficacy of treatment on ovarian follicular 
dynamics, pregnancy rate following TAI (56.1 and 56.4% for GnRH and ECP treatments, 
respectively) indirectly indicate that treatments were equally efficacious in synchronizing 
dominant (ovulatory) follicle development. Treatment with 1 mg ECP in Chapter 5 
(Experiment 2) resulted in 57% of heifers with synchronous follicular wave emergence 3 
to 4 d later. Other researchers have reported that only 54 to 56% of heifers ovulated 
following treatment with GnRH at random (Pursley et al., 1995), or at predetermined 
(Martínez et al., 1999) stages of the estrous cycle. Interestingly, the proportion of heifers 
that responded to the injection of GnRH by ovulating a dominant follicle (Pursley at al., 
1995; Martínez et al., 1999) was similar to proportion of heifers that responded to the 
injection of ECP by initiating synchronous emergence of a new follicular wave (Chapter 
5, Experiment 2).  
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  As stated earlier, follicular wave emergence must be induced in progestin-based 
estrus synchronization protocols to avoid the development of persistent follicles. Most 
progestin-treated-cattle that failed to respond to the treatment given to induce a new 
follicular wave developed a persistent follicle, which has been shown to result in reduced 
conception rates after AI. As it turns out, most of the nonresponding cattle were at late 
stages of the estrous cycle, or in proestrus, when treatment was administered. Martínez et 
al. (2002a) reported that estradiol/progesterone treatment did not consistently induce 
emergence of a new follicular wave in heifers undergoing spontaneous luteal regression 
at the time of treatment. Bó et al. (1994) also reported that estradiol treatment more 
effectively suppressed growth of the first-wave dominant follicle when administered with 
a progestogen implant than when administered alone in heifers during metestrus, 
indicating that the efficacy of estradiol treatment depends on circulating progesterone 
concentrations. On the possibility of encountering cows without a functional CL in a 
group of randomly cycling cows, we have consistently included progesterone with the 
first estrogen treatment. Even though treatment with a combination of estradiol and 
progesterone at the time of CIDR insertion may not consistently induce regression of the 
dominant follicle in cattle with low circulating progesterone, the progesterone may have a 
positive effect on fertility. Consequently, in studies reported in Chapter 8, we 
hypothesized that the ability of estradiol to consistently induce follicle atresia and 
synchronize follicular wave emergence is dependent on elevated plasma progesterone 
concentrations. Martinez et al. (2003a) have shown that new CIDR inserts in 
ovariectomized beef cows increased plasma progesterone concentrations by 
approximately 7 ng/mL within 24 h. However, if a once-used CIDR was inserted, an 
 165
 injection of 100 mg of progesterone was needed to increase plasma progesterone 
concentrations an equivalent amount. We speculated that the magnitude of the sudden 
increase in circulating progesterone concentrations within 24 h of CIDR insertion would 
affect the ability of estradiol to induce atresia followed by synchronous follicle 
development. However, pregnancy rate following TAI did not differ between cattle 
receiving a new versus a once-used CIDR insert, whether or not progesterone was 
administered at the time of CIDR insertion. Our hypothesis was rejected, and we 
speculated that the 2-3 ng/mL increases in plasma progesterone concentrations in cattle 
treated with a once-used CIDR (Martínez et al., 2003a) was sufficient to achieve 
acceptable pregnancy rates following TAI. In contrast, cattle treated with a twice-used 
CIDR had the lowest pregnancy rate following TAI. A twice-used CIDR may have 
increased circulating progesterone concentrations insufficiently for estradiol treatment to 
induce follicle atresia because an injection of 100 mg progesterone tended to increase 
pregnancy rate in animals receiving a twice-used CIDR. However, a twice-used CIDR 
may have also not maintained plasma progesterone concentrations sufficiently to prevent 
an LH surge during the treatment period.  
 
 All new CIDR inserts used in the studies reported in this thesis had 1.9 g of 
progesterone. Macmillan et al. (1991) reported that ovariectomized beef heifers treated 
with new CIDR for 12 d had average plasma progesterone concentrations of 5.6 ng/mL 
during treatment, varying from 8.7 ng/mL within 6 h of insertion to 2.5 ng/mL at CIDR 
removal. Similarly, treatment of ovariectomized dairy cows with a CIDR insert increased 
plasma progesterone concentrations from 0.3 to 8.6 ng/mL within 6 h, followed by a 
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 decline to 2.3 ng/mL at CIDR removal (Peterson and Henderson, 1991). Based on these 
data, CIDR inserts used for 7 (once-used) or 14 d (twice-used) should be able to maintain 
plasma progesterone concentrations above 1.5 ng/mL, which should suppress an 
endogenous LH surge and ovulation. However, methods of cleaning, disinfecting, and 
storage may have reduced progesterone content in some previously used CIDR inserts 
utilized in our studies. Macmillan and Peterson (1993) reported that the average 
progesterone content in 1.9 g CIDR inserts previously used for 15 d was 0.92 g. The 
amount of progesterone remaining in a used CIDR after 15 d insertion period is primarily 
dictated by the initial progesterone content and was not affected by inserting more than 
one insert (Macmillan et al., 1990). In this study, the average residual progesterone 
content of the used inserts was the same (1.07 g) irrespective of whether they were from 
cows treated with one or three CIDR inserts, indicating that the progesterone absorption 
was not affected by the number of CIDR inserted. We also expected that two twice-used 
CIDR inserts would increase plasma progesterone concentrations in beef heifers, but 
pregnancy rate was similar in heifers treated with two twice-used CIDR inserts to that in 
those receiving only one twice-used CIDR insert. 
 
 Treatments for synchronizing follicular wave emergence that are reported in this 
thesis are summarized in Table 11.1. It is clear that administration of 5 mg E-17β at 
progestin treatment consistenly resulted in emergence of a new follicular wave regardless 
of the progestin used and whether or not progesterone was injected at the same time. The 
mean (± SD) interval from treatment to follicular wave emergence varied from 3.0 ± 1.1 
to 3.6 ± 0.5 d. The same may be said of 1 or 2 mg EV with follicle wave emergence 
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occurring 3.2 ± 0.9 and 3.4 ± 0.8 d after treatment, respectively. Conversely, the inteval 
from treatment with 5 mg of EV to follicular wave emergence was longer and more 
variable (5.7 ± 1.5 and 4.8 ± 1.2 d in heifers and cows, respectively). Similarly, 
administration of 1 mg of ECP, another estradiol ester, resulted in considerable variability 
in the interval from treatment to follicular wave emergence (standard deviations varied 
from 1.4 to 4.1 d in heifers and cows, respectively). Hence, one could question whether 
follicle wave emergence was any more synchronous following administration of ECP 
(with or without progesterone) than the administration of a CIDR insert alone or plus 150 
mg of progesterone, which we concluded did not synchronize follicular wave emergence 
(standard deviations ranged from 2 to 3.7 d). Treatment with 100 μg GnRH resulted in 
follicular wave emergence in 0.8 ± 0.8 d in “presynchronized” cows in studies reported in 
Chapter 10. However, caution must be used in interpreting this result because animals at 
random stages of the estrous cycle were not studied. As indicated above, it has been 
previously shown that presynchronization procedures improve the efficacy of GnRH-
based TAI protocols by providing for an LH-responsive follicle at the time of the first 
GnRH treatment.  
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Table 11.1. Mean (+ SD) day of follicular wave emergence (FWE) following treatment at CIDR or Norgestomet implant insertion 
(all experiments combined). 
 
      FWE 
 
 Experiment (Chapter) Treatment Estrous cycle (d) Animal n (Mean ± SD) Range 
 
 3(7) nCIDR at random cows 10 3.8 ± 2.0 (-4 to 6) 
 1(10) oCIDR 12 ± 0.7 cows 10 0.2 ± 3.7 (-5 to 6) 
 1(10) oCIDR+150mg P4 12 ± 0.7 cows 11 -0.2 ± 3.3 (-6 to 5) 
 3(5) nCIDR+5mg E-17β at random heifers 15 3.0 ± 1.1 (-6 to 4) 
 3(5) nCIDR+5mg E-17β+100mg P4 at random heifers 15 3.4 ± 0.9 (-5 to 5) 
 2(5) oCIDR+5mg E-17β+100mg P4 at random heifers 30 3.3 ± 0.8 (2 to 5) 
 1(7) Norgestomet(I)+5mg E-17β+100mg P4 at random heifers 35 3.6 ± 0.5 (3 to 4) 
 1(5) oCIDR+1mg ECP at random heifers 13 3.7 ± 1.8 (2 to 7) 
 1(10) oCIDR+1mg ECP 12 ± 0.7 cows 11 0.7 ± 4.1 (-6 to 5) 
 1(5) oCIDR+1mg ECP+50mg P4 at random heifers 11 4.0 ± 1.6 (2 to 7) 
 2(5) oCIDR+1mg ECP+100mg P4 at random heifers 28 4.1 ± 1.4 (-4 to 8) 
 3(7) nCIDR+1mg EV at random  cows 11 3.2 ± 0.9 (-4 to 4) 
 3(7) nCIDR+2mg EV at random cows 10 3.4 ± 0.8 (2 to 5) 
 3(7) nCIDR+5mg EV at random cows 11 4.8 ± 1.2 (3 to 7) 
 1(7) Norgestomet(I)+5mg EV+3mg Norgestomet at random heifers 38 5.7 ± 1.5 (3 to 9) 
 1(10) oCIDR+100μg GnRH 12 ± 0.7 cows 11 0.8 ± 0.8 (-1 to 2) 
 
 
 
oCIDR = Once-used CIDR; nCIDR = New CIDR; Norgestomet(I) = Norgestomet implant 
E-17β = Estradiol-17β; ECP = Estradiol cypionate; EV = Estradiol valerate; P4 = Progesterone. 
 11.2 Synchronizing follicular wave emergence for superovulation treatments 
 
 The objective of ovarian superstimulatory treatment with exogenous 
gonadotrophins in cattle is to obtain the maximum number of viable embryos by 
stimulating growth and subsequent ovulation of competent antral follicles. Follicular 
response to superstimulation treatments remains variable both within and between cattle. 
The unpredictability of response causes severe logistical problems and contributes to the 
high cost of embryo production in conventional embryo transfer programs. However, 
superovulatory response of cattle is affected by various factors. It is well known that the 
presence of a dominant follicle at the time of gonadotrophin treatments will reduce the 
number of transferable embryos (Guilbault et al., 1991; Bungartz and Niemann, 1994). 
The synchronization of follicular wave emergence not only avoids the presence of a 
dominant follicle at initiation of gonadotrophin treatment, but it also allows for the 
scheduling of embryo collection and transfer at the most convenient time from a 
management perspective. Previous studies have shown the importance of synchrony 
between follicular wave emergence and initiation of gonadotrophin treatments (Nasser et 
al., 1993; Baracaldo et al., 2000). As little as one day of asynchrony resulted in decreased 
numbers of transferable embryos (Nasser et al., 1993). Therefore, we hypothesized that 
the estradiol/progesterone treatments that result in the most synchrony of follicular wave 
emergence would result in a higher superovulatory response in term of numbers of 
transferable embryos (Chapter 7). In this regard, E-17β treatment has consistently 
resulted in a greater degree of synchrony of follicular wave emergence, and FSH 
treatment 4 d later has tended to result in a consistently high number of transferable 
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 embryos. However, the most important benefit is that procedures can be done at a 
practitioner-appointed time, without consideration of the stage of the estrous cycle. 
 
11.3 Synchronizing LH surge and ovulation 
 
 The use of exogenous estradiol as part of an estrus synchronization protocol is 
also based on the ability of estradiol to induce an LH surge by stimulating hypothalamic 
secretion of GnRH (Nett et al., 1984; Turzillo and Nett, 1999). Estradiol also increases 
pituitary sensitivity to GnRH, apparently by increasing the number of GnRH receptors 
within the gonadotrope cells (Turzillo et al., 1994).  
 
 In Chapter 5, we hypothesized that a small dose of ECP would synchronize LH 
release and ovulation in heifers in which circulating concentrations of progesterone had 
been caused to decline. It was also hypothesized that due to the prolonged elevation of 
estradiol in the circulation, administration of ECP at CIDR removal would result in 
acceptable pregnancy rates following TAI. The first hypothesis was supported by studies 
presented here. The administration of 0.5 mg ECP 24 h after CIDR removal synchronized 
LH release and ovulation in beef heifers. The second hypothesis was partially supported. 
In this regard, an interesting observation was made in Experiment 2 (Chapter 5) and 
confirmed later in larger studies in Experiment 4, and in Chapter 6. Pregnancy rate 
following TAI in heifers treated with ECP at CIDR removal depended on the treatment 
used to synchronize follicular wave development. When GnRH or ECP had been given to 
synchronize follicular wave emergence, pregnancy rate was higher in heifers treated with 
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 ECP 24 h after CIDR removal. Conversely, if E-17β had been administered at CIDR 
insertion to synchronize follicle wave emergence, then the timing of ECP treatment to 
induce LH release and ovulation was less critical. The administration of ECP at CIDR 
removal resulted in pregnancy rates following TAI that did not differ from that when 
ECP was administered 24 h later. The reduced fertility observed following ECP treatment 
at CIDR removal in animals that had received ECP or GnRH to synchronize follicular 
wave emergence was likely due to asynchronous ovulation following asynchronous 
emergence of the ovulatory follicle. The administration of E-17β resulted in much more 
synchronous emergence of a growing dominant follicle than either GnRH or ECP. 
Several precocious ovulations occurred in ECP- and GnRH-treated heifers that received 
ECP at CIDR removal in Experiment 2 (Chapter 5). Overall, heifers that ovulated before 
TAI may have had low progesterone concentrations; estradiol treatment or an estrogen-
active dominant follicle may have induced an early LH surge, resulting in premature 
ovulation.  
 
 That ECP administered at CIDR removal resulted in acceptable pregnancy rates in 
E-17β-treated cattle is a very important finding, particularly for cow-calf operations. In 
extensively managed cattle herds, it is necessary to sort cows from calves every time that 
treatments must be administered. Increased animal handling is not only stressful to both 
cows and calves, but also requires input in time and labor for producers. Hence, estrus 
synchronization protocols that reduce the number of handling procedures would be well 
accepted among beef cattle producers.  
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  Although we did not investigate the effect of dose of ECP in beef cows, Pancarci 
et al, (2002) have suggested that 1 mg ECP is more efficacious than 0.5 mg ECP in 
synchronizing ovulation in lactating Holstein cows. However, the author of this thesis has 
utilized the CIDR-ECP protocol in lactating beef cows with acceptable pregnancy rate 
following TAI (unpublished). Wiltbank et al. (2000) have reported that lactating dairy 
cows had increased steroid hormone metabolism, which may have affected the 
effectiveness of 0.5 mg ECP in the study by Pancarci et al. (2002). 
 
 GnRH has been used to synchronize the LH surge and ovulation in estrus 
synchronization and TAI schemes. Geary et al. (2001) demonstrated that GnRH could be 
given at TAI without a detrimental effect on pregnancy rate when compared to GnRH 
given 16 h before TAI. In our study, pregnancy rate following TAI in heifers (Chapter 6) 
was not only affected by timing of ECP treatment, but also by type of treatment given 
after CIDR removal. Administration of ECP 24 h after CIDR removal resulted in higher 
pregnancy rates than GnRH treatment at the time of TAI, whether ECP or GnRH was 
administered at the time of CIDR insertion. A difference in CL formation and function 
may occur in cattle that have a spontaneous or estradiol-induced LH surge versus a 
GnRH-induced LH surge. The spontaneous (Thatcher and Chenault, 1976) or estradiol-
induced (Bó et al., 1994; Martínez et al., 2003a) preovulatory LH surge is of a longer 
duration (approximately 10 h) as compared to that following an injection of 100 μg 
GnRH (approximately 4 h; Chenault et al., 1990; Martínez et al., 2003b).  
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  The optimal duration and amplitude of the LH surge required for ovulatory events 
has been studied extensively in humans and primates; in both, the LH surge of 
spontaneous cycles had a duration of 48-50 h (Weick et al., 1973; Hoff et al., 1983). 
Endogenous LH surges of 14 h or less duration elicited by GnRH or GnRH agonist 
treatment were insufficient to induce periovulatory events in oocytes and granulosa cells 
in primates (Zelinski-Wooten et al., 1991; Chandrasekher et al., 1991). However, an LH 
surge of up to 24 h in primates induced oocyte maturation and granulosa cell 
luteinization, but did not support CL function (Zelinski-Wooten et al., 1992). Longer LH 
surges, (up to 48 h) similar to those endogenous surges, are needed to promote CL 
development and function in humans (Lanzone et al., 1989) and primates (Chandrasekher 
et al., 1994). Thus, genes involved in luteinization (e.g. steroidogenic enzymes StAR and 
P450scc) are also induced by the LH surge. The extent of the LH surge may have an effect 
on expression of genes necessary for steroid production by the new CL. A more-
developed and metabolically active CL may result in higher progesterone concentrations 
during the luteal phase. Recent studies in cattle suggest that many of the ovulations 
resulting from GnRH treatment may not result in normal CL formation. Cordoba and 
Fricke (2002) reported that about 12% of cows had a second insemination within 18 d 
following an Ovsynch® protocol in which a dose of 50 μg GnRH was used. Short cycles 
were also observed following an Ovsynch® protocol in which a dose of 100 μg GnRH 
was used (Shephard, 2002; Colazo unpublished). Abnormal CL formation seems not to 
be related to the dose of GnRH because differences in CL development and progesterone 
production were also found between cows with spontaneous or induced ovulation 
following administration of 250 μg of gonadorelin (Macmillan et al., 2003).  
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  There is also evidence that inadequate estradiol secretion by the preovulatory 
follicle may cause failure of normal luteal function or premature secretion of luteolytic 
PGF. Benoit et al. (1992) observed a delay in initiation of luteal function when ewes were 
treated with an aromatase inhibitor and then treated with hCG to induce ovulation in the 
absence of an estrogen-induced LH surge. A number of authors have reported sub-
optimal levels of preovulatory estradiol secretion preceding the formation of CL with 
short-life span (Garcia-Winder et al., 1986; Garverick et al., 1988). Inadequate 
preovulatory estradiol production leads to inadequate inhibition of oxytocin receptors in 
the uterus, resulting in premature secretion of PGF (Mann and Laming, 2000). Premature 
uterine secretion of PGF and a short luteal phase following first ovulation following onset 
of puberty, or post-partum or seasonal anestrus is common in ruminants. Pretreatment 
with progesterone has usually resulted in formation of a CL with a normal functional 
lifespan (Ramirez Godinez et al., 1981). However, prevention of the early secretion of 
PGF induced by oxytocin in ovariectomized cows required a sequence of exposure to 
estrogen and progesterone preceded by progesterone priming (Kierborz-Loos et al., 
2003). 
 
 Although estrus detection was not performed in the study described in Chapter 6, 
fewer GnRH-treated heifers were expected to show behavioural estrus than ECP-treated 
heifers. Estrus detection, and indeed, whether or not estrus is expressed, is not important 
if ovulation is synchronized for TAI. Nevertheless, estrus rate before TAI was higher in 
heifers treated with estradiol (92.0%) than in those treated with GnRH (50.7%) or pLH 
(47.2%) to induce ovulation (Martinez et al., 2002c). Interestingly, pregnancy rates were 
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 higher in GnRH- or pLH-treated heifers that were detected in estrus, but pregnancy rates 
were not different in estradiol-treated heifers that did or did not show behavioural estrus.  
 
 The use of long acting estradiol esters, such as ECP, to synchronize ovulation 
may be of some concern due to elevated concentrations of estradiol during ovum 
transport and fertilization, and early embryonic and CL development. However, results 
presented here did not support that concern. Conversely, estradiol has been shown to 
facilitate sperm transport in the female reproductive tract (Harper, 1994). Treatment with 
estradiol during proestrus increased the number of sperm in the oviducts, uterus and 
cervix after natural mating (Haw and Cooper, 1975). In cattle and sheep, an oviduct-
specific glycoprotein secreted mainly from Days -1 to 3 of the estrous cycle is 
synthesized by the ampulla region of the oviduct in response to estrogen (Nancarrow and 
Hill, 1995). This protein, and other amino acids, may interact with the gametes or embryo 
to facilitate the processes of fertilization and development. Therefore, the beneficial 
effects of estradiol during fertilization and embryo development may lead to increased 
pregnancy rates when ECP, rather than GnRH, is used to synchronize ovulation.  
 
Pregnancy rates following TAI for all experiments combined are shown in Table 
11.2. Treatment protocols in these studies differed somewhat, but they were all designed 
to synchronize follicle wave emergence and ovulation so as to facilitate TAI. Although 
group sizes varied considerably, pregnancy rates ranged from 44.3 to 100 % in 2507 
cattle. As discussed in Section 11.5, many other factors may have affected fertility 
following TAI, and nutrition and management are probably two of the most important. 
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Therefore, it is not the intention to draw conclusions from this table, but rather to present 
a summary of pregnancy rates following the use of similar or dissimilar protocols, all 
designed to accomplish the same thing. For example, data presented in Chapter 10 
suggest that GnRH was quite efficacious in synchronizing follicle wave emergence while 
ECP was not (see Table 11.1). However, ECP was at least as efficacious as GnRH 
(without presynchronization) in synchronizing follicular wave emergence and ovulation 
for TAI in Chapter 6 (see Table 11.2). The greatest benefit for the use of ECP seemed to 
be in the synchronization of LH release and ovulation. As one might expect, the 
synchrony of ovulation may be more critical than the synchrony of follicle wave 
emergence for the successful application of TAI. In other words, protocols for TAI would 
appear to have considerable flexibility in the synchronization of follicle wave emergence, 
providing the timing of ovulation was well controlled and AI was conducted at the 
appropriate time. 
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Table 11.2. Pregnancy rates (%) following timed-AI (TAI) for all experiments combined. Heifers received a CIDR insert for 7 or 9 d 
(brackets) and prostaglandin was administered at CIDR removal. TAI was done relative to CIDR removal. 
Experiment (Chapter) Treatment (d) TAI (h) Animal n Preg. rate (%) 
 2(5) oCIDR(7)+5mg E-17β+100mg P4+0.5mg ECP0 58-60 heifers 10 70 
 2(5) oCIDR(7)+5mg E-17β+100mg P4+0.5mg ECP24 58-60 heifers 10 60 
 2(5) oCIDR(7)+5mg E-17β+100mg P4+1mg EB24 58-60 heifers 10 80 
 4(5) nCIDR(7)+5mg E-17β+100mg P4+0.5mg ECP0 54-56 heifers 98 63.3 
 4(5) nCIDR(7)+5mg E-17β+100mg P4+0.5mg ECP24 56-58 heifers 99 64.6 
 4(5) nCIDR(7)+5mg E-17β+100mg P4+0.5mg EB24 56-58 heifers 103 63.1 
 2(8) oCIDR(7)+1mg EB+100mg P4+1mg EB24 52-56 heifers&cows 93 64.5 
 2(8) oCIDR+1mg EB+1mg EB24 52-56 heifers&cows 88 60.2 
 2(8) tCIDR(7)+1mg EB+1mg EB24 52-56 heifers&cows 92 45.6 
 2(8) tCIDR(7)+1mg EB+100mg P4+1mg EB24 52-56 heifers&cows 90 51.1 
 3(8) nCIDR(7)+2mg EB+50mg P4+1mg EB24 52-56 heifers 33 57.5 
 3(8) oCIDR(7)+2mg EB+50mg P4+1mg EB24 52-56 heifers 58 63.8 
 3(8) tCIDR(7)+2mg EB+50mg P4+1mg EB24 52-56 heifers 48 47.9 
 3(8) 2tCIDR(7)+2mg EB+50mg P4+1mg EB24 52-56 heifers 48 47.9 
 1(8) nCIDR(9)+1mg ECP+0.5mg ECP24 55-60 heifers 151 49.6 
 1(8) oCIDR(9)+1mg ECP+0.5mg ECP24 55-60 heifers 156 48.0 
 2(5) oCIDR(9)+1mg ECP+100mg P4+0.5mg ECP0 58-60 heifers 9 44.4 
 2(5) oCIDR(9)+1mg ECP+100mg P4+0.5mg ECP24 58-60 heifers 10 100 
 2(5) oCIDR(9)+1mg ECP+100mg P4+1mg EB24 58-60 heifers 9 55.5 
 1(6) oCIDR(9)+1mg ECP+50mg P4+0.5mg ECP0 58-60 heifers 160 56.2 
 1(6) oCIDR(9)+1mg ECP+50mg P4+0.5mg ECP24 58-60 heifers 165 64.8 
 1(6) oCIDR(9)+1mg ECP+50mg P4+100μg GnRH52 52-54 heifers 166 48.2 
 1(8) nCIDR(9)+1mg ECP+100mg P4+0.5mg ECP24 55-60 heifers 149 46.9 
 1(8) oCIDR(9)+1mg ECP+100mg P4+0.5mg ECP24 55-60 heifers 160 44.3 
 1(6) oCIDR(8)+100μg GnRH+100μg GnRH52 52-54 heifers 165 53.9 
 1(6) oCIDR(8)+100μg GnRH+0.5mg ECP0 58-60 heifers 162 48.1 
 1(6) oCIDR(8)+100μg GnRH+0.5mg ECP24 58-60 heifers 165 66.1 
 
oCIDR = Once-used CIDR; nCIDR = New CIDR; tCIDR = Twice-used CIDR 
E-17β = Estradiol-17β; ECP = Estradiol cypionate; EV = Estradiol valerate; EB = Estradiol benzoate; P4 = Progesterone. 
ECP0 = ECP treatment at CIDR removal; ECP24 = ECP treatment 24 h after CIDR removal; EB24 = EB treatment 24 h after CIDR removal; GnRH52 = GnRH 
treatment 52 h after CIDR removal. 
 11.4 Time of PGF treatment and progestin withdrawal  
 
 During proestrus (low progesterone environment), pulses of LH measured in the 
plasma occur with a high frequency and low amplitude (Rahe et al., 1980). LH pulse 
frequency increases as estradiol concentrations increase, leading to the preovulatory LH 
surge (Chenault et al., 1975). Hence, estradiol treatment would increase pituitary 
sensitivity to GnRH release and contribute to these episodes of increased LH release, 
which probably up-regulate mechanisms that contribute to final stages of follicular 
development. Furthermore, the preovulatory follicle expresses steroidogenic enzymes 
necessary for the synthesis of estradiol, which in turns triggers the LH surge. The 
preovulatory LH surge then acts on granulosa and theca cells to terminate gene 
expression associated with folliculogenesis (the CL of humans, pigs and rats retain the 
ability to produce estradiol) and this change in gene expression precedes luteinization or 
ovulation of the dominant follicle (Niswender et al., 2000). 
 
In estrus synchronization protocols, luteolysis is usually induced shortly after the 
establishment of dominance by the induced-ovulatory follicle. For example, in GnRH- 
(e.g. Ovsynch® ® and Cosynch ) or estradiol/progestin-based protocols, PGF is given 7 d 
after the first GnRH or estradiol treatment. A new dominant follicle should emerge, on 
average, 2 and 4 d after GnRH and estradiol treatment, respectively, in cattle responding 
to the initial treatment. Therefore, when luteolysis is induced, GnRH-treated cattle will 
have a dominant follicle that is 2 d older and larger than estradiol-treated cattle. 
Interestingly, ovulatory follicles are approximately 3 d older and 2 mm larger at the time 
of ovulation in two-wave than in three-wave cattle (Ginther et al., 1989b; Townson et al., 
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 2002; Bleach et al., 2004). Conception rate to AI has been reported to be lower in 
lactating dairy cows with two (63%), rather than three (81%) waves of follicular 
development (Townson et al., 2002). However, Bleach et al. (2003) report no diference in 
fertility between 2- and 3-wave dairy cows. The ovulatory wave emerges on Days 10 or 
16 and luteolysis occurs on Day 16.5 or 19 in two and three wave animals, respectively 
(Ginther et al., 1989b). Hence, the interval from ovulatory follicle emergence to luteal 
regression is approximately 3 d longer in 2-wave animals. Therefore, the age and larger 
size of the ovulatory follicle in two-wave animals is due to the period before luteolysis, in 
the same way as would occur in cattle treated with GnRH-based protocols. If there is a 
difference in fertily between 2- and 3-wave cattle, it would have to be a result of the 
interval from follicular wave emergence to luteolysis, and not due to the interval from 
luteolysis to ovulation.. However, the effect of the length of proestrus on fertility in TAI 
protocols still remains unresolved. 
 
A retrospective analysis of ovulatory follicle diameter between open and pregnant 
heifers in Experiment 2 (Chapter 5) suggested that an important factor related to fertility 
was size of the preovulatory follicle. Heifers that did not conceive had a smaller 
preovulatory follicle (12.7 ± 1.3 mm diameter) at the time of TAI than those that became 
pregnant (13.6 ± 1.6 mm). Recent studies, in which GnRH was used to induce ovulation, 
clearly showed that fertility is compromised when animals are induced to ovulate a 
dominant follicle that has not reached full maturity (Vasconcelos et al., 2001; Mussard et 
al., 2003; Colazo et al., 2004c). In essence, a small ovulatory follicle resulted in low 
pregnancy rates following TAI. In a study in which follicle wave emergence was induced 
by follicle ablation, mean ovulatory follicle diameter and conception rate was higher in 
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 cattle with spontaneous ovulation (12.0 ± 0.3 mm and 100%) than those in which GnRH 
was administered when the largest follicle was 10 mm in diameter (10.7 ± 0.1 mm and 
75.9%; Mussard et al., 2003). When PGF was given approximately 4.5 d after follicle 
ablation, conception rates were 4.4 and 57.4 % in cattle induced to ovulate follicles of 
11.1 or 13.6 mm in diameter, respectively. Mussard et al. (2003) suggested that follicle 
size was not the only component affecting fertility; length of proestrus and the associated 
endocrine environment to which a follicle has been exposed may also affect fertility. 
Exposure to increased LH pulse frequency and elevated estradiol concentrations 
characteristic of proestrus may also affect oocyte maturation and fertility. In this regard, 
there is evidence of an influence of follicular fluid (especially estradiol concentrations in 
follicular fluid) from different follicle populations, on oocyte maturation and blastocyst 
production in vitro (Sirard et al., 1995). The proportion of embryos reaching the 64-cell 
stage and the average number of nuclei per embryo at the 16- and 32-cell stages, were 
higher for oocytes maturated in the presence of follicular fluid from a dominant follicle 
than those matured in the presence of follicular fluid from superovulated animals (Sirard 
et al., 1995).  
 
It has been also shown that larger preovulatory dominant follicles form larger CLs 
that produce greater amounts of progesterone (Vasconcelos et al., 2001; Burke et al., 
2001; Mussard et al., 2003), resulting in lower embryonic mortality (Perry et al., 2003) 
and higher pregnancy rates following AI (Vasconcelos et al., 2001; Mussard et al., 2003; 
Colazo et al., 2004). Cattle induced to ovulate immature follicles had CL that produced 
plasma progesterone concentrations that were 61 to 89% that of normal CL (Mussard et 
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 al., 2003). Ewes induced to ovulate 24 h early also had subfunctional CLs that were 
deficient in large luteal cells (Murdoch and Van Kirk, 1998), and had attenuated 
endometrial gland development and gestational failure. Increased progesterone 
concentrations have been shown to be also associated with increased conceptus size and 
an increased ability to produce interferon tau (INF-τ; Mann et al., 1999), which is 
necessary for maternal recognition of pregnancy.  
 
Fertility would appear to be affected for several mechanisms. It has been 
suggested that extending the length of progestin treatment by 1d will result in a more 
synchronized ovulation (Macmillan et al., 1999), larger ovulatory follicles and a 
subsequent increase in pregnancy rate following TAI (Bó, personal communication 
2003). However, we were unable to show any difference in pregnancy rates following 
TAI in beef cattle treated with estradiol and a CIDR insert for either 7 or 8 d 
(unpublished). A longer progestin treatment may also result in a shorter interval from 
CIDR removal and PGF treatment to ovulation.. Perhaps size of the ovulatory follicle is 
not exclusively important and subtle changes in the endocrine environment in which the 
ovulatory follicle develops may affect oocyte competence, CL function and subsequently 
embryo development. 
 
 In Chapter 7, estradiol valerate (EV)-treated heifers had a shorter interval from 
follicular wave emergence to ovulation than E-17β- treated heifers. Although follicular 
wave emergence was more synchronous and dominant follicle size at norgestomet 
implant removal was larger in E-17β-treated heifers, the interval to ovulation was more 
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 synchronous in heifers treated with 5 mg EV. The EV treatment presumably caused luteal 
regression prior to progestin implant removal, while E-17β probably did not, so that when 
the norgestomet implant was removed, progestin concentrations fell more rapidly, and the 
suppressive effects of progesterone on LH release was removed earlier in EV-treated 
animals. In addition, the prolonged circulating blood levels of estradiol following the 
administration of 5 mg EV may have stimulated behavioural estrus and induced LH 
release shortly after norgestomet implant removal (Larson and Kiracofe, 1995; Martínez 
et al., 2003a). As synchrony of ovulation is required to achieve high pregnancy rates 
following TAI, cattle with synchronized follicular development and reduced 
concentrations of circulating endogenous progesterone at the time of progestin removal 
may have had more synchronous LH release and ovulation. Although the effects of low 
progestin concentrations on follicle growth and oocyte development have not been 
thoroughly studied, the subsequent high fertility warrants further investigation.  
 
11.5 Other factors that may affect fertility 
 
 It appears that the timing of AI is a compromise, where success in inseminating 
early appears to be limited by sperm life leading to fertilization failure and inseminating 
late is limited by declining oocyte viability and embryonic quality (Saacke et al., 2000). 
Using the HeatWatchTM system to identify onset of estrus, inseminations were performed 
approximately at 2, 12, or 24 hours following the first mount (Dalton et al., 2001) and 
embryos were recovered non-surgically 6 d later. When inseminations were delayed, 
fertilization rate and median number of accessory sperm increased from approximately 
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 66 to 82% and from 0 to 4/ovum, respectively. In contrast, embryo quality declined (78 to 
45%) for inseminations at onset of estrus to those performed 12 or 24 h later. Results 
indicate that AI 12 h after the onset of estrus provides a preferred compromise between 
potential fertilization failure and embryo failure, resulting in higher overall fertility. The 
longer the interval between AI and ovulation, the higher the embryo quality, suggesting 
that length of sperm residence in the female tract provides additional selection for more 
competent sperm. In cattle synchronized with estradiol/progesterone schemes, it is 
recommended that TAI be performed 48 to 52 h after CIDR removal (or 24 to 28 h after 
estradiol treatment). Based on endocrine and ultrasonographic studies conducted in our 
lab, this recommendation needs to be adjusted. Although timing of AI will mainly depend 
on hormone preparation used to synchronize ovulation, preliminary data indicate that 
following the use of a CIDR/EB protocol, TAI at 33 to 36 h yields higher pregnancy rates 
than TAI at 24 h (Whittaker et al., 2002; Colazo et al., 2003a). However, this must be 
confirmed in more comprensive studies. 
 
Accessory sperm trapped in the zona pelucida are believed to reflect the number 
of spermatozoa competing for fertilization (Saacke et al., 1998) and be associated with 
fertility (Hunter and Wilmut, 1984). In addition, the number of accessory sperm and 
fertility have been shown to increase with increasing dosages of either frozen or fresh 
spermatozoa (Nadir et al., 1993). Dalton et al. (2001) also compared fertilization rate and 
accessory sperm per ovum between AI and natural service. Fertilization rate and 
accessory sperm per ovum differed between AI at 12 h after onset of estrus and natural 
service (79 versus 98% and 10 versus 27 sperm/ovum, respectively). Embryo quality was 
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 numerically higher after natural service than AI (approximately 78 versus 61%). 
Although differences in ejaculate volume and sperm survival (fresh versus frozen) may 
explain the higher fertility following natural service, sperm selection may have 
potentially increased the population of more competent sperm. The authors suggested that 
potential benefits would come from more research designed to optimize sperm 
preservation technology or identification of biologically important components of fresh 
semen that would favor the functional life of sperm in vivo. It is important to note that in 
Dalton’s study, bull variation in accessory sperm number was large (median number of 
accessory sperm per ovum for the three bulls was 73, 37 and 2), even though 3 bulls 
considered to be fertile were used for natural service.  
 
Sire variation in fertility may be further magnified when frozen-thawed semen is 
used for TAI. Records for 6012 inseminations of cows were analyzed to determine the 
effect of the stage of estrus at the time of inseminations on conception rates for 3 groups 
of fertile sires (Macmillan and Watson, 1975). When cows were inseminated at the end of 
estrus, average conception rates were 73.3% for 7 sires of above average fertility, 71.3% 
for 5 sires of average fertility, and 68.3% for 6 sires of below average fertility. In 
contrast, when cows were inseminated at onset of estrus, conception rates were 74.3, 
62.7, and 58.4% for the 3 groups of sires, respectively. These differences may be 
exacerbated with TAI, and may not be explainable by conventional sperm viability or 
morphological assessment assays. Hence, new approaches to the examination of bull 
fertility for TAI are needed.  
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 Recently, antiluteolytic strategies to improve fertility in cattle have been reviewed 
(Binelli et al., 2001). Strategies include hormonal and nutritional manipulations to 
decrease plasma concentrations of estradiol while increasing plasma concentrations of 
progesterone, and inhibiting the PGF-synthesizing enzymatic machinery in the 
endometrium during maternal recognition of pregnancy. We attempted to improve 
fertility in heifers submitted to TAI by nutritional manipulation to inhibit the PGF-
synthesizing enzymatic machinery (Chapter 6). Prostaglandin F-2α is synthesized mainly 
from arachidonic acid (omega-6 fatty acid). Thatcher et al. (1994) identified linoleic acid 
(omega-6 fatty acid) as an endometrial PGF synthetase inhibitor. Two other lipids with 
cyclooxygenase-2 (COX-2; enzyme that catalyze the conversion of arachidonic acid to 
PGF) inhibiting activity are eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids 
(Levine and Worth, 1984). Although, most polyunsaturated fatty acids (PUFA) are 
preferentially incorporated in the metabolic pathway of arachidonic acid, linolenic acid 
(omega-3 fatty acid) also leads to EPA synthesis (Bereziat, 1978). Flax seed is a rich 
source of linolenic acid and sunflower seed is rich in linoleic acid (Ambrose and Kastelic, 
2003). It was hypothesized that feeding these two oilseeds would improve pregnancy 
rates in heifers submitted to estrus synchronization and TAI. Results of the experiment 
described in Chapter 6 did not support this hypothesis. There was no significant effect of 
oilseeds on fertility. In contrast, other studies reported increased fertility in lactating dairy 
cows following the addition of either linoleic or linolenic acid to the diet (Staples et al., 
1998; Petit et al., 2001; Ambrose et al., 2002). There may be important differences 
between these studies and our study. Luteolytic mechanism in lactating dairy cows may 
be more sensitive than beef heifers to changes in fatty acids in the diet. As previously 
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 mentioned, processing the oilseeds may have resulted in higher pregnancy rates, or an 
increase in pregnancy rates may be more likely when fertility is low to moderate in the 
control group. We numerically improved pregnancy rate by feeding oilseed, but the 
difference was not statistically significant. The 5% improvement in pregnancy rate was 
mainly in heifers treated with GnRH at TAI or ECP at CIDR removal. Both treatments 
resulted in a statistically lower pregnancy rate than ECP treatment 24 h after CIDR 
removal. Therefore, supplementation of oilseeds in the diet is most likely to increase 
pregnancy rate when other factors are limiting fertility. 
 
 Poor nutritional management of cattle involved in estrus synchronization for TAI 
has been shown to negatively affect fertility. Negative energy balance clearly affects a 
variety of circulating hormones such as growth hormone, insulin like growth factor-I 
(IGF-I), insulin, leptin, cortisol or thyroxine, all of which have been shown to affect 
bovine follicular cell proliferation, or steroidogenesis in vitro (reviewed in Mihm and 
Bleach, 2003). These metabolic hormones may exert their effects on follicles or oocytes 
through gonadotrophin release or directly on the ovary. It is remarkable that FSH-
dependent follicle growth and dominant follicle selection were not perturbed even under 
severe chronic undernutrition (Rhodes et al., 1995). However, an acute nutritional deficit 
influenced growth and estradiol synthesis of preovulatory follicle (Mackey et al., 1999). 
Although these two alterations were more likely to be mediated by insulin or IGF-I, 
others metabolic hormones such as leptin should not be ruled out (Kendall et al., 2004). 
Increased conception rates have been observed following the feeding of a diet which 
results in increased circulating concentrations of insulin in postpartum dairy cows (Gong 
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 et al., 2002), suggesting that metabolic hormones may alter oocyte competence. Other 
important factors that affect fertility in cattle synchronized for TAI are body condition 
score, cyclicity, and body weight in heifers and days post partum in cows (Roche et al., 
1978; reviewed in Rhodes et al., 2003).  
 
11.6 Resynchronization studies 
 
 The rationale for insertion of a previously used CIDR, or of feeding MGA to 
previous TAI animals, was to delay estrus in animals that were not pregnant following 
TAI or may have had early luteolysis. Progestin treatment (starting 13 ± 1 d after TAI) 
synchronized returns to estrus. Compared to untreated control heifers, the range interval 
to estrus following TAI was reduced by 6 and 9 d (see Experiments 1 and 2 in Chapter 9). 
 
Undoubtedly, estrus was delayed in progestin-treated animals. The number of 
heifers showing behavioural estrus reached a peak before Day 20 after TAI in control 
heifers, and after Day 20 in progestin-treated heifers. In Experiment 1 (Chapter 9), the 
pregnancy rate in heifers resynchronized with a used-CIDR tended to be lower than in 
control heifers because estrus and conception rates were numerically lower. Delaying 
estrus in cattle destined to return to estrus before progestin withdrawal could compromise 
fertility through the development of persistent follicles. Persistent follicles develop as a 
result of the higher frequency of LH pulses that have been shown to occur during the 
period of treatment with used-CIDR inserts in animals in which luteolysis has occurred 
(Savio et al., 1993). The greater frequency of LH release or the greater secretion of 
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 estradiol by the persistent follicle probably contributes to the reduced fertility. It has been 
reported that oocytes from persistent follicles were fertilizable but development of the 
resultant zygote usually stopped before the 16-cell stage (Ahmad et al., 1995). Increased 
concentrations of estradiol for an extended interval may also affect the oviductal or 
uterine environment so that embryonic development is compromised. Binelli et al. (1999) 
reported altered pattern of protein synthesis and secretion in the oviducts of cows with 
persistent dominant follicles, suggesting that an inappropriate oviductal environment may 
contribute to the lower fertility. However, when results from other studies are evaluated, 
the most likely cause for reduced fertility of cattle ovulating persistent follicles is 
abnormal oocyte development. Oocytes from persistent follicles were at more advanced 
stages of maturation than those from follicles of normal age and size (Revah and Butler, 
1996; Mihm et al., 1999). Wehrman et al. (1996b) showed that the development of a 
persistent follicle prior to the synchronized estrus did not adversely affect conception rate 
in recipients that received frozen-thawed embryos 7 d after estrus, and this has been 
confirmed in our unpublished studies. In addition, Wehrman et al. (1996a) 
superstimulated normal cycling cattle and those with persistent follicles. Although 
persistent follicles suppressed superovulatory response, embryo quality did not differ 
between groups suggesting that the oviductal and uterine environments in cows with 
persistent follicles are not detrimental to embryonic development. Although the cause of 
abnormal oocyte competence in persistent follicle is currently unknown, as with estrus 
synchronization regimens, persistent follicles must be avoided in resynchronization 
schemes. Hence, treatments to reset the follicle wave were administered in the 
experiments involving resynchronization. 
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  Although estrogens are highly efficacious in synchronizing ovarian follicle 
development, it is recognized that exogenous estrogens can induce luteolysis (Chapter 7). 
In this study (Chapter 9), the administration of 1.5 mg of E-17β and 50 mg of P at CIDR 
insertion did not adversely affect pregnancy rate following TAI, but the administration of 
0.5 mg E-17β 24 h after CIDR removal was associated with a reduction in pregnancy rate 
following TAI. As indicated in the Discussion in Chapter 9, these data are difficult to 
rationalize. These results could be by chance, or luteolysis may have occurred in E-17β-
treated heifers, or the administration of E-17β after CIDR removal may have resulted in 
the reinsemination of pregnant heifers. As only E-17β was used to synchronize LH 
release and ovulation, it is reasonable to conclude that the most likely cause of reduced 
fertility was reinsemination of pregnant heifers. However, only 1 to 4% of heifers 
detected in estrus and reinseminated following TAI were subsequently diagnosed 
pregnant in Experiment 1 and the field trial (Chapter 9). Embryonic or fetal mortality 
following AI of pregnant cattle has been estimated to range from 24 to 49% (Sturman et 
al., 1980; 2000). Based on these previous studies, the proportion of pregnant heifers 
detected in estrus and reinseminated would not have been more than 8% in our study. It is 
noteworthy that animals in Experiment 1 and the Field Trial received only CIDR inserts. 
Treatment with E-17β following progestin removal may have increased the incidence of 
behavioural estrus in pregnant animals.  
 
Regardless of the reason for reduced fertility following TAI in estradiol-treated 
heifers, treatments designed to induce a new ovarian follicular wave in cattle with 
unknown pregnancy status must not disrupt ongoing pregnancies from a previous 
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 insemination. Alternative treatments for the synchronization of follicle wave emergence 
in previously timed inseminated heifers were investigated. Although the administration of 
progesterone or GnRH did not adversely affect pregnancy rate following TAI, neither 
treatment increased estrus or conception rates in nonpregnant cattle. On the contrary, 
administration of 150 mg progesterone not only did not synchronize follicular wave 
emergence effectively, but also resulted in reduced expression of estrus and subsequent 
pregnancy rates to reinsemination. Administration of GnRH to synchronized follicular 
wave emergence was effective in more than 80% of cows without altering estrous cycle 
length. However, GnRH treatment did not increase conception rate in reinseminated 
heifers.  
 
Overall, the proportion of nonpregnant cattle resynchronized with either a used-
CIDR or MGA that showed behavioural estrus approached 80%, regardless of the estrus 
detection method utilized. In only one experiment was there more than 90% of non-
pregnant heifers returning to estrus over an 8-d interval. Failure to detect estrus in heifers 
that were subsequently diagnosed to be nonpregnant could have been due to unobserved 
estrus or embryonic loss (and returning to estrus after the estrus detection had ceased). 
We attempted to increase the proportion of nonpregnant heifers showing behavioural 
estrus by giving estradiol after progestin withdrawal. However, there was no benefit of 
estradiol treatment after the termination of MGA feeding, or at the time of CIDR 
removal. The administration of estradiol tended to increase the percentage of nonpregnant 
animals showing behavioural estrus in some experiments, while it did not in others. 
When treatment with estradiol tended to increase the incidence of behavioural estrus 
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 during the rebreeding period, there was a numerically decreased conception rate, 
resulting in similar pregnancy rates. Therefore, there was little benefit to the use of 
estradiol to increase the expression of behavioural estrus in nonpregnant heifers. 
 
The use of short-term progestins to resynchronize cattle that did not conceive to 
the TAI is an important tool to increase the cumulative pregnancy rates while minimizing 
the amount of time needed for estrus detection. Because CIDR inserts could be re-used in 
estrus synchronization schemes without a detrimental effect on fertility (Chapter 8), we 
investigated the use of an orally active synthetic progestin (MGA), as an alternative to 
CIDRs for the resynchronization of TAI animals. MGA supplementation would be less 
expensive and require less handling of the animals than the reinsertion of used-CIDR. 
However, conception and pregnancy rates in nonpregnant heifers were consistently 
higher in heifers receiving a used-CIDR as compared to those fed MGA for 
resynchronization following TAI.  
 
Synthetic and natural progestins, when administered at the dose used 
commercially for estrus synchronation, do not suppress LH pulse frequency to the extent 
that occurs in cattle during the mid-luteal phase of the estrous cycle (Kojima et al., 1995). 
Although estrus was delayed following the use of either progestin (CIDR and MGA), 
persistent follicles may have developed during the period of treatment. However, the 
reason for the further reduction in fertility that resulted from feeding MGA is unclear. 
Whether MGA treatment directly affects oocyte competence, oviductal or uterine 
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 environment, and subsequent embryo development is unknown and should be addressed 
in future studies.  
 
Although a detailed discussion of economics of protocols for TAI and 
resynchronization is not the purpose of this thesis, it is important to consider economic 
implications before implementing any resynchronization protocol. Based on Experiment 
1 (Chapter 9), treatment with a previously-used CIDR resulted in a synchronous return to 
estrus with 61.7% of the heifers in estrus over 2 d. However, the insertion and withdrawal 
of CIDR takes another 2 d. Alternatively, if estrus detection and AI were limited to 4 d 
(18 to 21 d after TAI) in untreated-control heifers, estrus rate would have been 54.3%. 
However, fertility rates tended to be higher in untreated-control than in CIDR-treated 
heifers, and pregnancy rates would not have been different (40.0 and 38.2%, 
respectively). Therefore, from an economical point of view, estrus resynchronization 
protocols should be implemented only if estrus and conception rates are improved. In this 
regard, although not significant, the inclusion of estradiol treatment at CIDR insertion on 
Day 13 increased the proportion of heifers pregnant by 15% compared to untreated-
control heifers (Experiment 2, Chapter 9). 
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 12.0 GENERAL CONCLUSIONS  
 
12.1 Synchronization studies for timed-AI 
 
1. Administration of 1 mg estradiol cypionate resulted in follicular wave emergence, 
but synchrony was less precise than with 5 mg of estradiol-17β. 
2. Treatment with 0.5 mg estradiol cypionate either at the time of CIDR removal or 
24 h later effectively synchronized the LH surge and ovulation of the dominant 
follicle of a follicular wave synchronized with E-17β. 
3. When estradiol-17β was used to synchronize follicular wave emergence, 
pregnancy rate did not differ in heifers treated either with estradiol cypionate at 0 
or 24 h after CIDR removal or estradiol benzoate at 24 h after CIDR removal. 
4. When GnRH or estradiol cypionate was given to synchronize follicular wave 
emergence, pregnancy rate in heifers treated with estradiol cypionate 24 h after 
CIDR removal was higher than in those treated with estradiol cypionate at CIDR 
removal or GnRH at TAI. 
5. Although the flax seed diet had a significantly greater linolenic acid content than 
the control or sunflower seed diet, a beneficial effect on fertility was not clearly 
demonstrated.  
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 6. Treatment with 5 mg EV resulted in luteolysis in norgestomet-implanted heifers, 
and a shorter interval from norgestomet implant removal to estrus and ovulation 
than treatment with 5 mg of estradiol -17β. 
7. The interval from treatment to follicular wave emergence in heifers was longer 
and more variable following administration of 5 mg of EV than 5 mg of estradiol-
17β. However, ovarian follicular wave emergence and synchrony of estrus and 
ovulation in CIDR-treated cows given 1 or 2 mg EV were similar to those given 5 
mg of estradiol-17β. 
8. The synchronization of follicle wave emergence with 5 mg EV for 
superstimulation in Holstein cows resulted in a lower number of transferable 
embryos than following the administration of 5 mg estradiol-17β. 
9. Fertility following TAI was not different between cattle receiving a new or once-
used CIDR, but pregnancy rate was reduced in cattle receiving a twice-used 
CIDR. 
10. The addition of 100 mg progesterone to the estradiol treatment for the 
synchronization of follicular wave emergence did not affect pregnancy rates, 
regardless of whether a new or used CIDR insert was used. 
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 12.2 Resynchronization studies for estrus detection and AI 
 
1 Progestin treatment starting 13 ± 1 d after TAI resulted in synchronized returns to 
estrus; compared to untreated control heifers, the range in the interval to onset of 
behavioural estrus was reduced by 6 to 9 d. 
2 Fertility was higher in nonpregnant heifers given a used-CIDR than those fed 
MGA for resynchronization following TAI. 
3 Administration of 1.5 mg of E-17β and 50 mg of P at CIDR insertion on Day 13 ± 
1 d after TAI plus 0.5 mg E-17β 24 h after CIDR removal was associated with a 
reduction in pregnancy rate following TAI. 
4 Administration of progesterone, ECP or GnRH to synchronize follicle wave 
emergence in nonpregnant heifers did not adversely affect pregnancy rate 
following TAI; however, only GnRH synchronized follicular wave emergence in 
cows. Although the administration of GnRH 13 ± 1 d after TAI did not alter 
estrous cycle length, it did not result in increased conception rates in 
reinseminated heifers. 
5 Administration of estradiol at progestin removal tended to increase the percentage 
of nonpregnant cattle showing behavioural estrus in some experiments, but it 
resulted in a numerically decreased conception rate, and a similar pregnancy rate 
as untreated control cattle. 
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 13.0 SUGGESTIONS FOR FUTURE RESEARCH  
 
The studies reported in this thesis offer the background for the formulation of new 
hypotheses and the design of future studies for alternatives approaches for estrus 
synchronization and improvement of fertility following TAI.  
 
In a short term, there would be a necessity to develop alternatives for the 
synchronization of follicular wave growth. There are no estradiol preparations on the 
veterinary market in North America at this time, and the European Union has indicated 
that estrogen and progesterone preparations will be removed from the veterinary market 
by 2007. Other estrus synchronization protocols (“Synch” family), which do not include 
the use of steroid hormones, are currently applied in cattle with variable results, 
particularly in heifers. For these reasons, the use of alternative approaches to the 
synchronization of follicular wave emergence, follicle growth and ovulation should be 
addressed in future studies on estrus synchronization for TAI.  
 
 Inhibin-A and other follicular secretions would be interesting candidates that need 
to be evaluated for the synchronization of follicular wave emergence. Steroid-free bovine 
follicular fluid treatment suppressed the peri-ovulatory FSH rise and follicular wave 
emergence in inhibin-immunised heifers (Wood et al., 1993). In addition, it has been 
shown that steroid- or inhibin-depleted follicular fluid can inhibit follicular development 
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 in sheep (Campbell et al., 1991; O’Shea et al., 1994) and cattle (Law et al., 1992). These 
findings suggest that other factors (other than steroids and inhibin) present in follicular 
fluid, may affect gonadotrophin secretory patterns and in turn, follicular dynamics. 
Indeed, several other non-steroidal factors such as the IGF family (Spicer and 
Echternkamp, 1995), Epidermal growth factor (EGF; Rall et al., 1985), Fibroblast growth 
factor (FGF; Gospodarowicz et al., 1987), Gonadotrophin surge-attenuating factor 
(GnSAF; Fowler et al., 2003,), Follistatin (Shimasaki et al., 1988), the Transforming 
growth factor-β superfamily (TGF-β; Knight and Glister, 2003) which includes Activin 
(Vale et al., 1986), Bone morphogenetic proteins (BMP; Shimasaki et al., 1999), and 
Growth differentiation factors (GDF; Eppig, 2001), and emerging new factors such as 
Kisspeptins (Gottsch et al., 2004) have been shown to exist in follicular fluid, 
hypothalamo and pituitary cells . An improved understanding of how these various local 
factors, steroids and gonadotrophin secretions are integrated into a coordinated response 
in terms of follicular development to ovulatory status will improve our ability to control 
follicular growth. 
 
 Ovarian steroid hormones, primarily progesterone, control LH release from the 
anterior pituitary. In cattle, LH secretion is essential to maintain ovarian follicular 
function (i.e. steroidogenesis) during the estrous cycle. Cortisol is a steroid hormone with 
a similar molecular structure as progesterone. Acute increases in defined stress levels of 
cortisol have been shown to rapidly and robustly suppress pulsatile LH secretion in 
ovariectomized ewes (Debus et al., 2002). However, cortisol did not suppress GnRH 
secretion (Breen and Karsch, 2004), indicating that the site of disruption of LH secretion 
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 is at pituitary level. Cortisol might also act at the level of the ovary; glucocorticoid 
receptors have been identified in granulosa cells of the rat (Schreiber et al., 1982). 
Despite all the evidence that elevations in glucocorticoids will inhibit reproductive 
neuroendocrine activity and folliculogenesis in animals through suppression of LH 
release, the use of cortisol to manipulate ovarian follicular development has not been 
studied. Studies are warranted to determine whether elevations in cortisol will interfere 
with the expression of endocrine events and follicular dynamics in cattle. 
 
 Even though the use of androgens to synchronize follicular wave development in 
food animals may be of some concern, testosterone is another candidate that could be 
investigated. In rats, high concentrations of androgens interfered with FSH and estrogen 
mediated events, which are critical for follicle development, and thereby promoted 
follicle atresia (Farookhi, 1980). Testosterone provides the primary negative feedback 
signal controlling LH secretion in bulls (Schanbacher et al., 1983). In Holstein heifers, 
persistent follicles maintained with norgestomet implants regressed following four 
consecutive treatments with 200 mg of testosterone (Rajamahendran and Manikkam, 
1994). Following testosterone injections, heifers had LH profiles that were not different 
from those in control heifers, indicating that testosterone may have caused atresia by 
decreasing basal FSH concentrations or through a direct effect on the persistent dominant 
follicle (Rajamahendran and Manikkam, 1994). The effect of acute treatment with 
testosterone on endocrine parameters and follicular dynamics in cattle has not been 
studied.  
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  Previous studies with ovariectomized cattle have shown that following the 
insertion of a new CIDR, plasma progesterone concentrations were elevated to more than 
6 ng/mL for 48 h before plasma progesterone concentrations stabilized at less than 3.5 
ng/mL (Macmillan and Peterson, 2003; Martínez et al., 2003a) However, when estradiol 
was given at the time of CIDR insertion, estradiol-induced LH release was not blocked, 
even though 100 mg progesterone was injected concurrently with estradiol (Martínez et 
al., 2003a). Furthermore, low plasma progesterone concentrations during an estrus 
synchronization treatment protocol has been associated with reduced fertility, indicating 
that stage of the estrous cycle at initiation of estradiol-progesterone treatment may be an 
important factor. Presynchronization with PGF or progestins before implementing 
estradiol/progesterone-based estrus synchonization schemes for TAI may improve 
pregnancy rates. Further studies are needed to characterize the effect of estradiol and 
progesterone treatments on follicular dynamics and fertility in cattle treated at various 
stages of the estrous cycle.  
 
Pulsatile secretion of GnRH from the hypothalamus is regulated by circulating 
progesterone concentrations during the estrous cycle (Kinder et al., 1996). The frequency 
of GnRH pulses, which is determined by progesterone concentrations, will determine the 
frequency of pulsatile secretion of LH from the anterior pituitary. It is known that long-
term progestin-treated cattle can develop a large dominant follicle with a prolonged 
lifespan, which secretes more estradiol and inhibin. However, it is not clear whether the 
reduction in fertility in cattle with persistent follicle is due to effects of estrogens, LH, or 
both. Although there is evidence that over-exposure of follicles to LH may be detrimental 
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 to oocyte/embryo quality in cattle (Murphy et al., 1984), it is unknown whether acute 
changes in the frequency of LH pulses will affect the developmental competence of 
oocytes in growing follicles. Future studies should be aimed at determining the 
developmental competence of oocytes from follicles that develop under different 
circulating concentrations of progesterone, estradiol and gonadotrophins.  
 
Mechanisms of physiological and pharmacological control of ovulation and their 
relationship with endocrinology, follicular development and the environment need to be 
systematically investigated. The effect of ovulatory follicle size on fertility in estrus 
synchronization programs is been currently investigated. However, studies should be 
designed to evaluate the effect of hormonal treatments and ovulatory follicle size on the 
temporal relationships of estrus, the LH surge, ovulation, oocyte competence, 
fertilization, embryo development, and CL function. Oocytes from preovulatory follicles 
induced by different hormonal treatments may have different developmental capacity due 
to changes in the follicular fluid as a result of changes in levels of circulating hormones. 
Oocyte competence may be also related to the interval from follicular wave emergence to 
luteolysis, or the interval from luteolysis to ovulation, and should be further investigated. 
 
Studies should also be directed to the effect of current hormonal treatment 
protocols to synchronize ovulation on early luteal development. One important 
characteristic of early luteal development is the rapid rate of cell proliferation, primarily 
of endothelial cells, associated with the growth of follicular-derived tissue into a CL. 
Several in vitro studies have shown that early CLs are capable of producing progesterone 
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 levels similar to midcycle CLs, suggesting that the early CL is functionally active. This is 
consistent with the fact that luteinization and CL development are accompanied by 
extensive angiogenensis (Smith et al., 1994), which correlates with an increased rate of 
luteal blood flow and progesterone production. The CL has an extensive capillary 
network and endothelial cells contribute to approximately 45% of the total luteal cell 
composition (Farin et al., 1986). Inhibited development and function of the CL has been 
associated with suppression of luteal angiogenesis. Hence, it is likely that any inadequacy 
in luteal angiogenesis would reduce progesterone production, which in turn could lead to 
reduced fertility. Vascular endothelial growth factor (VEGF) is a potent angiogenic factor 
that has been identified in the CL of many species including cattle (Berisha et al., 2000). 
Human and equine chorionic gonadotrophins (two hormone preparations used in estrus 
synchronization programs in ruminants) have been shown to stimulate the ovarian 
production of VEGF in vitro (Christenson and Stouffer, 1997; Laitinen et al., 1997). 
Whether hormone preparations, used to induce an LH surge and ovulation in estrus 
synchronization programs, would affect luteal angiogenesis has not been investigated.  
 
 Cumulus expansion is one of several processes that must occur in preovulatory 
follicles to enable ovulation and perhaps fertilization (Eppig, 2001). Follicle-stimulating 
hormone has been shown to stimulate the expansion of cumulus cells isolated from mice, 
rats and pigs in vitro (Dekel and Phillips, 1979; Eppig, 1979; Hillensjo and Channing, 
1980). Preovulatory estradiol concentration seems to be related to the preovulatory 
plasma gonadotrophin surge; it has been suggested that GnRH-induced preovulatory 
plasma FSH and LH concentrations are decreased in cows with low plasma estradiol 
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 concentrations but not in cows with high plasma estradiol concentrations (Gilad et al., 
1993). Hence, the secretory pattern of FSH and LH may be important to achieve high 
fertility. The developmental capacity of oocytes collected from the preovulatory follicle 
before and after an endogenous or induced gonadotrophin surge should be addressed in 
future studies.  
 
 Resynchronization protocols presented here synchronized estrus in cattle 
nonpregnant following TAI and facilitated estrus detection and reinsemination. However, 
fertility and particularly the number of open cattle observed in estrus, need to be 
increased. Treatments utilized here did not consistently increase these two reproductive 
parameters; therefore, the use of alternative protocols should be investigated in future 
studies.  
 
 Late embryonic mortality, in particular that occurring between maternal 
recognition of pregnancy and pregnancy diagnosis, reduces the proportion of cattle 
returning to estrus following TAI. However, a means of increasing estrus rate in 
nonpregnant cattle may be to induce luteolysis as early as possible following pregnancy 
diagnosis. Methods of early pregnancy diagnosis (before day 21 after TAI) would allow 
for the administration of exogenous PGF in those animals diagnosed nonpregnant before 
or around the time of endogenous PGF release. Early diagnosis of nonpregnant animals 
would also reduce the number of animals that need to be observed, permitting a more 
assertive and intensive estrus detection. A current alternative is to perform pregnancy 
diagnosis by ultrasonography on Day 26-28 following TAI and treat all nonpregnant 
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 animals with PGF. Administration of GnRH to synchronize follicular wave emergence 
can be given 7 days earlier, providing the possibility of a second TAI. However, a high 
proportion of lactating cows treated with GnRH on Day 21 displayed sign of estrus prior 
to pregnancy diagnosis and TAI (Chebel et al., 2003). Whether the addition of a CIDR 
would affect the proportion of cows that complete the TAI protocol should be 
investigated.  
 
 The knowledge acquired from experiments addressing factors that affect the 
developmental capability of oocytes, oviductal and uterine environment, embryo 
development and CL function after hormonal treatments will provide the means by which 
reproductive function can be controlled or manipulated, and make it possible to explain 
fertility observed in the field. Identification of these factors will provide the means for the 
development of strategies by which pregnancy rates can be optimized in estrus 
synchronization schemes for TAI.  
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